The power of culture

Article Type
Changed
Mon, 04/16/2018 - 13:19
Display Headline
The power of culture

We psychiatrists should take a biopsychosocial approach to assessing our patients. However, we are enamored with biology and individual psychodynamics. Thus, we often overlook the influence of culture, or the lack thereof, on human behavior.

The assertion of Dr. Douglas K. Novins that using foundational cultural beliefs and practices strengthens interventions with people of color is particularly powerful. Furthermore, Dr. Novins’s findings inform us about the importance of culture in the protective factors and risky behaviors of our patients.

 

Dr. Carl C. Bell

Culture Protects

While doing HIV prevention work in Durban, South Africa, I found it striking that 40% of the black African Zulu people were HIV positive, 6% of the white South Africans were HIV positive, but only 1% of the East Indian South Africans were HIV positive.

As it turns out, the East Indian South African culture (with its intact religious rituals, proscribed clothing customs, age-old mating practices, and so on) protected them. Meanwhile, the black African Zulu culture and its protective cultural influence had been stripped from them, making them vulnerable to activities such as risky sexual behavior, substance abuse, and violence.

In addition, it appears that the white South African culture is eroding, which is resulting in higher levels of HIV-positive individuals.

Culture Destroys

The latest Youth Risk Behavior Surveillance data offer a glimpse into just how paradoxical our world has become. The investigators looked at six categories of health-risk behaviors among young people and young adults.

Among their findings: The prevalence of having carried a weapon in general was higher among white males (27.2%) than among their black counterparts (21%). The prevalence of having carried a weapon onto school property was higher among white males (7.8%) than black males (6.7%). The prevalence of having ever used cocaine was higher among white males (7.6%) than black males (4.2%). Yet, people of color make up a higher proportion of children and young adults who are incarcerated. In fact, in 2010, the imprisonment rate for black non-Hispanic males (3,074/100,000 U.S. black male residents) was almost seven times higher than it was for white non-Hispanic males (459/100,000), according to the U.S. Bureau of Justice Statistics.

Some of these disparities can be deconstructed by looking at housing patterns. Structurally, we understand that most mid- and large-size cities have more absolute numbers of low-income whites than low-income blacks. But few low-income white neighborhoods exist because low-income whites have scattered-site housing, while low-income blacks are concentrated in inner cities. Police have a more difficult time finding and incarcerating illegal drug users when they live in scattered-site housing. Therefore, blacks who use illegal drugs are incarcerated more often than whites who use illegal drugs.

We also must acknowledge that some of these disparities are tied to the human construct of race. Buy-in to this construct explains why law enforcement officers traditionally "hunted" runaway slaves and returned them to their owners. It potentially explains the motivations of former Chicago police officer Jon Burge, who was convicted 2 years ago of lying about the torture of innocent black men in order to get confessions over many decades. Finally, this reality explains the thinking behind this saying in Chicago’s black community: "The police hunt black males!"

International psychiatrist Suman Fernando makes the point in his book "Mental Health, Race and Culture: Third Edition" (New York: Palgrave Macmillan, 2010) that much of Western culture is inherently racist. Derald Wing Sue, Ph.D., the preeminent multicultural scholar, reminds us of "ethnocentric monoculturalism," the notion that the only culture in the Western world that has any value is Western culture, and all other cultural values and practices are "primitive." Dr. Sue points out that ethnocentric monoculturalism and whiteness define a reality that puts those who are white European American males at an advantage (American Psychologist 2004;59:761-9).

In Canada, these destructive, entrenched views led to the removal of children from First Nations communities. This cultural dislocation, in turn, led to the loss of cultural protective factors, which ultimately contributed to the engagement in risky behaviors tied to suicide, intragroup homicide, and substance abuse. As I’ve discussed previously, many of the disruptive behaviors that result in incarceration can be traced back to alcohol consumption (Preventing fetal alcohol syndrome, April 12, 2012). It is well known that this syndrome is a leading cause of speech and language disorders, attention-deficit/hyperactivity disorder, and other developmental/cognitive disorders. These are often responsible for affect dysregulation, which leads to disruptive behaviors – which, in turn, can lead to incarceration.

It is heartening to see research like that produced by Dr. Novins and his colleagues. Their work reaffirms that culture protects. It also is a reminder that psychiatrists need to understand the sociological forces that exacerbate the emotional pain suffered by our patients – particularly those who are marginalized. We must redouble our efforts to incorporate respectful cultural components into our interventions. Doing so will produce better outcomes.

 

 

Dr. Bell is president and chief executive officer of Community Mental Health Council Inc. in Chicago. He also serves as director of the Institute for Juvenile Research at the University of Illinois at Chicago, and is director of public health and community psychiatry at the university.

Author and Disclosure Information

 

 

Publications
Topics
Legacy Keywords
psychiatrists, biopsychosocial, assessing, patients, biology, psychodynamics, culture, human behavior, cultural beliefs, protective factors, risky behaviors
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

We psychiatrists should take a biopsychosocial approach to assessing our patients. However, we are enamored with biology and individual psychodynamics. Thus, we often overlook the influence of culture, or the lack thereof, on human behavior.

The assertion of Dr. Douglas K. Novins that using foundational cultural beliefs and practices strengthens interventions with people of color is particularly powerful. Furthermore, Dr. Novins’s findings inform us about the importance of culture in the protective factors and risky behaviors of our patients.

 

Dr. Carl C. Bell

Culture Protects

While doing HIV prevention work in Durban, South Africa, I found it striking that 40% of the black African Zulu people were HIV positive, 6% of the white South Africans were HIV positive, but only 1% of the East Indian South Africans were HIV positive.

As it turns out, the East Indian South African culture (with its intact religious rituals, proscribed clothing customs, age-old mating practices, and so on) protected them. Meanwhile, the black African Zulu culture and its protective cultural influence had been stripped from them, making them vulnerable to activities such as risky sexual behavior, substance abuse, and violence.

In addition, it appears that the white South African culture is eroding, which is resulting in higher levels of HIV-positive individuals.

Culture Destroys

The latest Youth Risk Behavior Surveillance data offer a glimpse into just how paradoxical our world has become. The investigators looked at six categories of health-risk behaviors among young people and young adults.

Among their findings: The prevalence of having carried a weapon in general was higher among white males (27.2%) than among their black counterparts (21%). The prevalence of having carried a weapon onto school property was higher among white males (7.8%) than black males (6.7%). The prevalence of having ever used cocaine was higher among white males (7.6%) than black males (4.2%). Yet, people of color make up a higher proportion of children and young adults who are incarcerated. In fact, in 2010, the imprisonment rate for black non-Hispanic males (3,074/100,000 U.S. black male residents) was almost seven times higher than it was for white non-Hispanic males (459/100,000), according to the U.S. Bureau of Justice Statistics.

Some of these disparities can be deconstructed by looking at housing patterns. Structurally, we understand that most mid- and large-size cities have more absolute numbers of low-income whites than low-income blacks. But few low-income white neighborhoods exist because low-income whites have scattered-site housing, while low-income blacks are concentrated in inner cities. Police have a more difficult time finding and incarcerating illegal drug users when they live in scattered-site housing. Therefore, blacks who use illegal drugs are incarcerated more often than whites who use illegal drugs.

We also must acknowledge that some of these disparities are tied to the human construct of race. Buy-in to this construct explains why law enforcement officers traditionally "hunted" runaway slaves and returned them to their owners. It potentially explains the motivations of former Chicago police officer Jon Burge, who was convicted 2 years ago of lying about the torture of innocent black men in order to get confessions over many decades. Finally, this reality explains the thinking behind this saying in Chicago’s black community: "The police hunt black males!"

International psychiatrist Suman Fernando makes the point in his book "Mental Health, Race and Culture: Third Edition" (New York: Palgrave Macmillan, 2010) that much of Western culture is inherently racist. Derald Wing Sue, Ph.D., the preeminent multicultural scholar, reminds us of "ethnocentric monoculturalism," the notion that the only culture in the Western world that has any value is Western culture, and all other cultural values and practices are "primitive." Dr. Sue points out that ethnocentric monoculturalism and whiteness define a reality that puts those who are white European American males at an advantage (American Psychologist 2004;59:761-9).

In Canada, these destructive, entrenched views led to the removal of children from First Nations communities. This cultural dislocation, in turn, led to the loss of cultural protective factors, which ultimately contributed to the engagement in risky behaviors tied to suicide, intragroup homicide, and substance abuse. As I’ve discussed previously, many of the disruptive behaviors that result in incarceration can be traced back to alcohol consumption (Preventing fetal alcohol syndrome, April 12, 2012). It is well known that this syndrome is a leading cause of speech and language disorders, attention-deficit/hyperactivity disorder, and other developmental/cognitive disorders. These are often responsible for affect dysregulation, which leads to disruptive behaviors – which, in turn, can lead to incarceration.

It is heartening to see research like that produced by Dr. Novins and his colleagues. Their work reaffirms that culture protects. It also is a reminder that psychiatrists need to understand the sociological forces that exacerbate the emotional pain suffered by our patients – particularly those who are marginalized. We must redouble our efforts to incorporate respectful cultural components into our interventions. Doing so will produce better outcomes.

 

 

Dr. Bell is president and chief executive officer of Community Mental Health Council Inc. in Chicago. He also serves as director of the Institute for Juvenile Research at the University of Illinois at Chicago, and is director of public health and community psychiatry at the university.

We psychiatrists should take a biopsychosocial approach to assessing our patients. However, we are enamored with biology and individual psychodynamics. Thus, we often overlook the influence of culture, or the lack thereof, on human behavior.

The assertion of Dr. Douglas K. Novins that using foundational cultural beliefs and practices strengthens interventions with people of color is particularly powerful. Furthermore, Dr. Novins’s findings inform us about the importance of culture in the protective factors and risky behaviors of our patients.

 

Dr. Carl C. Bell

Culture Protects

While doing HIV prevention work in Durban, South Africa, I found it striking that 40% of the black African Zulu people were HIV positive, 6% of the white South Africans were HIV positive, but only 1% of the East Indian South Africans were HIV positive.

As it turns out, the East Indian South African culture (with its intact religious rituals, proscribed clothing customs, age-old mating practices, and so on) protected them. Meanwhile, the black African Zulu culture and its protective cultural influence had been stripped from them, making them vulnerable to activities such as risky sexual behavior, substance abuse, and violence.

In addition, it appears that the white South African culture is eroding, which is resulting in higher levels of HIV-positive individuals.

Culture Destroys

The latest Youth Risk Behavior Surveillance data offer a glimpse into just how paradoxical our world has become. The investigators looked at six categories of health-risk behaviors among young people and young adults.

Among their findings: The prevalence of having carried a weapon in general was higher among white males (27.2%) than among their black counterparts (21%). The prevalence of having carried a weapon onto school property was higher among white males (7.8%) than black males (6.7%). The prevalence of having ever used cocaine was higher among white males (7.6%) than black males (4.2%). Yet, people of color make up a higher proportion of children and young adults who are incarcerated. In fact, in 2010, the imprisonment rate for black non-Hispanic males (3,074/100,000 U.S. black male residents) was almost seven times higher than it was for white non-Hispanic males (459/100,000), according to the U.S. Bureau of Justice Statistics.

Some of these disparities can be deconstructed by looking at housing patterns. Structurally, we understand that most mid- and large-size cities have more absolute numbers of low-income whites than low-income blacks. But few low-income white neighborhoods exist because low-income whites have scattered-site housing, while low-income blacks are concentrated in inner cities. Police have a more difficult time finding and incarcerating illegal drug users when they live in scattered-site housing. Therefore, blacks who use illegal drugs are incarcerated more often than whites who use illegal drugs.

We also must acknowledge that some of these disparities are tied to the human construct of race. Buy-in to this construct explains why law enforcement officers traditionally "hunted" runaway slaves and returned them to their owners. It potentially explains the motivations of former Chicago police officer Jon Burge, who was convicted 2 years ago of lying about the torture of innocent black men in order to get confessions over many decades. Finally, this reality explains the thinking behind this saying in Chicago’s black community: "The police hunt black males!"

International psychiatrist Suman Fernando makes the point in his book "Mental Health, Race and Culture: Third Edition" (New York: Palgrave Macmillan, 2010) that much of Western culture is inherently racist. Derald Wing Sue, Ph.D., the preeminent multicultural scholar, reminds us of "ethnocentric monoculturalism," the notion that the only culture in the Western world that has any value is Western culture, and all other cultural values and practices are "primitive." Dr. Sue points out that ethnocentric monoculturalism and whiteness define a reality that puts those who are white European American males at an advantage (American Psychologist 2004;59:761-9).

In Canada, these destructive, entrenched views led to the removal of children from First Nations communities. This cultural dislocation, in turn, led to the loss of cultural protective factors, which ultimately contributed to the engagement in risky behaviors tied to suicide, intragroup homicide, and substance abuse. As I’ve discussed previously, many of the disruptive behaviors that result in incarceration can be traced back to alcohol consumption (Preventing fetal alcohol syndrome, April 12, 2012). It is well known that this syndrome is a leading cause of speech and language disorders, attention-deficit/hyperactivity disorder, and other developmental/cognitive disorders. These are often responsible for affect dysregulation, which leads to disruptive behaviors – which, in turn, can lead to incarceration.

It is heartening to see research like that produced by Dr. Novins and his colleagues. Their work reaffirms that culture protects. It also is a reminder that psychiatrists need to understand the sociological forces that exacerbate the emotional pain suffered by our patients – particularly those who are marginalized. We must redouble our efforts to incorporate respectful cultural components into our interventions. Doing so will produce better outcomes.

 

 

Dr. Bell is president and chief executive officer of Community Mental Health Council Inc. in Chicago. He also serves as director of the Institute for Juvenile Research at the University of Illinois at Chicago, and is director of public health and community psychiatry at the university.

Publications
Publications
Topics
Article Type
Display Headline
The power of culture
Display Headline
The power of culture
Legacy Keywords
psychiatrists, biopsychosocial, assessing, patients, biology, psychodynamics, culture, human behavior, cultural beliefs, protective factors, risky behaviors
Legacy Keywords
psychiatrists, biopsychosocial, assessing, patients, biology, psychodynamics, culture, human behavior, cultural beliefs, protective factors, risky behaviors
Disallow All Ads

Lab test for multiple gastroenteritis pathogens cleared for use

Article Type
Changed
Fri, 01/18/2019 - 12:27
Display Headline
Lab test for multiple gastroenteritis pathogens cleared for use

A test that can detect multiple causes of infectious gastroenteritis in one stool sample has been cleared for marketing by the Food and Drug Administration.

The xTAG Gastrointestinal Pathogen Panel (GPP), a multiplexed nucleic acid test, is the "first test that can simultaneously detect 11 common viral, bacterial, and parasitic causes of infectious gastroenteritis from a single patient sample," the agency said in a Jan. 14 statement announcing the approval.

Courtesy CDC/Dr. Gilda Jones
The enterotoxin, CPE, is the principal toxin involved in foodborne illness. is a spore-forming bacteria that can be part of the normal intestinal flora in as many as 50% of children under age two.

The xTAG GPP tests for the bacteria Campylobacter, Clostridium difficile toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, Salmonella, Shigella, and Shiga-like toxin-producing E. coli (STEC) stx1/stx2; the viruses norovirus and rotavirus A; and the parasites Cryptosporidium and Giardia lamblia.

This test can help clinicians identify and treat the cause of gastroenteritis in patients more quickly, and "could also allow clinicians and public health professionals to more quickly identify and investigate the source of potential gastroenteritis outbreaks," Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health, said in the statement.

In studies conducted by the manufacturer, Luminex, results of the xTAG GPP were "comparable" with the results of individual tests for the 11 pathogens in stool samples from 1,407 patients with suspected infectious gastroenteritis, 313 samples from pediatric patients with suspected infectious gastroenteritis, and 203 samples from patients with confirmed cases of infectious gastroenteritis, according to the FDA. Because of the risk of false positives, "all positive results from the xTAG GPP need to be confirmed by additional testing," the agency’s announcement said.

The test, which is now available in the United States, can provide multiple results within 5 hours. It is the first and most comprehensive multiplexed product of its kind in the United States, according to a statement from Luminex.

The FDA cites data from the Centers for Disease Control and Prevention reporting that the number of deaths associated with gastroenteritis increased from nearly 7,000 to more than 17,000 per year between 1999 and 2007 in the United States. Two-thirds of the deaths were attributed to norovirus and C. difficile

[email protected]

Author and Disclosure Information

Publications
Topics
Legacy Keywords
xTAG Gastrointestinal Pathogen Panel, GPP, multiplexed nucleic acid test, detect 11 common viral, bacterial, parasitic causes, infectious gastroenteritis, xTAG GPP tests, bacteria Campylobacter, Clostridium difficile toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, Salmonella, Shigella, and Shiga-like toxin-producing E. coli (STEC), the viruses norovirus and rotavirus A, parasites Cryptosporidium and Giardia lamblia, gastroenteritis, Alberto Gutierrez, Ph.D., Office of In Vitro Diagnostics, Luminex,
Author and Disclosure Information

Author and Disclosure Information

A test that can detect multiple causes of infectious gastroenteritis in one stool sample has been cleared for marketing by the Food and Drug Administration.

The xTAG Gastrointestinal Pathogen Panel (GPP), a multiplexed nucleic acid test, is the "first test that can simultaneously detect 11 common viral, bacterial, and parasitic causes of infectious gastroenteritis from a single patient sample," the agency said in a Jan. 14 statement announcing the approval.

Courtesy CDC/Dr. Gilda Jones
The enterotoxin, CPE, is the principal toxin involved in foodborne illness. is a spore-forming bacteria that can be part of the normal intestinal flora in as many as 50% of children under age two.

The xTAG GPP tests for the bacteria Campylobacter, Clostridium difficile toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, Salmonella, Shigella, and Shiga-like toxin-producing E. coli (STEC) stx1/stx2; the viruses norovirus and rotavirus A; and the parasites Cryptosporidium and Giardia lamblia.

This test can help clinicians identify and treat the cause of gastroenteritis in patients more quickly, and "could also allow clinicians and public health professionals to more quickly identify and investigate the source of potential gastroenteritis outbreaks," Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health, said in the statement.

In studies conducted by the manufacturer, Luminex, results of the xTAG GPP were "comparable" with the results of individual tests for the 11 pathogens in stool samples from 1,407 patients with suspected infectious gastroenteritis, 313 samples from pediatric patients with suspected infectious gastroenteritis, and 203 samples from patients with confirmed cases of infectious gastroenteritis, according to the FDA. Because of the risk of false positives, "all positive results from the xTAG GPP need to be confirmed by additional testing," the agency’s announcement said.

The test, which is now available in the United States, can provide multiple results within 5 hours. It is the first and most comprehensive multiplexed product of its kind in the United States, according to a statement from Luminex.

The FDA cites data from the Centers for Disease Control and Prevention reporting that the number of deaths associated with gastroenteritis increased from nearly 7,000 to more than 17,000 per year between 1999 and 2007 in the United States. Two-thirds of the deaths were attributed to norovirus and C. difficile

[email protected]

A test that can detect multiple causes of infectious gastroenteritis in one stool sample has been cleared for marketing by the Food and Drug Administration.

The xTAG Gastrointestinal Pathogen Panel (GPP), a multiplexed nucleic acid test, is the "first test that can simultaneously detect 11 common viral, bacterial, and parasitic causes of infectious gastroenteritis from a single patient sample," the agency said in a Jan. 14 statement announcing the approval.

Courtesy CDC/Dr. Gilda Jones
The enterotoxin, CPE, is the principal toxin involved in foodborne illness. is a spore-forming bacteria that can be part of the normal intestinal flora in as many as 50% of children under age two.

The xTAG GPP tests for the bacteria Campylobacter, Clostridium difficile toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, Salmonella, Shigella, and Shiga-like toxin-producing E. coli (STEC) stx1/stx2; the viruses norovirus and rotavirus A; and the parasites Cryptosporidium and Giardia lamblia.

This test can help clinicians identify and treat the cause of gastroenteritis in patients more quickly, and "could also allow clinicians and public health professionals to more quickly identify and investigate the source of potential gastroenteritis outbreaks," Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health, said in the statement.

In studies conducted by the manufacturer, Luminex, results of the xTAG GPP were "comparable" with the results of individual tests for the 11 pathogens in stool samples from 1,407 patients with suspected infectious gastroenteritis, 313 samples from pediatric patients with suspected infectious gastroenteritis, and 203 samples from patients with confirmed cases of infectious gastroenteritis, according to the FDA. Because of the risk of false positives, "all positive results from the xTAG GPP need to be confirmed by additional testing," the agency’s announcement said.

The test, which is now available in the United States, can provide multiple results within 5 hours. It is the first and most comprehensive multiplexed product of its kind in the United States, according to a statement from Luminex.

The FDA cites data from the Centers for Disease Control and Prevention reporting that the number of deaths associated with gastroenteritis increased from nearly 7,000 to more than 17,000 per year between 1999 and 2007 in the United States. Two-thirds of the deaths were attributed to norovirus and C. difficile

[email protected]

Publications
Publications
Topics
Article Type
Display Headline
Lab test for multiple gastroenteritis pathogens cleared for use
Display Headline
Lab test for multiple gastroenteritis pathogens cleared for use
Legacy Keywords
xTAG Gastrointestinal Pathogen Panel, GPP, multiplexed nucleic acid test, detect 11 common viral, bacterial, parasitic causes, infectious gastroenteritis, xTAG GPP tests, bacteria Campylobacter, Clostridium difficile toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, Salmonella, Shigella, and Shiga-like toxin-producing E. coli (STEC), the viruses norovirus and rotavirus A, parasites Cryptosporidium and Giardia lamblia, gastroenteritis, Alberto Gutierrez, Ph.D., Office of In Vitro Diagnostics, Luminex,
Legacy Keywords
xTAG Gastrointestinal Pathogen Panel, GPP, multiplexed nucleic acid test, detect 11 common viral, bacterial, parasitic causes, infectious gastroenteritis, xTAG GPP tests, bacteria Campylobacter, Clostridium difficile toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, Salmonella, Shigella, and Shiga-like toxin-producing E. coli (STEC), the viruses norovirus and rotavirus A, parasites Cryptosporidium and Giardia lamblia, gastroenteritis, Alberto Gutierrez, Ph.D., Office of In Vitro Diagnostics, Luminex,
Article Source

PURLs Copyright

Inside the Article

TORS: Postop bleeding risk rises with antithrombotic use

Article Type
Changed
Wed, 01/02/2019 - 08:22
Display Headline
TORS: Postop bleeding risk rises with antithrombotic use

The risk of postoperative hemorrhage after transoral robotic-assisted surgery was significantly higher in patients taking antithrombotic medication than in those not taking it, based on data from 147 consecutive patients.

"Even with this small sample size, we were able to identify that increased risk was associated with antithrombotic medication use," said Dr. Scott Asher of the University of Alabama at Birmingham.

Transoral robotic-assisted surgery (TORS) is gaining in popularity among head and neck surgeons, but the potential for postop bleeding in patients taking antithrombotic medication remains a problem, Dr. Asher said at the annual meeting of the American Academy of Otolaryngology – Head and Neck Surgery Foundation.

To assess the postop bleeding complications in TORS patients, Dr. Asher and his colleagues reviewed data from patients seen at a single tertiary academic medical center between March 2007 and September 2011.

Overall, 11 patients (8%) experienced some postop hemorrhage, but 8 of these hemorrhages (72%) occurred in patients taking antithrombotics, Dr. Asher said. Nine patients who hemorrhaged returned to the operating room for further examination and bleeding control, he noted. All postop hemorrhage events were controlled with standard techniques.

The incidence of postop hemorrhage was significantly higher among patients on antithrombotics (17%) compared with those not on antithrombotics (3%). However, no significant difference in the incidence of bleeding occurred between patients undergoing primary surgery and those undergoing salvage surgery (7% vs. 10%). Bleeding occurred an average of 11 days after surgery.

The bleeding events occurred past the time points when most patients would resume their antithrombotic medications, Dr. Asher noted.

"Our recommendation is that patients taking these meds should receive additional preop counseling when considering a TORS procedure," he said.

"A second recommendation is to collaborate preoperatively with the physicians who are prescribing," as well as the anesthesia team, to closely analyze the indications for use of antithrombotics, Dr. Asher added. "If you can safely discontinue them, you can potentially improve your TORS outcomes," he said.

Additional long-term safety and outcomes data are needed for TORS procedures, said Dr. Asher. "We are constantly reflecting on our own experience," he said. "We would encourage other institutions to collect and publish their complications-related data to continue to improve TORS outcomes."

Dr. Asher said he had no relevant financial conflicts.

[email protected]

Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
risk, postoperative hemorrhage, transoral, robotic-assisted surgery, antithrombotic, medication, the University of Alabama at Birmingham, TORS, head and neck surgeons, postop, bleeding the American Academy of Otolaryngology, Head and Neck Surgery Foundation
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event

The risk of postoperative hemorrhage after transoral robotic-assisted surgery was significantly higher in patients taking antithrombotic medication than in those not taking it, based on data from 147 consecutive patients.

"Even with this small sample size, we were able to identify that increased risk was associated with antithrombotic medication use," said Dr. Scott Asher of the University of Alabama at Birmingham.

Transoral robotic-assisted surgery (TORS) is gaining in popularity among head and neck surgeons, but the potential for postop bleeding in patients taking antithrombotic medication remains a problem, Dr. Asher said at the annual meeting of the American Academy of Otolaryngology – Head and Neck Surgery Foundation.

To assess the postop bleeding complications in TORS patients, Dr. Asher and his colleagues reviewed data from patients seen at a single tertiary academic medical center between March 2007 and September 2011.

Overall, 11 patients (8%) experienced some postop hemorrhage, but 8 of these hemorrhages (72%) occurred in patients taking antithrombotics, Dr. Asher said. Nine patients who hemorrhaged returned to the operating room for further examination and bleeding control, he noted. All postop hemorrhage events were controlled with standard techniques.

The incidence of postop hemorrhage was significantly higher among patients on antithrombotics (17%) compared with those not on antithrombotics (3%). However, no significant difference in the incidence of bleeding occurred between patients undergoing primary surgery and those undergoing salvage surgery (7% vs. 10%). Bleeding occurred an average of 11 days after surgery.

The bleeding events occurred past the time points when most patients would resume their antithrombotic medications, Dr. Asher noted.

"Our recommendation is that patients taking these meds should receive additional preop counseling when considering a TORS procedure," he said.

"A second recommendation is to collaborate preoperatively with the physicians who are prescribing," as well as the anesthesia team, to closely analyze the indications for use of antithrombotics, Dr. Asher added. "If you can safely discontinue them, you can potentially improve your TORS outcomes," he said.

Additional long-term safety and outcomes data are needed for TORS procedures, said Dr. Asher. "We are constantly reflecting on our own experience," he said. "We would encourage other institutions to collect and publish their complications-related data to continue to improve TORS outcomes."

Dr. Asher said he had no relevant financial conflicts.

[email protected]

The risk of postoperative hemorrhage after transoral robotic-assisted surgery was significantly higher in patients taking antithrombotic medication than in those not taking it, based on data from 147 consecutive patients.

"Even with this small sample size, we were able to identify that increased risk was associated with antithrombotic medication use," said Dr. Scott Asher of the University of Alabama at Birmingham.

Transoral robotic-assisted surgery (TORS) is gaining in popularity among head and neck surgeons, but the potential for postop bleeding in patients taking antithrombotic medication remains a problem, Dr. Asher said at the annual meeting of the American Academy of Otolaryngology – Head and Neck Surgery Foundation.

To assess the postop bleeding complications in TORS patients, Dr. Asher and his colleagues reviewed data from patients seen at a single tertiary academic medical center between March 2007 and September 2011.

Overall, 11 patients (8%) experienced some postop hemorrhage, but 8 of these hemorrhages (72%) occurred in patients taking antithrombotics, Dr. Asher said. Nine patients who hemorrhaged returned to the operating room for further examination and bleeding control, he noted. All postop hemorrhage events were controlled with standard techniques.

The incidence of postop hemorrhage was significantly higher among patients on antithrombotics (17%) compared with those not on antithrombotics (3%). However, no significant difference in the incidence of bleeding occurred between patients undergoing primary surgery and those undergoing salvage surgery (7% vs. 10%). Bleeding occurred an average of 11 days after surgery.

The bleeding events occurred past the time points when most patients would resume their antithrombotic medications, Dr. Asher noted.

"Our recommendation is that patients taking these meds should receive additional preop counseling when considering a TORS procedure," he said.

"A second recommendation is to collaborate preoperatively with the physicians who are prescribing," as well as the anesthesia team, to closely analyze the indications for use of antithrombotics, Dr. Asher added. "If you can safely discontinue them, you can potentially improve your TORS outcomes," he said.

Additional long-term safety and outcomes data are needed for TORS procedures, said Dr. Asher. "We are constantly reflecting on our own experience," he said. "We would encourage other institutions to collect and publish their complications-related data to continue to improve TORS outcomes."

Dr. Asher said he had no relevant financial conflicts.

[email protected]

Publications
Publications
Topics
Article Type
Display Headline
TORS: Postop bleeding risk rises with antithrombotic use
Display Headline
TORS: Postop bleeding risk rises with antithrombotic use
Legacy Keywords
risk, postoperative hemorrhage, transoral, robotic-assisted surgery, antithrombotic, medication, the University of Alabama at Birmingham, TORS, head and neck surgeons, postop, bleeding the American Academy of Otolaryngology, Head and Neck Surgery Foundation
Legacy Keywords
risk, postoperative hemorrhage, transoral, robotic-assisted surgery, antithrombotic, medication, the University of Alabama at Birmingham, TORS, head and neck surgeons, postop, bleeding the American Academy of Otolaryngology, Head and Neck Surgery Foundation
Article Source

AT THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF OTOLARYNGOLOGY; HEAD AND NECK SURGERY FOUNDATION

PURLs Copyright

Inside the Article

Vitals

Major Finding: Approximately three-quarters of patients (8 of 11) who underwent TORS and experienced some postop bleeding were on an antithrombotic medication.

Data Source: A review of 147 consecutive patients at a single surgery center.

Disclosures: Dr. Asher said he had no relevant financial conflicts.

Statins cut risk of hepatocellular carcinoma

Article Type
Changed
Wed, 05/26/2021 - 14:02
Display Headline
Statins cut risk of hepatocellular carcinoma

Statin therapy taken to prevent cardiovascular events also appears to protect against hepatocellular carcinoma, reducing the overall risk for the cancer by 37%, according to the results of a systematic review and meta-analysis.

In a meta-analysis of all the studies in the literature that have examined statins’ effect on HCC risk, use of the drugs was associated with a pronounced and consistent risk reduction (48%) in Asian populations, as well as a still-significant reduction (33%) in Western populations, reported Dr. Siddharth Singh and his associates at the Mayo Clinic, Rochester, Minn.

Video source: American Gastroenterological Association's YouTube page

At present, "it does not seem prudent to prescribe statins for chemoprevention" of HCC in the general population, mainly because of the high number of people who would need to be treated to prevent a single case of HCC. "However, in patients with multiple risk factors, such as East Asian men who have chronic HBV [hepatitis B virus] infection, statins may have a clinically relevant chemoprotective effect against HCC, the investigators said (Gastroenterology 2012 Oct. 15 [doi: 10.1053/j.gastro.2012.10.005]).

Prospective cohort studies or randomized clinical trials of the issue are warranted in populations at high risk for HCC, they noted.

The results of preclinical studies have suggested that statins may decrease the risk of cancers, perhaps because their antiproliferative, proapoptotic, antiangiogenic, immunomodulatory, and anti-infective effects may prevent cancer growth. But clinical studies have produced conflicting results.

Dr. Singh and his colleagues performed a systematic review of the literature for studies that clearly defined statin exposure, reported HCC risk, and either reported relative risks or odds ratios for the development of HCC or provided the data so those risks could be calculated. They then performed a meta-analysis of 10 studies: 7 observational studies and 3 that reported pooled data from 26 randomized clinical trials.

Most of the studies were considered to be of high quality. Most of them accounted for various potential confounders such as patient age; sex; medication use; and the presence of viral hepatitis, cirrhosis, diabetes, or alcoholic liver disease. The likelihood of selection bias and of publication bias in the included studies was judged to be very low.

Altogether the 10 studies included 1,459,417 subjects and 4,298 cases of HCC.

In an initial analysis of the data, the use of statins was associated with a significant 41% reduction in the rate of HCC. After the data were adjusted to account for several potential confounders, the risk reduction was altered slightly, but a robust 37% reduction in HCC rate remained.

The investigators also performed an analysis of the data based on the location of the studies, because the epidemiology of HCC is so different between Western and Asian populations. They found that statin use correlated with a 48% reduction in the rate of HCC in Asian populations, where viral hepatitis is the primary risk factor for the disease, and a 33% reduction in the rate of HCC in Western populations, where the metabolic syndrome, nonalcoholic fatty liver disease, and alcohol-related cirrhosis are the primary risk factors.

The researchers also performed sensitivity analyses according to the studies’ design (cohort vs. case control) and quality (high vs. low). Both cohort and case-control studies confirmed a protective effect of statins against the development of HCC, as did both high-quality and low-quality studies.

In a final sensitivity analysis, each study was serially excluded from the meta-analysis to determine whether any one study was having a dominant effect on the odds ratios. None of the studies was found to markedly affect the outcomes of the analyses.

The study design didn’t permit separate analyses of the protective effects of statins by drug type or by dose or duration of therapy.

The studies included in this meta-analysis were too heterogeneous to allow the investigators to calculate an overall number needed to treat. But the studies restricted to Asian patients were homogeneous and did allow this calculation for men of Asian ethnicity.

Dr. Singh and his associates determined that 5,209 East Asian men would need to be treated with statins to prevent 1 case of HCC per year. For very-high-risk Asian men with chronic HBV-associated cirrhosis, the number needed to treat with statins to prevent 1 case of HCC per year would be 57.

No financial conflicts of interest were reported.

Click for Credit Link
Author and Disclosure Information

Publications
Topics
Legacy Keywords
hepatocellular carcinoma, statins, HCC, Siddharth Singh, Mayo Clinic
Sections
Click for Credit Link
Click for Credit Link
Author and Disclosure Information

Author and Disclosure Information

Statin therapy taken to prevent cardiovascular events also appears to protect against hepatocellular carcinoma, reducing the overall risk for the cancer by 37%, according to the results of a systematic review and meta-analysis.

In a meta-analysis of all the studies in the literature that have examined statins’ effect on HCC risk, use of the drugs was associated with a pronounced and consistent risk reduction (48%) in Asian populations, as well as a still-significant reduction (33%) in Western populations, reported Dr. Siddharth Singh and his associates at the Mayo Clinic, Rochester, Minn.

Video source: American Gastroenterological Association's YouTube page

At present, "it does not seem prudent to prescribe statins for chemoprevention" of HCC in the general population, mainly because of the high number of people who would need to be treated to prevent a single case of HCC. "However, in patients with multiple risk factors, such as East Asian men who have chronic HBV [hepatitis B virus] infection, statins may have a clinically relevant chemoprotective effect against HCC, the investigators said (Gastroenterology 2012 Oct. 15 [doi: 10.1053/j.gastro.2012.10.005]).

Prospective cohort studies or randomized clinical trials of the issue are warranted in populations at high risk for HCC, they noted.

The results of preclinical studies have suggested that statins may decrease the risk of cancers, perhaps because their antiproliferative, proapoptotic, antiangiogenic, immunomodulatory, and anti-infective effects may prevent cancer growth. But clinical studies have produced conflicting results.

Dr. Singh and his colleagues performed a systematic review of the literature for studies that clearly defined statin exposure, reported HCC risk, and either reported relative risks or odds ratios for the development of HCC or provided the data so those risks could be calculated. They then performed a meta-analysis of 10 studies: 7 observational studies and 3 that reported pooled data from 26 randomized clinical trials.

Most of the studies were considered to be of high quality. Most of them accounted for various potential confounders such as patient age; sex; medication use; and the presence of viral hepatitis, cirrhosis, diabetes, or alcoholic liver disease. The likelihood of selection bias and of publication bias in the included studies was judged to be very low.

Altogether the 10 studies included 1,459,417 subjects and 4,298 cases of HCC.

In an initial analysis of the data, the use of statins was associated with a significant 41% reduction in the rate of HCC. After the data were adjusted to account for several potential confounders, the risk reduction was altered slightly, but a robust 37% reduction in HCC rate remained.

The investigators also performed an analysis of the data based on the location of the studies, because the epidemiology of HCC is so different between Western and Asian populations. They found that statin use correlated with a 48% reduction in the rate of HCC in Asian populations, where viral hepatitis is the primary risk factor for the disease, and a 33% reduction in the rate of HCC in Western populations, where the metabolic syndrome, nonalcoholic fatty liver disease, and alcohol-related cirrhosis are the primary risk factors.

The researchers also performed sensitivity analyses according to the studies’ design (cohort vs. case control) and quality (high vs. low). Both cohort and case-control studies confirmed a protective effect of statins against the development of HCC, as did both high-quality and low-quality studies.

In a final sensitivity analysis, each study was serially excluded from the meta-analysis to determine whether any one study was having a dominant effect on the odds ratios. None of the studies was found to markedly affect the outcomes of the analyses.

The study design didn’t permit separate analyses of the protective effects of statins by drug type or by dose or duration of therapy.

The studies included in this meta-analysis were too heterogeneous to allow the investigators to calculate an overall number needed to treat. But the studies restricted to Asian patients were homogeneous and did allow this calculation for men of Asian ethnicity.

Dr. Singh and his associates determined that 5,209 East Asian men would need to be treated with statins to prevent 1 case of HCC per year. For very-high-risk Asian men with chronic HBV-associated cirrhosis, the number needed to treat with statins to prevent 1 case of HCC per year would be 57.

No financial conflicts of interest were reported.

Statin therapy taken to prevent cardiovascular events also appears to protect against hepatocellular carcinoma, reducing the overall risk for the cancer by 37%, according to the results of a systematic review and meta-analysis.

In a meta-analysis of all the studies in the literature that have examined statins’ effect on HCC risk, use of the drugs was associated with a pronounced and consistent risk reduction (48%) in Asian populations, as well as a still-significant reduction (33%) in Western populations, reported Dr. Siddharth Singh and his associates at the Mayo Clinic, Rochester, Minn.

Video source: American Gastroenterological Association's YouTube page

At present, "it does not seem prudent to prescribe statins for chemoprevention" of HCC in the general population, mainly because of the high number of people who would need to be treated to prevent a single case of HCC. "However, in patients with multiple risk factors, such as East Asian men who have chronic HBV [hepatitis B virus] infection, statins may have a clinically relevant chemoprotective effect against HCC, the investigators said (Gastroenterology 2012 Oct. 15 [doi: 10.1053/j.gastro.2012.10.005]).

Prospective cohort studies or randomized clinical trials of the issue are warranted in populations at high risk for HCC, they noted.

The results of preclinical studies have suggested that statins may decrease the risk of cancers, perhaps because their antiproliferative, proapoptotic, antiangiogenic, immunomodulatory, and anti-infective effects may prevent cancer growth. But clinical studies have produced conflicting results.

Dr. Singh and his colleagues performed a systematic review of the literature for studies that clearly defined statin exposure, reported HCC risk, and either reported relative risks or odds ratios for the development of HCC or provided the data so those risks could be calculated. They then performed a meta-analysis of 10 studies: 7 observational studies and 3 that reported pooled data from 26 randomized clinical trials.

Most of the studies were considered to be of high quality. Most of them accounted for various potential confounders such as patient age; sex; medication use; and the presence of viral hepatitis, cirrhosis, diabetes, or alcoholic liver disease. The likelihood of selection bias and of publication bias in the included studies was judged to be very low.

Altogether the 10 studies included 1,459,417 subjects and 4,298 cases of HCC.

In an initial analysis of the data, the use of statins was associated with a significant 41% reduction in the rate of HCC. After the data were adjusted to account for several potential confounders, the risk reduction was altered slightly, but a robust 37% reduction in HCC rate remained.

The investigators also performed an analysis of the data based on the location of the studies, because the epidemiology of HCC is so different between Western and Asian populations. They found that statin use correlated with a 48% reduction in the rate of HCC in Asian populations, where viral hepatitis is the primary risk factor for the disease, and a 33% reduction in the rate of HCC in Western populations, where the metabolic syndrome, nonalcoholic fatty liver disease, and alcohol-related cirrhosis are the primary risk factors.

The researchers also performed sensitivity analyses according to the studies’ design (cohort vs. case control) and quality (high vs. low). Both cohort and case-control studies confirmed a protective effect of statins against the development of HCC, as did both high-quality and low-quality studies.

In a final sensitivity analysis, each study was serially excluded from the meta-analysis to determine whether any one study was having a dominant effect on the odds ratios. None of the studies was found to markedly affect the outcomes of the analyses.

The study design didn’t permit separate analyses of the protective effects of statins by drug type or by dose or duration of therapy.

The studies included in this meta-analysis were too heterogeneous to allow the investigators to calculate an overall number needed to treat. But the studies restricted to Asian patients were homogeneous and did allow this calculation for men of Asian ethnicity.

Dr. Singh and his associates determined that 5,209 East Asian men would need to be treated with statins to prevent 1 case of HCC per year. For very-high-risk Asian men with chronic HBV-associated cirrhosis, the number needed to treat with statins to prevent 1 case of HCC per year would be 57.

No financial conflicts of interest were reported.

Publications
Publications
Topics
Article Type
Display Headline
Statins cut risk of hepatocellular carcinoma
Display Headline
Statins cut risk of hepatocellular carcinoma
Legacy Keywords
hepatocellular carcinoma, statins, HCC, Siddharth Singh, Mayo Clinic
Legacy Keywords
hepatocellular carcinoma, statins, HCC, Siddharth Singh, Mayo Clinic
Sections
Article Source

FROM GASTROENTEROLOGY

PURLs Copyright

Inside the Article

Vitals

Major Finding: Statin therapy reduced the risk of developing hepatocellular carcinoma by 37% overall; the risk reduction was stronger (48%) in Asian populations but still significant (33%) in Western populations.

Data Source: A systematic review and meta-analysis of 10 observational studies or randomized clinical trials involving 1,459,417 subjects, of whom 4,298 developed HCC during follow-up.

Disclosures: No financial conflicts of interest were reported.

Case of the Month

Article Type
Changed
Fri, 01/11/2019 - 18:22
Display Headline
Case of the Month

A 56-year-old Hispanic female with a past medical history significant for basal cell carcinoma presented with a history of itchy, erythematous papules on her right cheek. Four days prior, she presented for suture removal after reconstruction with an island pedicle flap following Mohs micrographic surgery. She experienced a similar rash on her forearm following another surgery in the past.

a) Cellulitis

b) Contact dermatitis

c) Herpes simplex virus

Diagnosis: Contact dermatitis secondary to Mastisol and Steri-Strips

Courtesy Dr. Keyvan Nouri
The patient had a history of basal cell carcinoma, and presented with itchy, erythematous papules on her cheek.

Contact dermatitis is a localized, pruritic, erythematous rash that occurs after contact with a certain allergen or irritant. The disorder is typically classified as either allergic contact dermatitis or irritant contact dermatitis.

Allergic contact dermatitis is a T cell–mediated, type-IV, delayed-type hypersensitivity reaction that requires prior sensitization with the causative agent before the patient becomes allergic to it. The typical rash of pruritus, erythema, edema, and vesicle formation occurs with further exposures.

The mechanism of immune response to a particular allergen requires that the antigen be of low molecular weight (less than 500 d) in order to penetrate the stratum corneum and gain access to the immunologic system. CD4, CD8, T regulatory cells, and natural killer T cells have all been implicated.

The process is composed of an afferent (sensitization) phase and an efferent (elicitation) phase.

Common haptens or immunogenic agents include nickel, urushiol from poison ivy resin, ultraviolet light, dyes, and fragrances.

This patient revealed a history of a similar reaction to the one presented in this case following wound dressing on her forearm with two products: Steri-Strips and Mastisol liquid adhesive. Unfortunately, she did not reveal this history until she had experienced the reaction a second time. The patient was instructed to apply hydrocortisone 1% cream twice daily to the red areas only and to follow up with a clinic visit in 4-5 days. Documentation of her allergy was included in her medical record.

This case was submitted by Dr. Keyvan Nouri; Dr. Katlein Franca; Jennifer Ledon; and Jessica Savas of the University of Miami.

–Donna Bilu Martin, M.D.

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

A 56-year-old Hispanic female with a past medical history significant for basal cell carcinoma presented with a history of itchy, erythematous papules on her right cheek. Four days prior, she presented for suture removal after reconstruction with an island pedicle flap following Mohs micrographic surgery. She experienced a similar rash on her forearm following another surgery in the past.

a) Cellulitis

b) Contact dermatitis

c) Herpes simplex virus

Diagnosis: Contact dermatitis secondary to Mastisol and Steri-Strips

Courtesy Dr. Keyvan Nouri
The patient had a history of basal cell carcinoma, and presented with itchy, erythematous papules on her cheek.

Contact dermatitis is a localized, pruritic, erythematous rash that occurs after contact with a certain allergen or irritant. The disorder is typically classified as either allergic contact dermatitis or irritant contact dermatitis.

Allergic contact dermatitis is a T cell–mediated, type-IV, delayed-type hypersensitivity reaction that requires prior sensitization with the causative agent before the patient becomes allergic to it. The typical rash of pruritus, erythema, edema, and vesicle formation occurs with further exposures.

The mechanism of immune response to a particular allergen requires that the antigen be of low molecular weight (less than 500 d) in order to penetrate the stratum corneum and gain access to the immunologic system. CD4, CD8, T regulatory cells, and natural killer T cells have all been implicated.

The process is composed of an afferent (sensitization) phase and an efferent (elicitation) phase.

Common haptens or immunogenic agents include nickel, urushiol from poison ivy resin, ultraviolet light, dyes, and fragrances.

This patient revealed a history of a similar reaction to the one presented in this case following wound dressing on her forearm with two products: Steri-Strips and Mastisol liquid adhesive. Unfortunately, she did not reveal this history until she had experienced the reaction a second time. The patient was instructed to apply hydrocortisone 1% cream twice daily to the red areas only and to follow up with a clinic visit in 4-5 days. Documentation of her allergy was included in her medical record.

This case was submitted by Dr. Keyvan Nouri; Dr. Katlein Franca; Jennifer Ledon; and Jessica Savas of the University of Miami.

–Donna Bilu Martin, M.D.

A 56-year-old Hispanic female with a past medical history significant for basal cell carcinoma presented with a history of itchy, erythematous papules on her right cheek. Four days prior, she presented for suture removal after reconstruction with an island pedicle flap following Mohs micrographic surgery. She experienced a similar rash on her forearm following another surgery in the past.

a) Cellulitis

b) Contact dermatitis

c) Herpes simplex virus

Diagnosis: Contact dermatitis secondary to Mastisol and Steri-Strips

Courtesy Dr. Keyvan Nouri
The patient had a history of basal cell carcinoma, and presented with itchy, erythematous papules on her cheek.

Contact dermatitis is a localized, pruritic, erythematous rash that occurs after contact with a certain allergen or irritant. The disorder is typically classified as either allergic contact dermatitis or irritant contact dermatitis.

Allergic contact dermatitis is a T cell–mediated, type-IV, delayed-type hypersensitivity reaction that requires prior sensitization with the causative agent before the patient becomes allergic to it. The typical rash of pruritus, erythema, edema, and vesicle formation occurs with further exposures.

The mechanism of immune response to a particular allergen requires that the antigen be of low molecular weight (less than 500 d) in order to penetrate the stratum corneum and gain access to the immunologic system. CD4, CD8, T regulatory cells, and natural killer T cells have all been implicated.

The process is composed of an afferent (sensitization) phase and an efferent (elicitation) phase.

Common haptens or immunogenic agents include nickel, urushiol from poison ivy resin, ultraviolet light, dyes, and fragrances.

This patient revealed a history of a similar reaction to the one presented in this case following wound dressing on her forearm with two products: Steri-Strips and Mastisol liquid adhesive. Unfortunately, she did not reveal this history until she had experienced the reaction a second time. The patient was instructed to apply hydrocortisone 1% cream twice daily to the red areas only and to follow up with a clinic visit in 4-5 days. Documentation of her allergy was included in her medical record.

This case was submitted by Dr. Keyvan Nouri; Dr. Katlein Franca; Jennifer Ledon; and Jessica Savas of the University of Miami.

–Donna Bilu Martin, M.D.

Publications
Publications
Article Type
Display Headline
Case of the Month
Display Headline
Case of the Month
Sections
Article Source

PURLs Copyright

Inside the Article

FDA approves plasma product

Article Type
Changed
Fri, 01/18/2013 - 06:00
Display Headline
FDA approves plasma product

Plasma for donation

The FDA has approved a pooled plasma blood product (Octaplas) that can be used to replace coagulation factors in patients with certain medical conditions.

The product is a sterile, frozen solution of human plasma from several donors that has been treated with a solvent detergent process to minimize the risk of serious virus transmission.

The plasma used to manufacture Octaplas is collected from US donors who have been screened and tested for diseases transmitted by blood.

“For patients suffering with clotting disorders, this product provides a viable alternative to single-donor fresh-frozen plasma [FFP] and provides a reduced risk of certain viral transmissions,” said Karen Midthun, MD, director of the FDA’s Center for Biologics Evaluation and Research.

Indications and administration

Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease or undergoing cardiac surgery or liver transplant. Octaplas can also be

used for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

Like FFP, Octaplas should be matched to the recipient’s blood group to help avoid transfusion reactions. Each lot of Octaplas is tested for composition of key clotting factors and is only released if the levels are within acceptable ranges.

The product is administered by intravenous infusion after thawing, using an infusion set with a filter. An aseptic technique must be used throughout the infusion.

The dosage depends upon the clinical situation and the underlying disorder. But 12-15 mL/kg of body weight is a generally accepted starting dose, and it should increase the patient’s plasma coagulation factor levels by about 25%.

It is important to monitor patient response, both clinically and with measurement of prothrombin time, partial thromboplastin time, and/or specific coagulation factor assays.

Prior experience with Octaplas

The FDA’s approval of Octaplas was primarily based on studies conducted in patients with liver disease, liver transplant, heart surgery, and TTP. The most common adverse reactions observed in these trials were shortness of breath, dizziness, chest discomfort, pruritis/rash, headache, and paresthesia.

Additional data supporting the safe use of Octaplas for the US market came from prior use of the product in Europe and other approved markets, where it has been used extensively.

A previous generation of Octaplas was first marketed in 1992, and the current version has been marketed since 2006. In total, more than 2 million patients outside the US have been treated with more than 7 million doses of Octaplas.

The product is manufactured by Octapharma, located in Vienna, Austria. For more information on Octaplas, visit the Octapharma website.

Publications
Topics

Plasma for donation

The FDA has approved a pooled plasma blood product (Octaplas) that can be used to replace coagulation factors in patients with certain medical conditions.

The product is a sterile, frozen solution of human plasma from several donors that has been treated with a solvent detergent process to minimize the risk of serious virus transmission.

The plasma used to manufacture Octaplas is collected from US donors who have been screened and tested for diseases transmitted by blood.

“For patients suffering with clotting disorders, this product provides a viable alternative to single-donor fresh-frozen plasma [FFP] and provides a reduced risk of certain viral transmissions,” said Karen Midthun, MD, director of the FDA’s Center for Biologics Evaluation and Research.

Indications and administration

Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease or undergoing cardiac surgery or liver transplant. Octaplas can also be

used for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

Like FFP, Octaplas should be matched to the recipient’s blood group to help avoid transfusion reactions. Each lot of Octaplas is tested for composition of key clotting factors and is only released if the levels are within acceptable ranges.

The product is administered by intravenous infusion after thawing, using an infusion set with a filter. An aseptic technique must be used throughout the infusion.

The dosage depends upon the clinical situation and the underlying disorder. But 12-15 mL/kg of body weight is a generally accepted starting dose, and it should increase the patient’s plasma coagulation factor levels by about 25%.

It is important to monitor patient response, both clinically and with measurement of prothrombin time, partial thromboplastin time, and/or specific coagulation factor assays.

Prior experience with Octaplas

The FDA’s approval of Octaplas was primarily based on studies conducted in patients with liver disease, liver transplant, heart surgery, and TTP. The most common adverse reactions observed in these trials were shortness of breath, dizziness, chest discomfort, pruritis/rash, headache, and paresthesia.

Additional data supporting the safe use of Octaplas for the US market came from prior use of the product in Europe and other approved markets, where it has been used extensively.

A previous generation of Octaplas was first marketed in 1992, and the current version has been marketed since 2006. In total, more than 2 million patients outside the US have been treated with more than 7 million doses of Octaplas.

The product is manufactured by Octapharma, located in Vienna, Austria. For more information on Octaplas, visit the Octapharma website.

Plasma for donation

The FDA has approved a pooled plasma blood product (Octaplas) that can be used to replace coagulation factors in patients with certain medical conditions.

The product is a sterile, frozen solution of human plasma from several donors that has been treated with a solvent detergent process to minimize the risk of serious virus transmission.

The plasma used to manufacture Octaplas is collected from US donors who have been screened and tested for diseases transmitted by blood.

“For patients suffering with clotting disorders, this product provides a viable alternative to single-donor fresh-frozen plasma [FFP] and provides a reduced risk of certain viral transmissions,” said Karen Midthun, MD, director of the FDA’s Center for Biologics Evaluation and Research.

Indications and administration

Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease or undergoing cardiac surgery or liver transplant. Octaplas can also be

used for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

Like FFP, Octaplas should be matched to the recipient’s blood group to help avoid transfusion reactions. Each lot of Octaplas is tested for composition of key clotting factors and is only released if the levels are within acceptable ranges.

The product is administered by intravenous infusion after thawing, using an infusion set with a filter. An aseptic technique must be used throughout the infusion.

The dosage depends upon the clinical situation and the underlying disorder. But 12-15 mL/kg of body weight is a generally accepted starting dose, and it should increase the patient’s plasma coagulation factor levels by about 25%.

It is important to monitor patient response, both clinically and with measurement of prothrombin time, partial thromboplastin time, and/or specific coagulation factor assays.

Prior experience with Octaplas

The FDA’s approval of Octaplas was primarily based on studies conducted in patients with liver disease, liver transplant, heart surgery, and TTP. The most common adverse reactions observed in these trials were shortness of breath, dizziness, chest discomfort, pruritis/rash, headache, and paresthesia.

Additional data supporting the safe use of Octaplas for the US market came from prior use of the product in Europe and other approved markets, where it has been used extensively.

A previous generation of Octaplas was first marketed in 1992, and the current version has been marketed since 2006. In total, more than 2 million patients outside the US have been treated with more than 7 million doses of Octaplas.

The product is manufactured by Octapharma, located in Vienna, Austria. For more information on Octaplas, visit the Octapharma website.

Publications
Publications
Topics
Article Type
Display Headline
FDA approves plasma product
Display Headline
FDA approves plasma product
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica

Academic Hospitalist Balanced Scorecard

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Development and implementation of a balanced scorecard in an academic hospitalist group

The field of hospital medicine, now the fastest growing specialty in medical history,[1] was born out of pressure to improve the efficiency and quality of clinical care in US hospitals.[2] Delivering safe and high‐value clinical care is a central goal of the field and has been an essential component of its growth and success.

The clinical demands on academic hospitalists have grown recently, fueled by the need to staff services previously covered by housestaff, whose hours are now restricted. Despite these new demands, expectations have grown in other arenas as well. Academic hospitalist groups (AHGs) are often expected to make significant contributions in quality improvement, patient safety, education, research, and administration. With broad expectations beyond clinical care, AHGs face unique challenges. Groups that focus mainly on providing coverage and improving clinical performance may find that they are unable to fully contribute in these other domains. To be successful, AHGs must develop strategies that balance their energies, resources, and performance.

The balanced scorecard (BSC) was introduced by Kaplan and Norton in 1992 to allow corporations to view their performance broadly, rather than narrowly focusing on financial measures. The BSC requires organizations to develop a balanced portfolio of performance metrics across 4 key perspectives: financial, customers, internal processes, and learning and growth. Metrics within these perspectives should help answer fundamental questions about the organization (Table 1).[3] Over time, the BSC evolved from a performance measurement tool to a strategic management system.[4] Successful organizations translate their mission and vision to specific strategic objectives in each of the 4 perspectives, delineate how these objectives will help the organization reach its vision with a strategy map,[5] and then utilize the BSC to track and monitor performance to ensure that the vision is achieved.[6]

BSC Perspectives and the Questions That They Answer About the Organization: Traditional and Revised for AHCs
BSC Perspective Traditional Questions[3] Questions Revised for AHCs
  • NOTE: Adapted with permission from Zelman, et al. Academic Medicine. 1999; vol 74. Wolters Kluwer Health. [11] Abbreviations: AHCs, academic health centers; BSC, balanced scorecard.

Financial How do we look to our shareholders? What financial condition must we be in to allow us to accomplish our mission?
Customers How do customers see us? How do we ensure that our services and products add the level of value desired by our stakeholders?
Internal processes What must we excel at? How do we produce our products and services to add maximum value for our customers and stakeholders?
Learning and growth How can we continue to improve and create value? How do we ensure that we change and improve in order to achieve our vision?

Although originally conceived for businesses, the BSC has found its way into the healthcare industry, with reports of successful implementation in organizations ranging from individual departments to research collaboratives[7] to national healthcare systems.[8] However, there are few reports of BSC implementation in academic health centers.[9, 10] Because most academic centers are not‐for‐profit, Zelman suggests that the 4 BSC perspectives be modified to better fit their unique characteristics (Table 1).[11] To the best of our knowledge, there is no literature describing the development of a BSC in an academic hospitalist group. In this article, we describe the development of, and early experiences with, an academic hospital medicine BSC developed as part of a strategic planning initiative.

METHODS

The University of California, San Francisco (UCSF) Division of Hospital Medicine (DHM) was established in 2005. Currently, there are more than 50 faculty members, having doubled in the last 4 years. In addition to staffing several housestaff and nonhousestaff clinical services, faculty are involved in a wide variety of nonclinical endeavors at local and national levels. They participate and lead initiatives in education, faculty development, patient safety, care efficiency, quality improvement, information technology, and global health. There is an active research enterprise that generates nearly $5 million in grant funding annually.

Needs Assessment

During a division retreat in 2009, faculty identified several areas in need of improvement, including: clinical care processes, educational promotion, faculty development, and work‐life balance. Based on these needs, divisional mission and vision statements were created (Table 2).

UCSF DHM Mission and Vision Statements
  • NOTE: Abbreviations: DHM, Division of Hospital Medicine; UCSF, University of California, San Francisco.

Our mission: to provide the highest quality clinical care, education, research, and innovation in academic hospital medicine.
Our vision: to be the best division of hospital medicine by promoting excellence, integrity, innovation, and professional satisfaction among our faculty, trainees, and staff.

Division leadership made it a priority to create a strategic plan to address these wide‐ranging issues. To accomplish this, we recognized the need to develop a formal way of translating our vision into specific and measurable objectives, establish systems of performance measurement, improve accountability, and effectively communicate these strategic goals to the group. Based on these needs, we set out to develop a divisional BSC.

Development

At the time of BSC development, the DHM was organized into 4 functional areas: quality and safety, education, faculty development, and academics and research. A task force was formed, comprised of 8 senior faculty representing these key areas. The mission and vision statements were used as the foundation for the development of division goals and objectives. The group was careful to choose objectives within each of the 4 BSC perspectives for academic centers, as defined by Zelman (Table 1). The taskforce then brainstormed specific metrics that would track performance within the 4 functional areas. The only stipulation during this process was that the metrics had to meet the following criteria:

  1. Important to the division and to the individual faculty members
  2. Measurable through either current or developed processes
  3. Data are valid and their validity trusted by the faculty members
  4. Amenable to improvement by faculty (ie, through their individual action they could impact the metric)

From the subsequent list of metrics, we used a modified Delphi method to rank‐order them by importance to arrive at our final set of metrics. Kaplan and Norton noted that focusing on a manageable number of metrics (ie, a handful in each BSC perspective) is important for an achievable strategic vision.[6] With the metrics chosen, we identified data sources or developed new systems to collect data for which there was no current source. We assigned individuals responsible for collecting and analyzing the data, identified local or national benchmarks, if available, and established performance targets for the coming year, when possible.

The BSC is updated quarterly, and results are presented to the division during a noon meeting and posted on the division website. Metrics are re‐evaluated on a yearly basis. They are continued, modified, or discarded depending on performance and/or changes in strategic priorities.

The initial BSC focused on division‐wide metrics and performance. Early efforts to develop the scorecard were framed as experimental, with no clear decision taken regarding how metrics might ultimately be used to improve performance (ie, how public to make both individual and group results, whether to tie bonus payments to performance).

RESULTS

There were 41 initial metrics considered by the division BSC task force (Table 3). Of these, 16 were chosen for the initial BSC through the modified Delphi method. Over the past 2 years, these initial metrics have been modified to reflect current strategic goals and objectives. Figure 1 illustrates the BSC for fiscal year (FY) 2012. An online version of this, complete with graphical representations of the data and metric definitions, can be found at http://hospitalmedicine.ucsf.edu/bsc/fy2012.html. Our strategy map (Figure 2) demonstrates how these metrics are interconnected across the 4 BSC perspectives and how they fit into our overall strategic plan.

Figure 1
Division of Hospital Medicine balance scorecard FY 2012. Green shading signifies at or above target; pink shading signifies below target. Abbreviations: CY, calendar year; FY, fiscal year, NA, not available; Q, quarter.
Figure 2
Division of Hospital Medicine strategy map. Arrows denote relationships between objectives spanning the 4 balanced scorecard perspectives. Abbreviations: HCAHPS, Hospital Consumer Assessment of Healthcare Providers and Systems; PCP, primary care physician.
Brainstormed Competencies Across the Four DHM Functional Areas
Quality, Safety, and Operations Education Academics and Research Faculty Development
  • NOTE: Abbreviations: CME, continuing medical education; DHM, Division of Hospital Medicine; ICU, intensive care unit.

Appropriate level of care CME courses taught Abstracts accepted Attendance and participation
Billing and documentation Curriculum development Academic reputation Being an agent of change
Clinical efficiency Student/housestaff feedback Grant funding Division citizenship
Clinical professionalism Mentoring Mentorship Job satisfaction
Communication Quality of teaching rounds Papers published Mentorship
Core measures performance Participation in national organizations Committees and task forces
Practice evidence‐based medicine
Fund of knowledge
Guideline adherence
Unplanned transfers to ICU
Implementation and initiation of projects
Length of stay
Medical errors
Mortality
Multidisciplinary approach to patient care
Multisource feedback evaluations
Never events
Patient‐centered care
Patient satisfaction
Practice‐based learning
Procedures
Readmissions
Reputation and expertise
Seeing patient on the day of admission
Quality of transfers of care

DISCUSSION

Like many hospitalist groups, our division has experienced tremendous growth, both in our numbers and the breadth of roles that we fill. With this growth has come increasing expectations in multiple domains, competing priorities, and limited resources. We successfully developed a BSC as a tool to help our division reach its vision: balancing high quality clinical care, education, academics, and faculty development while maintaining a strong sense of community. We have found that the BSC has helped us meet several key goals.

The first goal was to allow for a broad view of our performance. This is the BSC's most basic function, and we saw immediate and tangible benefits. The scorecard provided a broad snapshot of our performance in a single place. For example, in the clinical domain, we saw that our direct cost per case was increasing despite our adjusted average length of stay remaining stable from FY2010‐FY2011. In academics and research, we saw that the number of abstracts accepted at national meetings increased by almost 30% in FY2011 (Figure 1).

The second goal was to create transparency and accountability. By measuring performance and displaying it on the division Web site, the BSC has promoted transparency. If performance does not meet our targets, the division as a whole becomes accountable. Leadership must understand why performance fell short and initiate changes to improve it. For instance, the rising direct cost per case has spurred the development of a high‐value care committee tasked with finding ways of reducing cost while providing high‐quality care.[12]

The third goal was to communicate goals and engage our faculty. As our division has grown, ensuring a shared vision among our entire faculty became an increasing challenge. The BSC functions as a communication platform between leadership and faculty, and yielded multiple benefits. As the metrics were born out of our mission and vision, the BSC has become a tangible representation of our core values. Moreover, individual faculty can see that they are part of a greater, high‐performing organization and realize they can impact the group's performance through their individual effort. For example, this has helped promote receptivity to carefully disseminated individual performance measures for billing and documentation, and patient satisfaction, in conjunction with faculty development in these areas.

The fourth goal was to ensure that we use data to guide strategic decisions. We felt that strategic decisions needed to be based on objective, rather than perceived or anecdotal, information. This meant translating our vision into measurable objectives that would drive performance improvement. For example, before the BSC, we were committed to the dissemination of our research and innovations. Yet, we quickly realized that we did not have a system to collect even basic data on academic performancea deficit we filled by leveraging information gathered from online databases and faculty curricula vitae. These data allowed us, for the first time, to objectively reflect on this as a strategic goal and to have an ongoing mechanism to monitor academic productivity.

Lessons Learned/Keys to Success

With our initial experience, we have gained insight that may be helpful to other AHGs considering implementing a BSC. First, and most importantly, AHGs should take the necessary time to build consensus and buy‐in. Particularly in areas where data are analyzed for the first time, faculty are often wary about the validity of the data or the purpose and utility of performance measurement. Faculty may be concerned about how collection of performance data could affect promotion or create a hostile and competitive work environment.

This concern grows when one moves from division‐wide to individual data. It is inevitable that the collection and dissemination of performance data will create some level of discomfort among faculty members, which can be a force for improvement or for angst. These issues should be anticipated, discussed, and actively managed. It is critical to be transparent with how data will be used. We have made clear that the transition from group to individual performance data, and from simple transparency to incentives, will be done thoughtfully and with tremendous input from our faculty. This tension can also be mitigated by choosing metrics that are internally driven, rather than determined by external groups (ie, following the principle that the measures should be important to the division and individual faculty members).

Next, the process of developing a mature BSC takes time. Much of our first year was spent developing systems for measurement, collecting data, and determining appropriate comparators and targets. The data in the first BSC functioned mainly as a baseline marker of performance. Some metrics, particularly in education and academics, had no national or local benchmarks. In these cases we identified comparable groups (such as other medical teaching services or other well‐established AHGs) or merely used our prior year's performance as a benchmark. Also, some of our metrics did not initially have performance targets. In most instances, this was because this was the first time that we looked at these data, and it was unclear what an appropriate target would be until more data became available.

Moving into our third year, we are seeing a natural evolution in the BSC's use. Some metrics that were initially chosen have been replaced or modified to reflect changing goals and priorities. Functional directors participate in choosing and developing performance metrics in their area. Previously, there was no formal structure for these groups to develop and measure strategic objectives and be accountable for performance improvement. They are now expected to define goals with measurable outcomes, to report progress to division leadership, and to develop their own scorecard to track performance. Each group chooses 2 to 4 metrics within their domain that are the most important for the division to improve on, which are then included in the division BSC.

We have also made efforts to build synergy between our BSC and performance goals set by external groups. Although continuing to favor metrics that are internally driven and meaningful to our faculty, we recognize that our goals must also reflect the needs and interests of broader stakeholders. For example, hand hygiene rates and patient satisfaction scores are UCSF medical center and divisional priorities (the former includes them in a financial incentive system for managers, staff, and many physicians) and are incorporated into the BSC as division‐wide incentive metrics.

Limitations

Our project has several limitations. It was conducted at a single institution, and our metrics may not be generalizable to other groups. However, the main goal of this article was not to focus on specific metrics but the process that we undertook to choose and develop them. Other institutions will likely identify different metrics based on their specific strategic objectives. We are also early in our experience with the BSC, and it is still not clear what effect it will have on the desired outcomes for our objectives. However, Henriksen recently reported that implementing a BSC at a large academic health center, in parallel with other performance improvement initiatives, resulted in substantial improvement in their chosen performance metrics.[13]

Despite the several years of development, we still view this as an early version of a BSC. To fully realize its benefits, an organization must choose metrics that will not simply measure performance but drive it. Our current BSC relies primarily on lagging measures, which show what our performance has been, and includes few leading metrics, which can predict trends in performance. As explained by Kaplan and Norton, this type of BSC risks skewing toward controlling rather than driving performance.[14] A mature BSC will include a mix of leading and lagging indicators, the combination illustrating a logical progression from measurement to performance. For instance, we measure total grant funding per year, which is a lagging indicator. However, to be most effective we could measure the percent of faculty who have attended grant‐writing workshops, the number of new grant sources identified, or the number of grant proposals submitted each quarter. These leading indicators would allow us to see performance trends that could be improved before the final outcome, total grant funding, is realized.

Finally, the issues surrounding the acceptability of this overall strategy will likely hinge on how we implement the more complex steps that relate to transparency, individual attribution, and perhaps ultimately incentives. Success in this area depends as much on culture as on strategy.

Next Steps

The next major step in the evolution of the BSC, and part of a broader faculty development program, will be the development of individual BSCs. They will be created using a similar methodology and allow faculty to reflect on their performance compared to peers and recognized benchmarks. Ideally, this will allow hospitalists in our group to establish personal strategic plans and monitor their performance over time. Individualizing these BSCs will be critical; although a research‐oriented faculty member might be striving for more than 5 publications and a large grant in a year, a clinician‐educator may seek outstanding teaching reviews and completion of a key quality improvement project. Both efforts need to be highly valued, and the divisional BSC should roll up these varied individual goals into a balanced whole.

In conclusion, we successfully developed and implemented a BSC to aid in strategic planning. The BSC ensures that we make strategic decisions using data, identify internally driven objectives, develop systems of performance measurement, and increase transparency and accountability. Our hope is that this description of the development of our BSC will be useful to other groups considering a similar endeavor.

Acknowledgments

The authors thank Noori Dhillon, Sadaf Akbaryar, Katie Quinn, Gerri Berg, and Maria Novelero for data collection and analysis. The authors also thank the faculty and staff who participated in the development process of the BSC.

Disclosure

Nothing to report.

Files
References
  1. Wachter RM. The hospitalist field turns 15: new opportunities and challenges. J Hosp Med. 2011;6(4):E1E4.
  2. Wachter RM, Goldman L. The emerging role of “hospitalists” in the American health care system. N Engl J Med. 1996;335(7):514517.
  3. Kaplan RS, Norton DP. The balanced scorecard—measures that drive performance. Harv Bus Rev. 1992;70(1):7179.
  4. Kaplan RS, Norton DP. Using the balanced scorecard as a strategic management system. Harv Bus Rev. 1996;74(1):7585.
  5. Kaplan RS, Norton DP. Having trouble with your strategy? Then map it. Harv Bus Rev. 2000;78:167176, 202.
  6. Kaplan RS, Norton DP. Putting the balanced scorecard to work. Harv Bus Rev. 1993;71:134147.
  7. Stanley R, Lillis KA, Zuspan SJ, et al. Development and implementation of a performance measure tool in an academic pediatric research network. Contemp Clin Trials. 2010;31(5):429437.
  8. Gurd B, Gao T. Lives in the balance: an analysis of the balanced scorecard (BSC) in healthcare organizations. Int J Prod Perform Manag. 2007;57(1):621.
  9. Rimar S, Garstka SJ. The “Balanced Scorecard”: development and implementation in an academic clinical department. Acad Med. 1999;74(2):114122.
  10. Zbinden AM. Introducing a balanced scorecard management system in a university anesthesiology department. Anesth Analg. 2002;95(6):17311738, table of contents.
  11. Zelman WN, Blazer D, Gower JM, Bumgarner PO, Cancilla LM. Issues for academic health centers to consider before implementing a balanced‐scorecard effort. Acad Med. 1999;74(12):12691277.
  12. Rosenbaum L, Lamas D. Cents and sensitivity—teaching physicians to think about costs. N Engl J Med. 2012;367(2):99101.
  13. Meliones JN, Alton M, Mericle J, et al. 10‐year experience integrating strategic performance improvement initiatives: can the balanced scorecard, Six Sigma, and team training all thrive in a single hospital? In: Henriksen K, Battles JB, Keyes MA, Grady ML, eds. Advances in Patient Safety: New Directions and Alternative Approaches. Vol 3. Performance and Tools. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK43660. Accessed 15 June 2011.
  14. Kaplan RS, Norton DP. Linking the balanced scorecard to strategy. Calif Manage Rev. 1996;39(1):5379.
Article PDF
Issue
Journal of Hospital Medicine - 8(3)
Page Number
148-153
Sections
Files
Files
Article PDF
Article PDF

The field of hospital medicine, now the fastest growing specialty in medical history,[1] was born out of pressure to improve the efficiency and quality of clinical care in US hospitals.[2] Delivering safe and high‐value clinical care is a central goal of the field and has been an essential component of its growth and success.

The clinical demands on academic hospitalists have grown recently, fueled by the need to staff services previously covered by housestaff, whose hours are now restricted. Despite these new demands, expectations have grown in other arenas as well. Academic hospitalist groups (AHGs) are often expected to make significant contributions in quality improvement, patient safety, education, research, and administration. With broad expectations beyond clinical care, AHGs face unique challenges. Groups that focus mainly on providing coverage and improving clinical performance may find that they are unable to fully contribute in these other domains. To be successful, AHGs must develop strategies that balance their energies, resources, and performance.

The balanced scorecard (BSC) was introduced by Kaplan and Norton in 1992 to allow corporations to view their performance broadly, rather than narrowly focusing on financial measures. The BSC requires organizations to develop a balanced portfolio of performance metrics across 4 key perspectives: financial, customers, internal processes, and learning and growth. Metrics within these perspectives should help answer fundamental questions about the organization (Table 1).[3] Over time, the BSC evolved from a performance measurement tool to a strategic management system.[4] Successful organizations translate their mission and vision to specific strategic objectives in each of the 4 perspectives, delineate how these objectives will help the organization reach its vision with a strategy map,[5] and then utilize the BSC to track and monitor performance to ensure that the vision is achieved.[6]

BSC Perspectives and the Questions That They Answer About the Organization: Traditional and Revised for AHCs
BSC Perspective Traditional Questions[3] Questions Revised for AHCs
  • NOTE: Adapted with permission from Zelman, et al. Academic Medicine. 1999; vol 74. Wolters Kluwer Health. [11] Abbreviations: AHCs, academic health centers; BSC, balanced scorecard.

Financial How do we look to our shareholders? What financial condition must we be in to allow us to accomplish our mission?
Customers How do customers see us? How do we ensure that our services and products add the level of value desired by our stakeholders?
Internal processes What must we excel at? How do we produce our products and services to add maximum value for our customers and stakeholders?
Learning and growth How can we continue to improve and create value? How do we ensure that we change and improve in order to achieve our vision?

Although originally conceived for businesses, the BSC has found its way into the healthcare industry, with reports of successful implementation in organizations ranging from individual departments to research collaboratives[7] to national healthcare systems.[8] However, there are few reports of BSC implementation in academic health centers.[9, 10] Because most academic centers are not‐for‐profit, Zelman suggests that the 4 BSC perspectives be modified to better fit their unique characteristics (Table 1).[11] To the best of our knowledge, there is no literature describing the development of a BSC in an academic hospitalist group. In this article, we describe the development of, and early experiences with, an academic hospital medicine BSC developed as part of a strategic planning initiative.

METHODS

The University of California, San Francisco (UCSF) Division of Hospital Medicine (DHM) was established in 2005. Currently, there are more than 50 faculty members, having doubled in the last 4 years. In addition to staffing several housestaff and nonhousestaff clinical services, faculty are involved in a wide variety of nonclinical endeavors at local and national levels. They participate and lead initiatives in education, faculty development, patient safety, care efficiency, quality improvement, information technology, and global health. There is an active research enterprise that generates nearly $5 million in grant funding annually.

Needs Assessment

During a division retreat in 2009, faculty identified several areas in need of improvement, including: clinical care processes, educational promotion, faculty development, and work‐life balance. Based on these needs, divisional mission and vision statements were created (Table 2).

UCSF DHM Mission and Vision Statements
  • NOTE: Abbreviations: DHM, Division of Hospital Medicine; UCSF, University of California, San Francisco.

Our mission: to provide the highest quality clinical care, education, research, and innovation in academic hospital medicine.
Our vision: to be the best division of hospital medicine by promoting excellence, integrity, innovation, and professional satisfaction among our faculty, trainees, and staff.

Division leadership made it a priority to create a strategic plan to address these wide‐ranging issues. To accomplish this, we recognized the need to develop a formal way of translating our vision into specific and measurable objectives, establish systems of performance measurement, improve accountability, and effectively communicate these strategic goals to the group. Based on these needs, we set out to develop a divisional BSC.

Development

At the time of BSC development, the DHM was organized into 4 functional areas: quality and safety, education, faculty development, and academics and research. A task force was formed, comprised of 8 senior faculty representing these key areas. The mission and vision statements were used as the foundation for the development of division goals and objectives. The group was careful to choose objectives within each of the 4 BSC perspectives for academic centers, as defined by Zelman (Table 1). The taskforce then brainstormed specific metrics that would track performance within the 4 functional areas. The only stipulation during this process was that the metrics had to meet the following criteria:

  1. Important to the division and to the individual faculty members
  2. Measurable through either current or developed processes
  3. Data are valid and their validity trusted by the faculty members
  4. Amenable to improvement by faculty (ie, through their individual action they could impact the metric)

From the subsequent list of metrics, we used a modified Delphi method to rank‐order them by importance to arrive at our final set of metrics. Kaplan and Norton noted that focusing on a manageable number of metrics (ie, a handful in each BSC perspective) is important for an achievable strategic vision.[6] With the metrics chosen, we identified data sources or developed new systems to collect data for which there was no current source. We assigned individuals responsible for collecting and analyzing the data, identified local or national benchmarks, if available, and established performance targets for the coming year, when possible.

The BSC is updated quarterly, and results are presented to the division during a noon meeting and posted on the division website. Metrics are re‐evaluated on a yearly basis. They are continued, modified, or discarded depending on performance and/or changes in strategic priorities.

The initial BSC focused on division‐wide metrics and performance. Early efforts to develop the scorecard were framed as experimental, with no clear decision taken regarding how metrics might ultimately be used to improve performance (ie, how public to make both individual and group results, whether to tie bonus payments to performance).

RESULTS

There were 41 initial metrics considered by the division BSC task force (Table 3). Of these, 16 were chosen for the initial BSC through the modified Delphi method. Over the past 2 years, these initial metrics have been modified to reflect current strategic goals and objectives. Figure 1 illustrates the BSC for fiscal year (FY) 2012. An online version of this, complete with graphical representations of the data and metric definitions, can be found at http://hospitalmedicine.ucsf.edu/bsc/fy2012.html. Our strategy map (Figure 2) demonstrates how these metrics are interconnected across the 4 BSC perspectives and how they fit into our overall strategic plan.

Figure 1
Division of Hospital Medicine balance scorecard FY 2012. Green shading signifies at or above target; pink shading signifies below target. Abbreviations: CY, calendar year; FY, fiscal year, NA, not available; Q, quarter.
Figure 2
Division of Hospital Medicine strategy map. Arrows denote relationships between objectives spanning the 4 balanced scorecard perspectives. Abbreviations: HCAHPS, Hospital Consumer Assessment of Healthcare Providers and Systems; PCP, primary care physician.
Brainstormed Competencies Across the Four DHM Functional Areas
Quality, Safety, and Operations Education Academics and Research Faculty Development
  • NOTE: Abbreviations: CME, continuing medical education; DHM, Division of Hospital Medicine; ICU, intensive care unit.

Appropriate level of care CME courses taught Abstracts accepted Attendance and participation
Billing and documentation Curriculum development Academic reputation Being an agent of change
Clinical efficiency Student/housestaff feedback Grant funding Division citizenship
Clinical professionalism Mentoring Mentorship Job satisfaction
Communication Quality of teaching rounds Papers published Mentorship
Core measures performance Participation in national organizations Committees and task forces
Practice evidence‐based medicine
Fund of knowledge
Guideline adherence
Unplanned transfers to ICU
Implementation and initiation of projects
Length of stay
Medical errors
Mortality
Multidisciplinary approach to patient care
Multisource feedback evaluations
Never events
Patient‐centered care
Patient satisfaction
Practice‐based learning
Procedures
Readmissions
Reputation and expertise
Seeing patient on the day of admission
Quality of transfers of care

DISCUSSION

Like many hospitalist groups, our division has experienced tremendous growth, both in our numbers and the breadth of roles that we fill. With this growth has come increasing expectations in multiple domains, competing priorities, and limited resources. We successfully developed a BSC as a tool to help our division reach its vision: balancing high quality clinical care, education, academics, and faculty development while maintaining a strong sense of community. We have found that the BSC has helped us meet several key goals.

The first goal was to allow for a broad view of our performance. This is the BSC's most basic function, and we saw immediate and tangible benefits. The scorecard provided a broad snapshot of our performance in a single place. For example, in the clinical domain, we saw that our direct cost per case was increasing despite our adjusted average length of stay remaining stable from FY2010‐FY2011. In academics and research, we saw that the number of abstracts accepted at national meetings increased by almost 30% in FY2011 (Figure 1).

The second goal was to create transparency and accountability. By measuring performance and displaying it on the division Web site, the BSC has promoted transparency. If performance does not meet our targets, the division as a whole becomes accountable. Leadership must understand why performance fell short and initiate changes to improve it. For instance, the rising direct cost per case has spurred the development of a high‐value care committee tasked with finding ways of reducing cost while providing high‐quality care.[12]

The third goal was to communicate goals and engage our faculty. As our division has grown, ensuring a shared vision among our entire faculty became an increasing challenge. The BSC functions as a communication platform between leadership and faculty, and yielded multiple benefits. As the metrics were born out of our mission and vision, the BSC has become a tangible representation of our core values. Moreover, individual faculty can see that they are part of a greater, high‐performing organization and realize they can impact the group's performance through their individual effort. For example, this has helped promote receptivity to carefully disseminated individual performance measures for billing and documentation, and patient satisfaction, in conjunction with faculty development in these areas.

The fourth goal was to ensure that we use data to guide strategic decisions. We felt that strategic decisions needed to be based on objective, rather than perceived or anecdotal, information. This meant translating our vision into measurable objectives that would drive performance improvement. For example, before the BSC, we were committed to the dissemination of our research and innovations. Yet, we quickly realized that we did not have a system to collect even basic data on academic performancea deficit we filled by leveraging information gathered from online databases and faculty curricula vitae. These data allowed us, for the first time, to objectively reflect on this as a strategic goal and to have an ongoing mechanism to monitor academic productivity.

Lessons Learned/Keys to Success

With our initial experience, we have gained insight that may be helpful to other AHGs considering implementing a BSC. First, and most importantly, AHGs should take the necessary time to build consensus and buy‐in. Particularly in areas where data are analyzed for the first time, faculty are often wary about the validity of the data or the purpose and utility of performance measurement. Faculty may be concerned about how collection of performance data could affect promotion or create a hostile and competitive work environment.

This concern grows when one moves from division‐wide to individual data. It is inevitable that the collection and dissemination of performance data will create some level of discomfort among faculty members, which can be a force for improvement or for angst. These issues should be anticipated, discussed, and actively managed. It is critical to be transparent with how data will be used. We have made clear that the transition from group to individual performance data, and from simple transparency to incentives, will be done thoughtfully and with tremendous input from our faculty. This tension can also be mitigated by choosing metrics that are internally driven, rather than determined by external groups (ie, following the principle that the measures should be important to the division and individual faculty members).

Next, the process of developing a mature BSC takes time. Much of our first year was spent developing systems for measurement, collecting data, and determining appropriate comparators and targets. The data in the first BSC functioned mainly as a baseline marker of performance. Some metrics, particularly in education and academics, had no national or local benchmarks. In these cases we identified comparable groups (such as other medical teaching services or other well‐established AHGs) or merely used our prior year's performance as a benchmark. Also, some of our metrics did not initially have performance targets. In most instances, this was because this was the first time that we looked at these data, and it was unclear what an appropriate target would be until more data became available.

Moving into our third year, we are seeing a natural evolution in the BSC's use. Some metrics that were initially chosen have been replaced or modified to reflect changing goals and priorities. Functional directors participate in choosing and developing performance metrics in their area. Previously, there was no formal structure for these groups to develop and measure strategic objectives and be accountable for performance improvement. They are now expected to define goals with measurable outcomes, to report progress to division leadership, and to develop their own scorecard to track performance. Each group chooses 2 to 4 metrics within their domain that are the most important for the division to improve on, which are then included in the division BSC.

We have also made efforts to build synergy between our BSC and performance goals set by external groups. Although continuing to favor metrics that are internally driven and meaningful to our faculty, we recognize that our goals must also reflect the needs and interests of broader stakeholders. For example, hand hygiene rates and patient satisfaction scores are UCSF medical center and divisional priorities (the former includes them in a financial incentive system for managers, staff, and many physicians) and are incorporated into the BSC as division‐wide incentive metrics.

Limitations

Our project has several limitations. It was conducted at a single institution, and our metrics may not be generalizable to other groups. However, the main goal of this article was not to focus on specific metrics but the process that we undertook to choose and develop them. Other institutions will likely identify different metrics based on their specific strategic objectives. We are also early in our experience with the BSC, and it is still not clear what effect it will have on the desired outcomes for our objectives. However, Henriksen recently reported that implementing a BSC at a large academic health center, in parallel with other performance improvement initiatives, resulted in substantial improvement in their chosen performance metrics.[13]

Despite the several years of development, we still view this as an early version of a BSC. To fully realize its benefits, an organization must choose metrics that will not simply measure performance but drive it. Our current BSC relies primarily on lagging measures, which show what our performance has been, and includes few leading metrics, which can predict trends in performance. As explained by Kaplan and Norton, this type of BSC risks skewing toward controlling rather than driving performance.[14] A mature BSC will include a mix of leading and lagging indicators, the combination illustrating a logical progression from measurement to performance. For instance, we measure total grant funding per year, which is a lagging indicator. However, to be most effective we could measure the percent of faculty who have attended grant‐writing workshops, the number of new grant sources identified, or the number of grant proposals submitted each quarter. These leading indicators would allow us to see performance trends that could be improved before the final outcome, total grant funding, is realized.

Finally, the issues surrounding the acceptability of this overall strategy will likely hinge on how we implement the more complex steps that relate to transparency, individual attribution, and perhaps ultimately incentives. Success in this area depends as much on culture as on strategy.

Next Steps

The next major step in the evolution of the BSC, and part of a broader faculty development program, will be the development of individual BSCs. They will be created using a similar methodology and allow faculty to reflect on their performance compared to peers and recognized benchmarks. Ideally, this will allow hospitalists in our group to establish personal strategic plans and monitor their performance over time. Individualizing these BSCs will be critical; although a research‐oriented faculty member might be striving for more than 5 publications and a large grant in a year, a clinician‐educator may seek outstanding teaching reviews and completion of a key quality improvement project. Both efforts need to be highly valued, and the divisional BSC should roll up these varied individual goals into a balanced whole.

In conclusion, we successfully developed and implemented a BSC to aid in strategic planning. The BSC ensures that we make strategic decisions using data, identify internally driven objectives, develop systems of performance measurement, and increase transparency and accountability. Our hope is that this description of the development of our BSC will be useful to other groups considering a similar endeavor.

Acknowledgments

The authors thank Noori Dhillon, Sadaf Akbaryar, Katie Quinn, Gerri Berg, and Maria Novelero for data collection and analysis. The authors also thank the faculty and staff who participated in the development process of the BSC.

Disclosure

Nothing to report.

The field of hospital medicine, now the fastest growing specialty in medical history,[1] was born out of pressure to improve the efficiency and quality of clinical care in US hospitals.[2] Delivering safe and high‐value clinical care is a central goal of the field and has been an essential component of its growth and success.

The clinical demands on academic hospitalists have grown recently, fueled by the need to staff services previously covered by housestaff, whose hours are now restricted. Despite these new demands, expectations have grown in other arenas as well. Academic hospitalist groups (AHGs) are often expected to make significant contributions in quality improvement, patient safety, education, research, and administration. With broad expectations beyond clinical care, AHGs face unique challenges. Groups that focus mainly on providing coverage and improving clinical performance may find that they are unable to fully contribute in these other domains. To be successful, AHGs must develop strategies that balance their energies, resources, and performance.

The balanced scorecard (BSC) was introduced by Kaplan and Norton in 1992 to allow corporations to view their performance broadly, rather than narrowly focusing on financial measures. The BSC requires organizations to develop a balanced portfolio of performance metrics across 4 key perspectives: financial, customers, internal processes, and learning and growth. Metrics within these perspectives should help answer fundamental questions about the organization (Table 1).[3] Over time, the BSC evolved from a performance measurement tool to a strategic management system.[4] Successful organizations translate their mission and vision to specific strategic objectives in each of the 4 perspectives, delineate how these objectives will help the organization reach its vision with a strategy map,[5] and then utilize the BSC to track and monitor performance to ensure that the vision is achieved.[6]

BSC Perspectives and the Questions That They Answer About the Organization: Traditional and Revised for AHCs
BSC Perspective Traditional Questions[3] Questions Revised for AHCs
  • NOTE: Adapted with permission from Zelman, et al. Academic Medicine. 1999; vol 74. Wolters Kluwer Health. [11] Abbreviations: AHCs, academic health centers; BSC, balanced scorecard.

Financial How do we look to our shareholders? What financial condition must we be in to allow us to accomplish our mission?
Customers How do customers see us? How do we ensure that our services and products add the level of value desired by our stakeholders?
Internal processes What must we excel at? How do we produce our products and services to add maximum value for our customers and stakeholders?
Learning and growth How can we continue to improve and create value? How do we ensure that we change and improve in order to achieve our vision?

Although originally conceived for businesses, the BSC has found its way into the healthcare industry, with reports of successful implementation in organizations ranging from individual departments to research collaboratives[7] to national healthcare systems.[8] However, there are few reports of BSC implementation in academic health centers.[9, 10] Because most academic centers are not‐for‐profit, Zelman suggests that the 4 BSC perspectives be modified to better fit their unique characteristics (Table 1).[11] To the best of our knowledge, there is no literature describing the development of a BSC in an academic hospitalist group. In this article, we describe the development of, and early experiences with, an academic hospital medicine BSC developed as part of a strategic planning initiative.

METHODS

The University of California, San Francisco (UCSF) Division of Hospital Medicine (DHM) was established in 2005. Currently, there are more than 50 faculty members, having doubled in the last 4 years. In addition to staffing several housestaff and nonhousestaff clinical services, faculty are involved in a wide variety of nonclinical endeavors at local and national levels. They participate and lead initiatives in education, faculty development, patient safety, care efficiency, quality improvement, information technology, and global health. There is an active research enterprise that generates nearly $5 million in grant funding annually.

Needs Assessment

During a division retreat in 2009, faculty identified several areas in need of improvement, including: clinical care processes, educational promotion, faculty development, and work‐life balance. Based on these needs, divisional mission and vision statements were created (Table 2).

UCSF DHM Mission and Vision Statements
  • NOTE: Abbreviations: DHM, Division of Hospital Medicine; UCSF, University of California, San Francisco.

Our mission: to provide the highest quality clinical care, education, research, and innovation in academic hospital medicine.
Our vision: to be the best division of hospital medicine by promoting excellence, integrity, innovation, and professional satisfaction among our faculty, trainees, and staff.

Division leadership made it a priority to create a strategic plan to address these wide‐ranging issues. To accomplish this, we recognized the need to develop a formal way of translating our vision into specific and measurable objectives, establish systems of performance measurement, improve accountability, and effectively communicate these strategic goals to the group. Based on these needs, we set out to develop a divisional BSC.

Development

At the time of BSC development, the DHM was organized into 4 functional areas: quality and safety, education, faculty development, and academics and research. A task force was formed, comprised of 8 senior faculty representing these key areas. The mission and vision statements were used as the foundation for the development of division goals and objectives. The group was careful to choose objectives within each of the 4 BSC perspectives for academic centers, as defined by Zelman (Table 1). The taskforce then brainstormed specific metrics that would track performance within the 4 functional areas. The only stipulation during this process was that the metrics had to meet the following criteria:

  1. Important to the division and to the individual faculty members
  2. Measurable through either current or developed processes
  3. Data are valid and their validity trusted by the faculty members
  4. Amenable to improvement by faculty (ie, through their individual action they could impact the metric)

From the subsequent list of metrics, we used a modified Delphi method to rank‐order them by importance to arrive at our final set of metrics. Kaplan and Norton noted that focusing on a manageable number of metrics (ie, a handful in each BSC perspective) is important for an achievable strategic vision.[6] With the metrics chosen, we identified data sources or developed new systems to collect data for which there was no current source. We assigned individuals responsible for collecting and analyzing the data, identified local or national benchmarks, if available, and established performance targets for the coming year, when possible.

The BSC is updated quarterly, and results are presented to the division during a noon meeting and posted on the division website. Metrics are re‐evaluated on a yearly basis. They are continued, modified, or discarded depending on performance and/or changes in strategic priorities.

The initial BSC focused on division‐wide metrics and performance. Early efforts to develop the scorecard were framed as experimental, with no clear decision taken regarding how metrics might ultimately be used to improve performance (ie, how public to make both individual and group results, whether to tie bonus payments to performance).

RESULTS

There were 41 initial metrics considered by the division BSC task force (Table 3). Of these, 16 were chosen for the initial BSC through the modified Delphi method. Over the past 2 years, these initial metrics have been modified to reflect current strategic goals and objectives. Figure 1 illustrates the BSC for fiscal year (FY) 2012. An online version of this, complete with graphical representations of the data and metric definitions, can be found at http://hospitalmedicine.ucsf.edu/bsc/fy2012.html. Our strategy map (Figure 2) demonstrates how these metrics are interconnected across the 4 BSC perspectives and how they fit into our overall strategic plan.

Figure 1
Division of Hospital Medicine balance scorecard FY 2012. Green shading signifies at or above target; pink shading signifies below target. Abbreviations: CY, calendar year; FY, fiscal year, NA, not available; Q, quarter.
Figure 2
Division of Hospital Medicine strategy map. Arrows denote relationships between objectives spanning the 4 balanced scorecard perspectives. Abbreviations: HCAHPS, Hospital Consumer Assessment of Healthcare Providers and Systems; PCP, primary care physician.
Brainstormed Competencies Across the Four DHM Functional Areas
Quality, Safety, and Operations Education Academics and Research Faculty Development
  • NOTE: Abbreviations: CME, continuing medical education; DHM, Division of Hospital Medicine; ICU, intensive care unit.

Appropriate level of care CME courses taught Abstracts accepted Attendance and participation
Billing and documentation Curriculum development Academic reputation Being an agent of change
Clinical efficiency Student/housestaff feedback Grant funding Division citizenship
Clinical professionalism Mentoring Mentorship Job satisfaction
Communication Quality of teaching rounds Papers published Mentorship
Core measures performance Participation in national organizations Committees and task forces
Practice evidence‐based medicine
Fund of knowledge
Guideline adherence
Unplanned transfers to ICU
Implementation and initiation of projects
Length of stay
Medical errors
Mortality
Multidisciplinary approach to patient care
Multisource feedback evaluations
Never events
Patient‐centered care
Patient satisfaction
Practice‐based learning
Procedures
Readmissions
Reputation and expertise
Seeing patient on the day of admission
Quality of transfers of care

DISCUSSION

Like many hospitalist groups, our division has experienced tremendous growth, both in our numbers and the breadth of roles that we fill. With this growth has come increasing expectations in multiple domains, competing priorities, and limited resources. We successfully developed a BSC as a tool to help our division reach its vision: balancing high quality clinical care, education, academics, and faculty development while maintaining a strong sense of community. We have found that the BSC has helped us meet several key goals.

The first goal was to allow for a broad view of our performance. This is the BSC's most basic function, and we saw immediate and tangible benefits. The scorecard provided a broad snapshot of our performance in a single place. For example, in the clinical domain, we saw that our direct cost per case was increasing despite our adjusted average length of stay remaining stable from FY2010‐FY2011. In academics and research, we saw that the number of abstracts accepted at national meetings increased by almost 30% in FY2011 (Figure 1).

The second goal was to create transparency and accountability. By measuring performance and displaying it on the division Web site, the BSC has promoted transparency. If performance does not meet our targets, the division as a whole becomes accountable. Leadership must understand why performance fell short and initiate changes to improve it. For instance, the rising direct cost per case has spurred the development of a high‐value care committee tasked with finding ways of reducing cost while providing high‐quality care.[12]

The third goal was to communicate goals and engage our faculty. As our division has grown, ensuring a shared vision among our entire faculty became an increasing challenge. The BSC functions as a communication platform between leadership and faculty, and yielded multiple benefits. As the metrics were born out of our mission and vision, the BSC has become a tangible representation of our core values. Moreover, individual faculty can see that they are part of a greater, high‐performing organization and realize they can impact the group's performance through their individual effort. For example, this has helped promote receptivity to carefully disseminated individual performance measures for billing and documentation, and patient satisfaction, in conjunction with faculty development in these areas.

The fourth goal was to ensure that we use data to guide strategic decisions. We felt that strategic decisions needed to be based on objective, rather than perceived or anecdotal, information. This meant translating our vision into measurable objectives that would drive performance improvement. For example, before the BSC, we were committed to the dissemination of our research and innovations. Yet, we quickly realized that we did not have a system to collect even basic data on academic performancea deficit we filled by leveraging information gathered from online databases and faculty curricula vitae. These data allowed us, for the first time, to objectively reflect on this as a strategic goal and to have an ongoing mechanism to monitor academic productivity.

Lessons Learned/Keys to Success

With our initial experience, we have gained insight that may be helpful to other AHGs considering implementing a BSC. First, and most importantly, AHGs should take the necessary time to build consensus and buy‐in. Particularly in areas where data are analyzed for the first time, faculty are often wary about the validity of the data or the purpose and utility of performance measurement. Faculty may be concerned about how collection of performance data could affect promotion or create a hostile and competitive work environment.

This concern grows when one moves from division‐wide to individual data. It is inevitable that the collection and dissemination of performance data will create some level of discomfort among faculty members, which can be a force for improvement or for angst. These issues should be anticipated, discussed, and actively managed. It is critical to be transparent with how data will be used. We have made clear that the transition from group to individual performance data, and from simple transparency to incentives, will be done thoughtfully and with tremendous input from our faculty. This tension can also be mitigated by choosing metrics that are internally driven, rather than determined by external groups (ie, following the principle that the measures should be important to the division and individual faculty members).

Next, the process of developing a mature BSC takes time. Much of our first year was spent developing systems for measurement, collecting data, and determining appropriate comparators and targets. The data in the first BSC functioned mainly as a baseline marker of performance. Some metrics, particularly in education and academics, had no national or local benchmarks. In these cases we identified comparable groups (such as other medical teaching services or other well‐established AHGs) or merely used our prior year's performance as a benchmark. Also, some of our metrics did not initially have performance targets. In most instances, this was because this was the first time that we looked at these data, and it was unclear what an appropriate target would be until more data became available.

Moving into our third year, we are seeing a natural evolution in the BSC's use. Some metrics that were initially chosen have been replaced or modified to reflect changing goals and priorities. Functional directors participate in choosing and developing performance metrics in their area. Previously, there was no formal structure for these groups to develop and measure strategic objectives and be accountable for performance improvement. They are now expected to define goals with measurable outcomes, to report progress to division leadership, and to develop their own scorecard to track performance. Each group chooses 2 to 4 metrics within their domain that are the most important for the division to improve on, which are then included in the division BSC.

We have also made efforts to build synergy between our BSC and performance goals set by external groups. Although continuing to favor metrics that are internally driven and meaningful to our faculty, we recognize that our goals must also reflect the needs and interests of broader stakeholders. For example, hand hygiene rates and patient satisfaction scores are UCSF medical center and divisional priorities (the former includes them in a financial incentive system for managers, staff, and many physicians) and are incorporated into the BSC as division‐wide incentive metrics.

Limitations

Our project has several limitations. It was conducted at a single institution, and our metrics may not be generalizable to other groups. However, the main goal of this article was not to focus on specific metrics but the process that we undertook to choose and develop them. Other institutions will likely identify different metrics based on their specific strategic objectives. We are also early in our experience with the BSC, and it is still not clear what effect it will have on the desired outcomes for our objectives. However, Henriksen recently reported that implementing a BSC at a large academic health center, in parallel with other performance improvement initiatives, resulted in substantial improvement in their chosen performance metrics.[13]

Despite the several years of development, we still view this as an early version of a BSC. To fully realize its benefits, an organization must choose metrics that will not simply measure performance but drive it. Our current BSC relies primarily on lagging measures, which show what our performance has been, and includes few leading metrics, which can predict trends in performance. As explained by Kaplan and Norton, this type of BSC risks skewing toward controlling rather than driving performance.[14] A mature BSC will include a mix of leading and lagging indicators, the combination illustrating a logical progression from measurement to performance. For instance, we measure total grant funding per year, which is a lagging indicator. However, to be most effective we could measure the percent of faculty who have attended grant‐writing workshops, the number of new grant sources identified, or the number of grant proposals submitted each quarter. These leading indicators would allow us to see performance trends that could be improved before the final outcome, total grant funding, is realized.

Finally, the issues surrounding the acceptability of this overall strategy will likely hinge on how we implement the more complex steps that relate to transparency, individual attribution, and perhaps ultimately incentives. Success in this area depends as much on culture as on strategy.

Next Steps

The next major step in the evolution of the BSC, and part of a broader faculty development program, will be the development of individual BSCs. They will be created using a similar methodology and allow faculty to reflect on their performance compared to peers and recognized benchmarks. Ideally, this will allow hospitalists in our group to establish personal strategic plans and monitor their performance over time. Individualizing these BSCs will be critical; although a research‐oriented faculty member might be striving for more than 5 publications and a large grant in a year, a clinician‐educator may seek outstanding teaching reviews and completion of a key quality improvement project. Both efforts need to be highly valued, and the divisional BSC should roll up these varied individual goals into a balanced whole.

In conclusion, we successfully developed and implemented a BSC to aid in strategic planning. The BSC ensures that we make strategic decisions using data, identify internally driven objectives, develop systems of performance measurement, and increase transparency and accountability. Our hope is that this description of the development of our BSC will be useful to other groups considering a similar endeavor.

Acknowledgments

The authors thank Noori Dhillon, Sadaf Akbaryar, Katie Quinn, Gerri Berg, and Maria Novelero for data collection and analysis. The authors also thank the faculty and staff who participated in the development process of the BSC.

Disclosure

Nothing to report.

References
  1. Wachter RM. The hospitalist field turns 15: new opportunities and challenges. J Hosp Med. 2011;6(4):E1E4.
  2. Wachter RM, Goldman L. The emerging role of “hospitalists” in the American health care system. N Engl J Med. 1996;335(7):514517.
  3. Kaplan RS, Norton DP. The balanced scorecard—measures that drive performance. Harv Bus Rev. 1992;70(1):7179.
  4. Kaplan RS, Norton DP. Using the balanced scorecard as a strategic management system. Harv Bus Rev. 1996;74(1):7585.
  5. Kaplan RS, Norton DP. Having trouble with your strategy? Then map it. Harv Bus Rev. 2000;78:167176, 202.
  6. Kaplan RS, Norton DP. Putting the balanced scorecard to work. Harv Bus Rev. 1993;71:134147.
  7. Stanley R, Lillis KA, Zuspan SJ, et al. Development and implementation of a performance measure tool in an academic pediatric research network. Contemp Clin Trials. 2010;31(5):429437.
  8. Gurd B, Gao T. Lives in the balance: an analysis of the balanced scorecard (BSC) in healthcare organizations. Int J Prod Perform Manag. 2007;57(1):621.
  9. Rimar S, Garstka SJ. The “Balanced Scorecard”: development and implementation in an academic clinical department. Acad Med. 1999;74(2):114122.
  10. Zbinden AM. Introducing a balanced scorecard management system in a university anesthesiology department. Anesth Analg. 2002;95(6):17311738, table of contents.
  11. Zelman WN, Blazer D, Gower JM, Bumgarner PO, Cancilla LM. Issues for academic health centers to consider before implementing a balanced‐scorecard effort. Acad Med. 1999;74(12):12691277.
  12. Rosenbaum L, Lamas D. Cents and sensitivity—teaching physicians to think about costs. N Engl J Med. 2012;367(2):99101.
  13. Meliones JN, Alton M, Mericle J, et al. 10‐year experience integrating strategic performance improvement initiatives: can the balanced scorecard, Six Sigma, and team training all thrive in a single hospital? In: Henriksen K, Battles JB, Keyes MA, Grady ML, eds. Advances in Patient Safety: New Directions and Alternative Approaches. Vol 3. Performance and Tools. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK43660. Accessed 15 June 2011.
  14. Kaplan RS, Norton DP. Linking the balanced scorecard to strategy. Calif Manage Rev. 1996;39(1):5379.
References
  1. Wachter RM. The hospitalist field turns 15: new opportunities and challenges. J Hosp Med. 2011;6(4):E1E4.
  2. Wachter RM, Goldman L. The emerging role of “hospitalists” in the American health care system. N Engl J Med. 1996;335(7):514517.
  3. Kaplan RS, Norton DP. The balanced scorecard—measures that drive performance. Harv Bus Rev. 1992;70(1):7179.
  4. Kaplan RS, Norton DP. Using the balanced scorecard as a strategic management system. Harv Bus Rev. 1996;74(1):7585.
  5. Kaplan RS, Norton DP. Having trouble with your strategy? Then map it. Harv Bus Rev. 2000;78:167176, 202.
  6. Kaplan RS, Norton DP. Putting the balanced scorecard to work. Harv Bus Rev. 1993;71:134147.
  7. Stanley R, Lillis KA, Zuspan SJ, et al. Development and implementation of a performance measure tool in an academic pediatric research network. Contemp Clin Trials. 2010;31(5):429437.
  8. Gurd B, Gao T. Lives in the balance: an analysis of the balanced scorecard (BSC) in healthcare organizations. Int J Prod Perform Manag. 2007;57(1):621.
  9. Rimar S, Garstka SJ. The “Balanced Scorecard”: development and implementation in an academic clinical department. Acad Med. 1999;74(2):114122.
  10. Zbinden AM. Introducing a balanced scorecard management system in a university anesthesiology department. Anesth Analg. 2002;95(6):17311738, table of contents.
  11. Zelman WN, Blazer D, Gower JM, Bumgarner PO, Cancilla LM. Issues for academic health centers to consider before implementing a balanced‐scorecard effort. Acad Med. 1999;74(12):12691277.
  12. Rosenbaum L, Lamas D. Cents and sensitivity—teaching physicians to think about costs. N Engl J Med. 2012;367(2):99101.
  13. Meliones JN, Alton M, Mericle J, et al. 10‐year experience integrating strategic performance improvement initiatives: can the balanced scorecard, Six Sigma, and team training all thrive in a single hospital? In: Henriksen K, Battles JB, Keyes MA, Grady ML, eds. Advances in Patient Safety: New Directions and Alternative Approaches. Vol 3. Performance and Tools. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK43660. Accessed 15 June 2011.
  14. Kaplan RS, Norton DP. Linking the balanced scorecard to strategy. Calif Manage Rev. 1996;39(1):5379.
Issue
Journal of Hospital Medicine - 8(3)
Issue
Journal of Hospital Medicine - 8(3)
Page Number
148-153
Page Number
148-153
Article Type
Display Headline
Development and implementation of a balanced scorecard in an academic hospitalist group
Display Headline
Development and implementation of a balanced scorecard in an academic hospitalist group
Sections
Article Source
Copyright © 2013 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Michael Hwa, MD, University of California, San Francisco, 533 Parnassus Avenue, Box 0131, San Francisco, CA 94143; Telephone: 415‐502‐1413; Fax: 415‐514‐2094; E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media
Media Files

It's Not About Pager Replacement

Article Type
Changed
Mon, 05/22/2017 - 18:10
Display Headline
It's not about pager replacement: An in‐depth look at the interprofessional nature of communication in healthcare

Clinical communication among healthcare providers to coordinate patient care is important, accounting for the majority of information exchanges in healthcare.[1, 2] Breakdowns in communication have therefore been identified as the major contributor to medical errors.[3, 4, 5]

There is a growing literature related to asynchronous clinical communication practices, or communication that does not occur at the same time in hospitals, and the limitations of using the traditional numeric pager. These include the inability to indicate the urgency of the message, frequent interruptions, contacting the wrong physician, and inefficiencies coordinating care across multiple disciplines and specialties.[6, 7, 8, 9, 10, 11, 12]

Hospitals have implemented a variety of health information technology (HIT) solutions to replace the numeric pager and address these clinical communication issues, including the use of alphanumeric pagers, smartphone devices, and Web‐based applications that allow clinicians to triage the urgency of issues.[13, 14, 15, 16] Although these solutions have resolved some of the deficiencies previously identified, issues relating to the impact on the interprofessional nature of healthcare remain unaddressed.[17] In some cases, the implementation of HIT has created unintended consequences that have an impact on effective communication.

One of the widely cited examples of HIT creating unintended consequences is the implementation of computerized physician order entry systems.[18, 19, 20] Other studies looking more broadly at patient information systems have identified problems caused by poor user interfaces that promoted errors in entry and retrieval of data, inflexible features forcing clinician workarounds, and technology designs that impeded clinical workflow.[21, 22, 23]

These observations suggest that although many of the issues with clinical communication stem from the reliance on numeric paging, simply replacing pagers with newer technology may not solve the problems and can in fact create other unintended consequences. These include unintended consequences resulting from the sociotechnical aspects of HIT, which is the interplay of technology with existing clinical workflow, culture, and social interactions.[21] Our institution recently implemented a Web‐based messaging system to replace the use of numeric pagers. We aimed to evaluate the unintended consequences resulting from the implementation of this system and to describe their impact on the delivery of clinical care on a general internal medicine (GIM) service.

METHODS

This was a pre‐post mixed‐methods study utilizing both quantitative and qualitative measures. We integrated these 2 data‐collection methods to improve the quality of the results. The study was conducted on the GIM service at the University Health Network Toronto Western Hospital site, a tertiary‐care academic teaching center fully affiliated with the University of Toronto (Toronto, Canada). The GIM service at Toronto Western Hospital consists of 4 clinical teams, each staffed by an attending physician, 3 to 4 residents, and 2 to 3 medical students.

Prior to this study, nonface‐to‐face communication on the wards was facilitated through numeric paging, where nurses, pharmacists, and social workers on the GIM wards would page residents to a hospital phone and wait for them to call back. Figures 1, 2, and 3 visualize the Web‐based messaging system we implemented at the University Health Network in May 2010. All residents on the service were provided smartphones that they used for communication. In addition to these, there was a dedicated team smartphone that acted as a central point of contact for the team 24 hours a day, 7 days a week and was carried by the physician covering the team at the time. The system allowed nurses, pharmacists, and social workers to triage the urgency of messages and include details providing context to the issue. Issues flagged as urgent were immediately sent to the team smartphone by e‐mail to alert the physician, who could respond from the smartphone. These messages could be forwarded to a team member, often the physician most familiar with the patient, to address. Issues flagged as nonurgent were posted to the system's message board, which the physicians accessed by logging into the Web‐based messaging system on a regular basis. The message board was designed to allow physicians to respond to multiple non‐urgent issues at once. To close the loop on communication, logic was developed so that if a physician did not respond to a non‐urgent message within the specified timeframe, the message was escalated and sent as an alerting e‐mail to the team smartphone every 15 minutes until it was addressed. The timeframes for responding varied from 1 hour to not needing a response until the next morning.

Figure 1
Sending a message.
Figure 2
Reading and replying to a message. Abbreviations: ambu trans, ambulance transport; d/c, discharge; pls, please; pt, patient.
Figure 3
Example of a message received on a smartphone. Abbreviations: bp, blood pressure; c/o, complains of; GIM, general internal medicine; O2 sat, oxygen saturation; p, pulse; po, by mouth; prn, as needed; pt, patient; r, respirations; RA, room air; temp, temperature.

Ongoing training on the use of the system was built into the clinical orientation for the physician and nursing staff, as turnover in an academic teaching hospital is quite high. The orientation included instructions on how to use the features of the Web‐based messaging system but also provided guidelines on general etiquette with using the system to ensure sustainability of the communication process. For example, physicians were asked to check the system regularly, as the process worked only if they responded to messages. Nurses were asked not to send messages during scheduled educational sessions unless necessary and to limit messages they flagged as urgent to ones that were in fact urgent.

Our quantitative evaluation compared interruptions, which we define as communication that caused a medical resident to stop current activity to address, before and after the implementation of the Web‐based messaging system to assess the volume and time distribution of messages, and compared these results with our qualitative evaluation. For the pre‐implementation phase, interruptions were all numeric pages sent to all residents during the period of July 1427, 2008. For the post‐implementation phase, interruptions were the e‐mails sent directly to the team smartphones from the Web‐based messaging system to all residents during the period of October 1124, 2010. We excluded messages from the postimplementation phase if the same message was sent >10 times, typically indicating technical issues such as a malfunction of the smartphone causing the escalation process to continue.

Our qualitative evaluation consisted of semistructured interviews that were conducted after implementation. A research coordinator sent e‐mails to potential physician participants during a 1‐month rotation (n=16), and nurses (N=50), pharmacists (N=4), and social workers (N=4) from a representative ward inviting them to be part of this study. A set of open‐ended questions (see Supporting Information, Appendix A, in the online version of this article) developed based on informal feedback regarding the system provided by physicians, nurses, pharmacists, and social workers served as a guide to highlight key themes of interest. Based on the participants' responses, further questions were asked to drill down into more detail. Interviews were transcribed verbatim and anonymized.

The interview data were analyzed using thematic analysis to generate categories and overarching themes.[24, 25] Once the coding structure was developed, the transcripts were imported into qualitative analysis software (NVivo 9, QSR International) and then coded and analyzed, pulling the key themes that emerged from the text to be used in interpreting the data.

RESULTS

Our quantitative before‐after comparison of clinical messages sent to physicians revealed an increase in interruptions. We compared these results to the results of our interviews to understand why this might have occurred. Several key themes emerged from the analysis of the interviews, including increase in interruptions, accountability, and tactics to improve personal productivity. We interviewed 5 physicians, 8 nurses, 2 pharmacists, and 2 social workers.

Pre‐Post System Usage Data: Quantitative Assessment

Table 1 outlines the number of numeric pages sent during the pre‐implementation phase of July 1427, 2008. All pages sent immediately alerted the resident and so were all considered interruptions. Table 1 also outlines the number of urgent and escalation messages sent via e‐mail to the residents during the post‐implementation phase of October 1124, 2010. All messages were sent immediately to the team smartphone alerting the resident and so were all considered interruptions. During both timeframes, there were 15 resident physicians on service. During the pre‐implementation phase, 117 patients were admitted to the GIM service, and 162 patients were admitted during the post‐implementation phase.

Message Counts for 14 Days Before and After Implementation
Numeric Paging (Predata)Advance Communication System (Postdata)
Pages sent710Urgent951
Interruptions710Escalations1245
Interruptions per resident per day3Interruptions2196
  Interruptions per resident per day10

Table 1 shows that the number of interruptions in the pre‐implementation phase was 710 (3 per resident per day) compared with 2196 (10 per resident per day) in the post‐implementation phase, a 233% increase in interruptions. Because admissions were higher in the post‐implementation phase, it is possible that higher patient volumes could have contributed to the increase in interruptions.

Semi‐Structured Interviews: Qualitative Assessment

Increase in Interruptions

The intent of the web‐based messaging system was to reduce interruptions by triaging clinical messages and allowing healthcare professionals to respond to multiple non‐urgent issues at once. The unexpected result, however, was that the frequency at which physicians were interrupted actually increased following implementation.

I feel like I'm constantly bombarded with things Just psychologically I feel like it's harassing me a lot more than the pager used to. [MD02, physician]

Yes. Definitely, I'm paging them more frequently in general than I would have previously. [RN02, nurse]

 

Increased interruptions occurred in part because traditional barriers to paging, like having to wait by a phone for a response, were eliminated by the new system. Sending a message was easy, and with the reliability introduced through team‐based paging, there was greater temptation to send separate messages for singular issues.

I think [that] before, things were saved up and then paged and given all at once. And now it's, like, there's a temptation just to send things all the time, like, small issues. [AH01, pharmacist]

 

Communication also increased due to the impersonal nature of the electronic system. With many of the barriers to communicating removed, such as receiving immediate feedback regarding the appropriateness of a message, staff no longer hesitated when sending messages regarding less‐important issues.

So some stuff that you may have not wanted to call for before 'cause it's kind of silly, you can just send it information‐only. So they're aware 'cause the thing about with using electronics it's a lot more impersonal and indirect. [RN03, nurse]

 

At the same time, nurses, pharmacists, and social workers acknowledged that receiving all of this additional, sometimes unnecessary, information could be frustrating for the physicians. This recognition alone, however, was not sufficient to modify their behavior.

So I find that I can imagine for them it may be a little frustrating 'cause they're getting all these tidbits of information. [RN03, nurse]

I'm sure they get overwhelmed and I've had the feedback from the team They were saying that they were getting constantly paged, not by me, just by me, but by everybody. [AH01, pharmacist]

 

Accountability

As part of their professional practice, nurses described a medico‐legal obligation to inform physicians about relevant patient issues such as abnormal laboratory values. A culture of accountability, therefore, underpinned many of the actions taken by the nurses, reinforced because the electronic messages sent through the system were permanent and retrievable. The physicians also used the system as an electronic record of discussions that occurred.

Because it's just, like, this thing about accountability in terms of letting them know, that they are aware. [RN03, nurse]

And I think everything you do is recorded, like, you can go back and check, so there's that legal piece, which I guess covers you, in terms of time you called, those things which are critical, what you are calling for. [RN09, nurse]

'Cause I use it now as a reference. So even if I have a phone conversation with a nurse, based on a message that we've had, I will record what we said and send it. [MD03, physician]

 

Some of the more junior nurses periodically felt unsure or uncomfortable with clinical situations and would send a message to the physician to share their concerns. The messaging reassured the nurses and made them feel like they were fulfilling their professional responsibilities.

So a senior nurse could probably take a look at some situation and they can acknowledge whether the issue is urgent or nonurgent But from a novice perspective, as you're still learning it kind of gives you peace of mind and feels like you're filling your responsibility and accountability, that you're passing on the messages. [RN03, nurse]

 

Whereas nurses felt they were fulfilling their professional obligations, some physicians felt that nurses were using the system to absolve themselves of their clinical responsibilities.

Some just feel the need to send everything on there and maybe they feel that by sending it on here they absolve themselves of responsibility. [MD05, physician]

 

Other clinicians felt that the system created more of a responsibility or obligation for the physicians to respond. They believed the escalation feature of the system helped ensure the physicians responded in some fashion to close the loop.

[T]hey have the responsibility to answer it if it's an urgent message and because it keeps coming on to remind them. [AH02, social worker]

 

Interestingly, there were physicians that identified the opposite and felt the system created less of a responsibility or obligation for them to respond. By knowing the context of the message, it gave them the ability to prioritize or ignore the message if they knew it was not life threatening.

[T]here's less of a responsibility or an obligation They get a message and then they can actually delay the process So in a way it actually allows us to kind of get away with some things and that happens because, you know, we're prioritizing something that we're doing as being more important to us. [MD01, physician]

 

Tactics to Improve Personal Productivity

The web‐based messaging system's triaging feature allows the sender of the message to indicate whether an issue is urgent or non‐urgent. Urgent issues result in an immediate e‐mail that is intended to elicit an immediate response. Some of the nurses, pharmacists, and social workers exploited features of the system to elicit immediate responses from the physicians for non‐urgent issues, including using their knowledge of the urgent and non‐urgent features of the system to interrupt the physicians.

I kind of cheat and don't use the system properly. So every message I send I always send it as urgent because I want it go to the smartphone. [AH01, pharmacist]

I like that if you know how to use the urgent and nonurgent features effectively it generally works quite well in getting a response in a timely fashion. [RN02, nurse]

 

One tactic that physicians perceived the nurses were using to elicit a response from them was to exaggerate the severity or urgency of the issue in their message.

Some details will be sort of cherry picked to make the issue sound very dire I'll give you a classic, like, high blood pressure and patient has a headache. So initially, you know, I have to think, does this patient have a hypertensive emergency? So by putting sort of history together in this way, that sort of suggestive way, then yeah. [MD03, physician]

 

The nurses, pharmacists. and social workers frequently exaggerated the urgency of their clinical messages at the end of their shifts in an effort to resolve outstanding issues immediately in order to avoid transferring tasks to another colleague or delaying them until the next day.

But in terms of a shift change, for example, I need a response now 'cause that is a lot of times where it is that although it's not clinically urgent it's time sensitive. So it is urgent. [RN02, nurse]

I do also notice that around changeover time, issues that have been sort of chronically or have preexisting, become urgent issues. [MD01, physician]

 

Messages were also sent inappropriately as urgent as a strategy to ensure the physician dealt with the issue promptly and did not forget to complete the requested task associated with the issue.

Everybody puts urgent because we want the response immediately. Otherwise, if you put nonurgent, the doctors will just drag and drag and will forget to respond to the issue. [RN09, nurse]

 

However, because physicians received context clarifying the urgency of the message, they were able to prioritize their tasks and defer less‐important issues without compromising patient safety or quality of care, allowing them to use their time more productively. This, however, did not always align with the sender's request.

I think the key thing is that the information coming to us is text and it describes the issue. So we can, at our end, then we can make a call as to what the priority is. [MD03, physician]

 

DISCUSSION

The purpose of this study was to evaluate a Web‐based messaging system and identify the unintended consequences observed with implementing HIT to improve clinical communication. This is an important study because healthcare organizations are beginning to develop strategies for improving clinical communication but believe the solution involves simply replacing pager technology. Support for this approach is seen with larger vendors in the smartphone and communication industry, who promote their products as pager‐replacement solutions and even help customers develop pager‐replacement strategies.[26, 27, 28] Simply replacing pagers with smartphones and sending text messages will have only a limited impact on improving clinical communication and will likely result in unintended negative consequences, as seen in this study.

Whereas the Web‐based messaging system was designed to reduce interruptions from clinical messaging, interruptions actually increased, although the mental burden of each interruption was likely lower because responding to a text message is less interruptive than finding a telephone to answer a page. A key contributor to this effect was a culture of accountability among nurses, pharmacists, and social workers who felt it was their professional obligation to notify physicians about all issues of concern. This belief and related behavior is aligned with the standards promoted by professional regulatory bodies that identify accountability as a vital practice expectation.[29] Nurses and nursing staff take responsibility for the care they provide and answer for their own judgments and actions.[30] The system eliminated many of the previous barriers to paging and provided a less‐personal form of communication. The cumulative and unexpected outcome was an increase of interruptions for physicians and the adoption of workarounds by all healthcare professionals to improve personal productivity. Although the system was built in an iterative fashion with frontline clinicians, it is likely that oversights in the design of the system also contributed to these problems, which speaks to the complexity of clinical communication. Centralizing communication to the team smartphone could have overburdened the physicians covering it at the time, causing them to ignore messages because they were too busy to address them.

There were limitations to this study. One limitation was that this study examined only a cross‐section of messaging activity at a given point in time, and therefore it may not be representative of the behaviors of the physicians, nurses, pharmacists, and social workers over time as the culture of the environment evolves and they adjust to the new technology. The pre‐implementation data were collected 2 years prior to the post‐implementation data, but it was necessary to use data this old because other interventions were implemented prior to the Web‐based messaging system, so baseline paging data were no longer available. Whereas most clinical disciplines were represented in the interviews, the sample included only 17 participants from 1 clinical service, so generalizability of the results may be limited.

Although the reliance on numeric paging technology was previously identified as a primary source of problems with communication, the real issues are much more complex. This study highlighted that many of the underlying obstacles relate to existing social interactions and habits of multiple professions working together. Failures in collaboration among healthcare professionals have a negative impact on health outcomes and routinely stem from the lack of explicit definitions of roles, the absence of clear leadership, insufficient time for team‐building, the us‐and‐them effects created by professional socialization, and frustration created by power and status differentials of each discipline.[31, 32, 33] Therefore, it is critical that healthcare organizations focus on the people and clinical processes when implementing technology to solve issues with clinical communication. These observations are consistent with other studies examining the unintended consequences caused by the sociotechnical aspects of HIT implementation, where workarounds to game the system were also employed.[21]

In summary, improving clinical communication cannot be achieved simply by replacing pagers with newer technology; it requires a fundamental shift in how healthcare professionals interact, with a focus on the sociotechnical aspects of HIT. As patient volumes and the complexity of care continue to increase, more effective methods for facilitating interprofessional communication and collaboration must be developed.

Acknowledgements

Disclosures: This study was funded in part by a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research. The authors report no conflicts of interest.

Files
References
  1. Coiera E. When conversation is better than computation. J Am Med Inform Assoc. 2000;7(3):277286.
  2. Edwards A, Fitzpatrick LA, Augustine S, et al. Synchronous communication facilitates interruptive workflow for attending physicians and nurses in clinical settings. Int J Med Inform. 2009;78(9):629637.
  3. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377384.
  4. Sutcliffe KM, Lewton E, Rosenthal MM. Communication failures: an insidious contributor to medical mishaps. Acad Med. 2004;79(2):186194.
  5. The Joint Commission. Improving America's Hospitals: The Joint Commission's Annual Report on Quality and Safety. Oakbrook Terrace, IL: The Joint Commission; 2007. Available at: http://www.jointcommission.org/assets/1/6/2007_Annual_Report.pdf. Accessed on April 16, 2012.
  6. Volpp KG, Grande D. Residents' suggestions for reducing errors in teaching hospitals. N Engl J Med. 2003;348(9):851855.
  7. Grundgeiger T, Sanderson P. Interruptions in healthcare: theoretical views. Int J Med Inform. 2009;78(5):293307.
  8. Wong BM, Quan S, Cheung CM, et al. Frequency and clinical importance of pages sent to the wrong physician. Arch Intern Med. 2009;169(11):10721073.
  9. Arora V, Johnson J, Lovinger D, Humphrey HJ, Meltzer DO. Communication failures in patient sign‐out and suggestions for improvement: a critical incident analysis. Qual Saf Health Care. 2005;14(6):401407.
  10. Lingard L, Whyte S, Espin S, Baker GR, Orser B, Doran D. Towards safer interprofessional communication: Constructing a model of “utility” from preoperative team briefings. J Interprof Care. 2006;20(5):471483.
  11. Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice‐based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009(3):CD000072.
  12. Richardson JE, Ash JS. The effects of hands free communication devices on clinical communication: balancing communication access needs with user control. AMIA Annu Symp Proc. 2008;621625.
  13. Locke KA, Duffey‐Rosenstein B, Lio G, Morra D, Hariton N. Beyond paging: building a web‐based communication tool for nurses and physicians. J Gen Intern Med. 2009;24(1):105110.
  14. Wu RC, Morra D, Quan S, et al. The use of smartphones for clinical communication on internal medicine wards. J Hosp Med. 2010;5(9):553559.
  15. Wong BM, Quan S, Shadowitz S, Etchells E. Implementation and evaluation of an alpha‐numeric paging system on a resident inpatient teaching service. J Hosp Med. 2009;4(8):E34E40.
  16. Wu RC, Tran K, Lo V, et al. Effects of clinical communication interventions in hospitals: a systematic review of information and communication technology adoptions for improved communication between clinicians. Int J Med Inform. 2012;81(11):723732.
  17. Wu R, Rossos P, Quan S, et al. An evaluation of the use of smartphones to communicate between clinicians: a mixed‐methods study. J Med Internet Res. 2011;13(3):e59.
  18. Maslove DM, Rizk N, Lowe HJ. Computerized physician order entry in the critical care environment: a review of current literature. J Intensive Care Med. 2011;26(3):165171.
  19. Wetterneck TB, Walker JM, Blosky MA, et al. Factors contributing to an increase in duplicate medication order errors after CPOE implementation. J Am Med Inform Assoc. 2011;18(6):774782.
  20. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293(10):11971203.
  21. Harrison MI, Koppel R, Bar‐Lev S. Unintended consequences of information technologies in health care—an interactive sociotechnical analysis. J Am Med Inform Assoc. 2007;14(5):542549.
  22. Johnson CW. Why did that happen? Exploring the proliferation of barely usable software in healthcare systems. Qual Saf Health Care. 2006;(15 suppl 1):i76i81.
  23. Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system‐related errors. J Am Med Inform Assoc. 2004;11(2):104112.
  24. Priest H, Roberts P, Woods L. An overview of three different approaches to the interpretation of qualitative data. Part 1: Theoretical issues. Nurse Res. 2002;10(1):3042.
  25. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):12771288.
  26. Research in Motion, Amcom Software. Six things hospitals need to know about replacing pagers with smartphones. Available at: http://us.blackberry.com/business/industry/healthcare/6ThingstoKnow_ReplacingHospitalPagers_WhitePaper.pdf. Accessed on April 16, 2012.
  27. Vocera, Wallace Wireless. The Longstreet Clinic: replacing pagers, supercharging communication with WIC pager. Available at: http://www.vocera.com/assets/pdf/case_studies/cs_longstreetclinic_0910_v1.pdf. Accessed on April 16, 2012.
  28. Amcom Software reports strong momentum with its new smartphone messaging and pager replacement solution [press release]. Minneapolis, MN: Amcom Software; September 29, 2010. Available at: http://www.amcomsoftware.com/News/09‐29‐10.aspx. Accessed on April 16, 2012.
  29. College of Nurses of Ontario. 2011 standards and guidelines. Availableat: http://www.cno.org/en/learn‐about‐standards‐guidelines/publications‐list/standards‐and‐guidelines. Accessed on April 16, 2012.
  30. Scrivener R, Hand T, Hooper R. Accountability and responsibility: principle of nursing practice B. Nurs Stand. 2011;25(29):3536.
  31. Baggs JG, Ryan SA, Phelps CE, Richeson JF, Johnson JE. The association between interdisciplinary collaboration and patient outcomes in a medical intensive care unit. Heart Lung. 1992;21(1):1824.
  32. Waugaman WR. Professionalization and socialization in interprofessional collaboration. In: Casto RM, Julia MC, eds. Interprofessional Care and Collaborative Practice. 1st ed. Independence, KY: Cengage Learning; 1994:2331.
  33. Zwarenstein M, Reeves S. Knowledge translation and interprofessional collaboration: where the rubber of evidence‐based care hits the road of teamwork. J Contin Educ Health Prof. 2006;26(1):4654.
Article PDF
Issue
Journal of Hospital Medicine - 8(3)
Page Number
137-143
Sections
Files
Files
Article PDF
Article PDF

Clinical communication among healthcare providers to coordinate patient care is important, accounting for the majority of information exchanges in healthcare.[1, 2] Breakdowns in communication have therefore been identified as the major contributor to medical errors.[3, 4, 5]

There is a growing literature related to asynchronous clinical communication practices, or communication that does not occur at the same time in hospitals, and the limitations of using the traditional numeric pager. These include the inability to indicate the urgency of the message, frequent interruptions, contacting the wrong physician, and inefficiencies coordinating care across multiple disciplines and specialties.[6, 7, 8, 9, 10, 11, 12]

Hospitals have implemented a variety of health information technology (HIT) solutions to replace the numeric pager and address these clinical communication issues, including the use of alphanumeric pagers, smartphone devices, and Web‐based applications that allow clinicians to triage the urgency of issues.[13, 14, 15, 16] Although these solutions have resolved some of the deficiencies previously identified, issues relating to the impact on the interprofessional nature of healthcare remain unaddressed.[17] In some cases, the implementation of HIT has created unintended consequences that have an impact on effective communication.

One of the widely cited examples of HIT creating unintended consequences is the implementation of computerized physician order entry systems.[18, 19, 20] Other studies looking more broadly at patient information systems have identified problems caused by poor user interfaces that promoted errors in entry and retrieval of data, inflexible features forcing clinician workarounds, and technology designs that impeded clinical workflow.[21, 22, 23]

These observations suggest that although many of the issues with clinical communication stem from the reliance on numeric paging, simply replacing pagers with newer technology may not solve the problems and can in fact create other unintended consequences. These include unintended consequences resulting from the sociotechnical aspects of HIT, which is the interplay of technology with existing clinical workflow, culture, and social interactions.[21] Our institution recently implemented a Web‐based messaging system to replace the use of numeric pagers. We aimed to evaluate the unintended consequences resulting from the implementation of this system and to describe their impact on the delivery of clinical care on a general internal medicine (GIM) service.

METHODS

This was a pre‐post mixed‐methods study utilizing both quantitative and qualitative measures. We integrated these 2 data‐collection methods to improve the quality of the results. The study was conducted on the GIM service at the University Health Network Toronto Western Hospital site, a tertiary‐care academic teaching center fully affiliated with the University of Toronto (Toronto, Canada). The GIM service at Toronto Western Hospital consists of 4 clinical teams, each staffed by an attending physician, 3 to 4 residents, and 2 to 3 medical students.

Prior to this study, nonface‐to‐face communication on the wards was facilitated through numeric paging, where nurses, pharmacists, and social workers on the GIM wards would page residents to a hospital phone and wait for them to call back. Figures 1, 2, and 3 visualize the Web‐based messaging system we implemented at the University Health Network in May 2010. All residents on the service were provided smartphones that they used for communication. In addition to these, there was a dedicated team smartphone that acted as a central point of contact for the team 24 hours a day, 7 days a week and was carried by the physician covering the team at the time. The system allowed nurses, pharmacists, and social workers to triage the urgency of messages and include details providing context to the issue. Issues flagged as urgent were immediately sent to the team smartphone by e‐mail to alert the physician, who could respond from the smartphone. These messages could be forwarded to a team member, often the physician most familiar with the patient, to address. Issues flagged as nonurgent were posted to the system's message board, which the physicians accessed by logging into the Web‐based messaging system on a regular basis. The message board was designed to allow physicians to respond to multiple non‐urgent issues at once. To close the loop on communication, logic was developed so that if a physician did not respond to a non‐urgent message within the specified timeframe, the message was escalated and sent as an alerting e‐mail to the team smartphone every 15 minutes until it was addressed. The timeframes for responding varied from 1 hour to not needing a response until the next morning.

Figure 1
Sending a message.
Figure 2
Reading and replying to a message. Abbreviations: ambu trans, ambulance transport; d/c, discharge; pls, please; pt, patient.
Figure 3
Example of a message received on a smartphone. Abbreviations: bp, blood pressure; c/o, complains of; GIM, general internal medicine; O2 sat, oxygen saturation; p, pulse; po, by mouth; prn, as needed; pt, patient; r, respirations; RA, room air; temp, temperature.

Ongoing training on the use of the system was built into the clinical orientation for the physician and nursing staff, as turnover in an academic teaching hospital is quite high. The orientation included instructions on how to use the features of the Web‐based messaging system but also provided guidelines on general etiquette with using the system to ensure sustainability of the communication process. For example, physicians were asked to check the system regularly, as the process worked only if they responded to messages. Nurses were asked not to send messages during scheduled educational sessions unless necessary and to limit messages they flagged as urgent to ones that were in fact urgent.

Our quantitative evaluation compared interruptions, which we define as communication that caused a medical resident to stop current activity to address, before and after the implementation of the Web‐based messaging system to assess the volume and time distribution of messages, and compared these results with our qualitative evaluation. For the pre‐implementation phase, interruptions were all numeric pages sent to all residents during the period of July 1427, 2008. For the post‐implementation phase, interruptions were the e‐mails sent directly to the team smartphones from the Web‐based messaging system to all residents during the period of October 1124, 2010. We excluded messages from the postimplementation phase if the same message was sent >10 times, typically indicating technical issues such as a malfunction of the smartphone causing the escalation process to continue.

Our qualitative evaluation consisted of semistructured interviews that were conducted after implementation. A research coordinator sent e‐mails to potential physician participants during a 1‐month rotation (n=16), and nurses (N=50), pharmacists (N=4), and social workers (N=4) from a representative ward inviting them to be part of this study. A set of open‐ended questions (see Supporting Information, Appendix A, in the online version of this article) developed based on informal feedback regarding the system provided by physicians, nurses, pharmacists, and social workers served as a guide to highlight key themes of interest. Based on the participants' responses, further questions were asked to drill down into more detail. Interviews were transcribed verbatim and anonymized.

The interview data were analyzed using thematic analysis to generate categories and overarching themes.[24, 25] Once the coding structure was developed, the transcripts were imported into qualitative analysis software (NVivo 9, QSR International) and then coded and analyzed, pulling the key themes that emerged from the text to be used in interpreting the data.

RESULTS

Our quantitative before‐after comparison of clinical messages sent to physicians revealed an increase in interruptions. We compared these results to the results of our interviews to understand why this might have occurred. Several key themes emerged from the analysis of the interviews, including increase in interruptions, accountability, and tactics to improve personal productivity. We interviewed 5 physicians, 8 nurses, 2 pharmacists, and 2 social workers.

Pre‐Post System Usage Data: Quantitative Assessment

Table 1 outlines the number of numeric pages sent during the pre‐implementation phase of July 1427, 2008. All pages sent immediately alerted the resident and so were all considered interruptions. Table 1 also outlines the number of urgent and escalation messages sent via e‐mail to the residents during the post‐implementation phase of October 1124, 2010. All messages were sent immediately to the team smartphone alerting the resident and so were all considered interruptions. During both timeframes, there were 15 resident physicians on service. During the pre‐implementation phase, 117 patients were admitted to the GIM service, and 162 patients were admitted during the post‐implementation phase.

Message Counts for 14 Days Before and After Implementation
Numeric Paging (Predata)Advance Communication System (Postdata)
Pages sent710Urgent951
Interruptions710Escalations1245
Interruptions per resident per day3Interruptions2196
  Interruptions per resident per day10

Table 1 shows that the number of interruptions in the pre‐implementation phase was 710 (3 per resident per day) compared with 2196 (10 per resident per day) in the post‐implementation phase, a 233% increase in interruptions. Because admissions were higher in the post‐implementation phase, it is possible that higher patient volumes could have contributed to the increase in interruptions.

Semi‐Structured Interviews: Qualitative Assessment

Increase in Interruptions

The intent of the web‐based messaging system was to reduce interruptions by triaging clinical messages and allowing healthcare professionals to respond to multiple non‐urgent issues at once. The unexpected result, however, was that the frequency at which physicians were interrupted actually increased following implementation.

I feel like I'm constantly bombarded with things Just psychologically I feel like it's harassing me a lot more than the pager used to. [MD02, physician]

Yes. Definitely, I'm paging them more frequently in general than I would have previously. [RN02, nurse]

 

Increased interruptions occurred in part because traditional barriers to paging, like having to wait by a phone for a response, were eliminated by the new system. Sending a message was easy, and with the reliability introduced through team‐based paging, there was greater temptation to send separate messages for singular issues.

I think [that] before, things were saved up and then paged and given all at once. And now it's, like, there's a temptation just to send things all the time, like, small issues. [AH01, pharmacist]

 

Communication also increased due to the impersonal nature of the electronic system. With many of the barriers to communicating removed, such as receiving immediate feedback regarding the appropriateness of a message, staff no longer hesitated when sending messages regarding less‐important issues.

So some stuff that you may have not wanted to call for before 'cause it's kind of silly, you can just send it information‐only. So they're aware 'cause the thing about with using electronics it's a lot more impersonal and indirect. [RN03, nurse]

 

At the same time, nurses, pharmacists, and social workers acknowledged that receiving all of this additional, sometimes unnecessary, information could be frustrating for the physicians. This recognition alone, however, was not sufficient to modify their behavior.

So I find that I can imagine for them it may be a little frustrating 'cause they're getting all these tidbits of information. [RN03, nurse]

I'm sure they get overwhelmed and I've had the feedback from the team They were saying that they were getting constantly paged, not by me, just by me, but by everybody. [AH01, pharmacist]

 

Accountability

As part of their professional practice, nurses described a medico‐legal obligation to inform physicians about relevant patient issues such as abnormal laboratory values. A culture of accountability, therefore, underpinned many of the actions taken by the nurses, reinforced because the electronic messages sent through the system were permanent and retrievable. The physicians also used the system as an electronic record of discussions that occurred.

Because it's just, like, this thing about accountability in terms of letting them know, that they are aware. [RN03, nurse]

And I think everything you do is recorded, like, you can go back and check, so there's that legal piece, which I guess covers you, in terms of time you called, those things which are critical, what you are calling for. [RN09, nurse]

'Cause I use it now as a reference. So even if I have a phone conversation with a nurse, based on a message that we've had, I will record what we said and send it. [MD03, physician]

 

Some of the more junior nurses periodically felt unsure or uncomfortable with clinical situations and would send a message to the physician to share their concerns. The messaging reassured the nurses and made them feel like they were fulfilling their professional responsibilities.

So a senior nurse could probably take a look at some situation and they can acknowledge whether the issue is urgent or nonurgent But from a novice perspective, as you're still learning it kind of gives you peace of mind and feels like you're filling your responsibility and accountability, that you're passing on the messages. [RN03, nurse]

 

Whereas nurses felt they were fulfilling their professional obligations, some physicians felt that nurses were using the system to absolve themselves of their clinical responsibilities.

Some just feel the need to send everything on there and maybe they feel that by sending it on here they absolve themselves of responsibility. [MD05, physician]

 

Other clinicians felt that the system created more of a responsibility or obligation for the physicians to respond. They believed the escalation feature of the system helped ensure the physicians responded in some fashion to close the loop.

[T]hey have the responsibility to answer it if it's an urgent message and because it keeps coming on to remind them. [AH02, social worker]

 

Interestingly, there were physicians that identified the opposite and felt the system created less of a responsibility or obligation for them to respond. By knowing the context of the message, it gave them the ability to prioritize or ignore the message if they knew it was not life threatening.

[T]here's less of a responsibility or an obligation They get a message and then they can actually delay the process So in a way it actually allows us to kind of get away with some things and that happens because, you know, we're prioritizing something that we're doing as being more important to us. [MD01, physician]

 

Tactics to Improve Personal Productivity

The web‐based messaging system's triaging feature allows the sender of the message to indicate whether an issue is urgent or non‐urgent. Urgent issues result in an immediate e‐mail that is intended to elicit an immediate response. Some of the nurses, pharmacists, and social workers exploited features of the system to elicit immediate responses from the physicians for non‐urgent issues, including using their knowledge of the urgent and non‐urgent features of the system to interrupt the physicians.

I kind of cheat and don't use the system properly. So every message I send I always send it as urgent because I want it go to the smartphone. [AH01, pharmacist]

I like that if you know how to use the urgent and nonurgent features effectively it generally works quite well in getting a response in a timely fashion. [RN02, nurse]

 

One tactic that physicians perceived the nurses were using to elicit a response from them was to exaggerate the severity or urgency of the issue in their message.

Some details will be sort of cherry picked to make the issue sound very dire I'll give you a classic, like, high blood pressure and patient has a headache. So initially, you know, I have to think, does this patient have a hypertensive emergency? So by putting sort of history together in this way, that sort of suggestive way, then yeah. [MD03, physician]

 

The nurses, pharmacists. and social workers frequently exaggerated the urgency of their clinical messages at the end of their shifts in an effort to resolve outstanding issues immediately in order to avoid transferring tasks to another colleague or delaying them until the next day.

But in terms of a shift change, for example, I need a response now 'cause that is a lot of times where it is that although it's not clinically urgent it's time sensitive. So it is urgent. [RN02, nurse]

I do also notice that around changeover time, issues that have been sort of chronically or have preexisting, become urgent issues. [MD01, physician]

 

Messages were also sent inappropriately as urgent as a strategy to ensure the physician dealt with the issue promptly and did not forget to complete the requested task associated with the issue.

Everybody puts urgent because we want the response immediately. Otherwise, if you put nonurgent, the doctors will just drag and drag and will forget to respond to the issue. [RN09, nurse]

 

However, because physicians received context clarifying the urgency of the message, they were able to prioritize their tasks and defer less‐important issues without compromising patient safety or quality of care, allowing them to use their time more productively. This, however, did not always align with the sender's request.

I think the key thing is that the information coming to us is text and it describes the issue. So we can, at our end, then we can make a call as to what the priority is. [MD03, physician]

 

DISCUSSION

The purpose of this study was to evaluate a Web‐based messaging system and identify the unintended consequences observed with implementing HIT to improve clinical communication. This is an important study because healthcare organizations are beginning to develop strategies for improving clinical communication but believe the solution involves simply replacing pager technology. Support for this approach is seen with larger vendors in the smartphone and communication industry, who promote their products as pager‐replacement solutions and even help customers develop pager‐replacement strategies.[26, 27, 28] Simply replacing pagers with smartphones and sending text messages will have only a limited impact on improving clinical communication and will likely result in unintended negative consequences, as seen in this study.

Whereas the Web‐based messaging system was designed to reduce interruptions from clinical messaging, interruptions actually increased, although the mental burden of each interruption was likely lower because responding to a text message is less interruptive than finding a telephone to answer a page. A key contributor to this effect was a culture of accountability among nurses, pharmacists, and social workers who felt it was their professional obligation to notify physicians about all issues of concern. This belief and related behavior is aligned with the standards promoted by professional regulatory bodies that identify accountability as a vital practice expectation.[29] Nurses and nursing staff take responsibility for the care they provide and answer for their own judgments and actions.[30] The system eliminated many of the previous barriers to paging and provided a less‐personal form of communication. The cumulative and unexpected outcome was an increase of interruptions for physicians and the adoption of workarounds by all healthcare professionals to improve personal productivity. Although the system was built in an iterative fashion with frontline clinicians, it is likely that oversights in the design of the system also contributed to these problems, which speaks to the complexity of clinical communication. Centralizing communication to the team smartphone could have overburdened the physicians covering it at the time, causing them to ignore messages because they were too busy to address them.

There were limitations to this study. One limitation was that this study examined only a cross‐section of messaging activity at a given point in time, and therefore it may not be representative of the behaviors of the physicians, nurses, pharmacists, and social workers over time as the culture of the environment evolves and they adjust to the new technology. The pre‐implementation data were collected 2 years prior to the post‐implementation data, but it was necessary to use data this old because other interventions were implemented prior to the Web‐based messaging system, so baseline paging data were no longer available. Whereas most clinical disciplines were represented in the interviews, the sample included only 17 participants from 1 clinical service, so generalizability of the results may be limited.

Although the reliance on numeric paging technology was previously identified as a primary source of problems with communication, the real issues are much more complex. This study highlighted that many of the underlying obstacles relate to existing social interactions and habits of multiple professions working together. Failures in collaboration among healthcare professionals have a negative impact on health outcomes and routinely stem from the lack of explicit definitions of roles, the absence of clear leadership, insufficient time for team‐building, the us‐and‐them effects created by professional socialization, and frustration created by power and status differentials of each discipline.[31, 32, 33] Therefore, it is critical that healthcare organizations focus on the people and clinical processes when implementing technology to solve issues with clinical communication. These observations are consistent with other studies examining the unintended consequences caused by the sociotechnical aspects of HIT implementation, where workarounds to game the system were also employed.[21]

In summary, improving clinical communication cannot be achieved simply by replacing pagers with newer technology; it requires a fundamental shift in how healthcare professionals interact, with a focus on the sociotechnical aspects of HIT. As patient volumes and the complexity of care continue to increase, more effective methods for facilitating interprofessional communication and collaboration must be developed.

Acknowledgements

Disclosures: This study was funded in part by a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research. The authors report no conflicts of interest.

Clinical communication among healthcare providers to coordinate patient care is important, accounting for the majority of information exchanges in healthcare.[1, 2] Breakdowns in communication have therefore been identified as the major contributor to medical errors.[3, 4, 5]

There is a growing literature related to asynchronous clinical communication practices, or communication that does not occur at the same time in hospitals, and the limitations of using the traditional numeric pager. These include the inability to indicate the urgency of the message, frequent interruptions, contacting the wrong physician, and inefficiencies coordinating care across multiple disciplines and specialties.[6, 7, 8, 9, 10, 11, 12]

Hospitals have implemented a variety of health information technology (HIT) solutions to replace the numeric pager and address these clinical communication issues, including the use of alphanumeric pagers, smartphone devices, and Web‐based applications that allow clinicians to triage the urgency of issues.[13, 14, 15, 16] Although these solutions have resolved some of the deficiencies previously identified, issues relating to the impact on the interprofessional nature of healthcare remain unaddressed.[17] In some cases, the implementation of HIT has created unintended consequences that have an impact on effective communication.

One of the widely cited examples of HIT creating unintended consequences is the implementation of computerized physician order entry systems.[18, 19, 20] Other studies looking more broadly at patient information systems have identified problems caused by poor user interfaces that promoted errors in entry and retrieval of data, inflexible features forcing clinician workarounds, and technology designs that impeded clinical workflow.[21, 22, 23]

These observations suggest that although many of the issues with clinical communication stem from the reliance on numeric paging, simply replacing pagers with newer technology may not solve the problems and can in fact create other unintended consequences. These include unintended consequences resulting from the sociotechnical aspects of HIT, which is the interplay of technology with existing clinical workflow, culture, and social interactions.[21] Our institution recently implemented a Web‐based messaging system to replace the use of numeric pagers. We aimed to evaluate the unintended consequences resulting from the implementation of this system and to describe their impact on the delivery of clinical care on a general internal medicine (GIM) service.

METHODS

This was a pre‐post mixed‐methods study utilizing both quantitative and qualitative measures. We integrated these 2 data‐collection methods to improve the quality of the results. The study was conducted on the GIM service at the University Health Network Toronto Western Hospital site, a tertiary‐care academic teaching center fully affiliated with the University of Toronto (Toronto, Canada). The GIM service at Toronto Western Hospital consists of 4 clinical teams, each staffed by an attending physician, 3 to 4 residents, and 2 to 3 medical students.

Prior to this study, nonface‐to‐face communication on the wards was facilitated through numeric paging, where nurses, pharmacists, and social workers on the GIM wards would page residents to a hospital phone and wait for them to call back. Figures 1, 2, and 3 visualize the Web‐based messaging system we implemented at the University Health Network in May 2010. All residents on the service were provided smartphones that they used for communication. In addition to these, there was a dedicated team smartphone that acted as a central point of contact for the team 24 hours a day, 7 days a week and was carried by the physician covering the team at the time. The system allowed nurses, pharmacists, and social workers to triage the urgency of messages and include details providing context to the issue. Issues flagged as urgent were immediately sent to the team smartphone by e‐mail to alert the physician, who could respond from the smartphone. These messages could be forwarded to a team member, often the physician most familiar with the patient, to address. Issues flagged as nonurgent were posted to the system's message board, which the physicians accessed by logging into the Web‐based messaging system on a regular basis. The message board was designed to allow physicians to respond to multiple non‐urgent issues at once. To close the loop on communication, logic was developed so that if a physician did not respond to a non‐urgent message within the specified timeframe, the message was escalated and sent as an alerting e‐mail to the team smartphone every 15 minutes until it was addressed. The timeframes for responding varied from 1 hour to not needing a response until the next morning.

Figure 1
Sending a message.
Figure 2
Reading and replying to a message. Abbreviations: ambu trans, ambulance transport; d/c, discharge; pls, please; pt, patient.
Figure 3
Example of a message received on a smartphone. Abbreviations: bp, blood pressure; c/o, complains of; GIM, general internal medicine; O2 sat, oxygen saturation; p, pulse; po, by mouth; prn, as needed; pt, patient; r, respirations; RA, room air; temp, temperature.

Ongoing training on the use of the system was built into the clinical orientation for the physician and nursing staff, as turnover in an academic teaching hospital is quite high. The orientation included instructions on how to use the features of the Web‐based messaging system but also provided guidelines on general etiquette with using the system to ensure sustainability of the communication process. For example, physicians were asked to check the system regularly, as the process worked only if they responded to messages. Nurses were asked not to send messages during scheduled educational sessions unless necessary and to limit messages they flagged as urgent to ones that were in fact urgent.

Our quantitative evaluation compared interruptions, which we define as communication that caused a medical resident to stop current activity to address, before and after the implementation of the Web‐based messaging system to assess the volume and time distribution of messages, and compared these results with our qualitative evaluation. For the pre‐implementation phase, interruptions were all numeric pages sent to all residents during the period of July 1427, 2008. For the post‐implementation phase, interruptions were the e‐mails sent directly to the team smartphones from the Web‐based messaging system to all residents during the period of October 1124, 2010. We excluded messages from the postimplementation phase if the same message was sent >10 times, typically indicating technical issues such as a malfunction of the smartphone causing the escalation process to continue.

Our qualitative evaluation consisted of semistructured interviews that were conducted after implementation. A research coordinator sent e‐mails to potential physician participants during a 1‐month rotation (n=16), and nurses (N=50), pharmacists (N=4), and social workers (N=4) from a representative ward inviting them to be part of this study. A set of open‐ended questions (see Supporting Information, Appendix A, in the online version of this article) developed based on informal feedback regarding the system provided by physicians, nurses, pharmacists, and social workers served as a guide to highlight key themes of interest. Based on the participants' responses, further questions were asked to drill down into more detail. Interviews were transcribed verbatim and anonymized.

The interview data were analyzed using thematic analysis to generate categories and overarching themes.[24, 25] Once the coding structure was developed, the transcripts were imported into qualitative analysis software (NVivo 9, QSR International) and then coded and analyzed, pulling the key themes that emerged from the text to be used in interpreting the data.

RESULTS

Our quantitative before‐after comparison of clinical messages sent to physicians revealed an increase in interruptions. We compared these results to the results of our interviews to understand why this might have occurred. Several key themes emerged from the analysis of the interviews, including increase in interruptions, accountability, and tactics to improve personal productivity. We interviewed 5 physicians, 8 nurses, 2 pharmacists, and 2 social workers.

Pre‐Post System Usage Data: Quantitative Assessment

Table 1 outlines the number of numeric pages sent during the pre‐implementation phase of July 1427, 2008. All pages sent immediately alerted the resident and so were all considered interruptions. Table 1 also outlines the number of urgent and escalation messages sent via e‐mail to the residents during the post‐implementation phase of October 1124, 2010. All messages were sent immediately to the team smartphone alerting the resident and so were all considered interruptions. During both timeframes, there were 15 resident physicians on service. During the pre‐implementation phase, 117 patients were admitted to the GIM service, and 162 patients were admitted during the post‐implementation phase.

Message Counts for 14 Days Before and After Implementation
Numeric Paging (Predata)Advance Communication System (Postdata)
Pages sent710Urgent951
Interruptions710Escalations1245
Interruptions per resident per day3Interruptions2196
  Interruptions per resident per day10

Table 1 shows that the number of interruptions in the pre‐implementation phase was 710 (3 per resident per day) compared with 2196 (10 per resident per day) in the post‐implementation phase, a 233% increase in interruptions. Because admissions were higher in the post‐implementation phase, it is possible that higher patient volumes could have contributed to the increase in interruptions.

Semi‐Structured Interviews: Qualitative Assessment

Increase in Interruptions

The intent of the web‐based messaging system was to reduce interruptions by triaging clinical messages and allowing healthcare professionals to respond to multiple non‐urgent issues at once. The unexpected result, however, was that the frequency at which physicians were interrupted actually increased following implementation.

I feel like I'm constantly bombarded with things Just psychologically I feel like it's harassing me a lot more than the pager used to. [MD02, physician]

Yes. Definitely, I'm paging them more frequently in general than I would have previously. [RN02, nurse]

 

Increased interruptions occurred in part because traditional barriers to paging, like having to wait by a phone for a response, were eliminated by the new system. Sending a message was easy, and with the reliability introduced through team‐based paging, there was greater temptation to send separate messages for singular issues.

I think [that] before, things were saved up and then paged and given all at once. And now it's, like, there's a temptation just to send things all the time, like, small issues. [AH01, pharmacist]

 

Communication also increased due to the impersonal nature of the electronic system. With many of the barriers to communicating removed, such as receiving immediate feedback regarding the appropriateness of a message, staff no longer hesitated when sending messages regarding less‐important issues.

So some stuff that you may have not wanted to call for before 'cause it's kind of silly, you can just send it information‐only. So they're aware 'cause the thing about with using electronics it's a lot more impersonal and indirect. [RN03, nurse]

 

At the same time, nurses, pharmacists, and social workers acknowledged that receiving all of this additional, sometimes unnecessary, information could be frustrating for the physicians. This recognition alone, however, was not sufficient to modify their behavior.

So I find that I can imagine for them it may be a little frustrating 'cause they're getting all these tidbits of information. [RN03, nurse]

I'm sure they get overwhelmed and I've had the feedback from the team They were saying that they were getting constantly paged, not by me, just by me, but by everybody. [AH01, pharmacist]

 

Accountability

As part of their professional practice, nurses described a medico‐legal obligation to inform physicians about relevant patient issues such as abnormal laboratory values. A culture of accountability, therefore, underpinned many of the actions taken by the nurses, reinforced because the electronic messages sent through the system were permanent and retrievable. The physicians also used the system as an electronic record of discussions that occurred.

Because it's just, like, this thing about accountability in terms of letting them know, that they are aware. [RN03, nurse]

And I think everything you do is recorded, like, you can go back and check, so there's that legal piece, which I guess covers you, in terms of time you called, those things which are critical, what you are calling for. [RN09, nurse]

'Cause I use it now as a reference. So even if I have a phone conversation with a nurse, based on a message that we've had, I will record what we said and send it. [MD03, physician]

 

Some of the more junior nurses periodically felt unsure or uncomfortable with clinical situations and would send a message to the physician to share their concerns. The messaging reassured the nurses and made them feel like they were fulfilling their professional responsibilities.

So a senior nurse could probably take a look at some situation and they can acknowledge whether the issue is urgent or nonurgent But from a novice perspective, as you're still learning it kind of gives you peace of mind and feels like you're filling your responsibility and accountability, that you're passing on the messages. [RN03, nurse]

 

Whereas nurses felt they were fulfilling their professional obligations, some physicians felt that nurses were using the system to absolve themselves of their clinical responsibilities.

Some just feel the need to send everything on there and maybe they feel that by sending it on here they absolve themselves of responsibility. [MD05, physician]

 

Other clinicians felt that the system created more of a responsibility or obligation for the physicians to respond. They believed the escalation feature of the system helped ensure the physicians responded in some fashion to close the loop.

[T]hey have the responsibility to answer it if it's an urgent message and because it keeps coming on to remind them. [AH02, social worker]

 

Interestingly, there were physicians that identified the opposite and felt the system created less of a responsibility or obligation for them to respond. By knowing the context of the message, it gave them the ability to prioritize or ignore the message if they knew it was not life threatening.

[T]here's less of a responsibility or an obligation They get a message and then they can actually delay the process So in a way it actually allows us to kind of get away with some things and that happens because, you know, we're prioritizing something that we're doing as being more important to us. [MD01, physician]

 

Tactics to Improve Personal Productivity

The web‐based messaging system's triaging feature allows the sender of the message to indicate whether an issue is urgent or non‐urgent. Urgent issues result in an immediate e‐mail that is intended to elicit an immediate response. Some of the nurses, pharmacists, and social workers exploited features of the system to elicit immediate responses from the physicians for non‐urgent issues, including using their knowledge of the urgent and non‐urgent features of the system to interrupt the physicians.

I kind of cheat and don't use the system properly. So every message I send I always send it as urgent because I want it go to the smartphone. [AH01, pharmacist]

I like that if you know how to use the urgent and nonurgent features effectively it generally works quite well in getting a response in a timely fashion. [RN02, nurse]

 

One tactic that physicians perceived the nurses were using to elicit a response from them was to exaggerate the severity or urgency of the issue in their message.

Some details will be sort of cherry picked to make the issue sound very dire I'll give you a classic, like, high blood pressure and patient has a headache. So initially, you know, I have to think, does this patient have a hypertensive emergency? So by putting sort of history together in this way, that sort of suggestive way, then yeah. [MD03, physician]

 

The nurses, pharmacists. and social workers frequently exaggerated the urgency of their clinical messages at the end of their shifts in an effort to resolve outstanding issues immediately in order to avoid transferring tasks to another colleague or delaying them until the next day.

But in terms of a shift change, for example, I need a response now 'cause that is a lot of times where it is that although it's not clinically urgent it's time sensitive. So it is urgent. [RN02, nurse]

I do also notice that around changeover time, issues that have been sort of chronically or have preexisting, become urgent issues. [MD01, physician]

 

Messages were also sent inappropriately as urgent as a strategy to ensure the physician dealt with the issue promptly and did not forget to complete the requested task associated with the issue.

Everybody puts urgent because we want the response immediately. Otherwise, if you put nonurgent, the doctors will just drag and drag and will forget to respond to the issue. [RN09, nurse]

 

However, because physicians received context clarifying the urgency of the message, they were able to prioritize their tasks and defer less‐important issues without compromising patient safety or quality of care, allowing them to use their time more productively. This, however, did not always align with the sender's request.

I think the key thing is that the information coming to us is text and it describes the issue. So we can, at our end, then we can make a call as to what the priority is. [MD03, physician]

 

DISCUSSION

The purpose of this study was to evaluate a Web‐based messaging system and identify the unintended consequences observed with implementing HIT to improve clinical communication. This is an important study because healthcare organizations are beginning to develop strategies for improving clinical communication but believe the solution involves simply replacing pager technology. Support for this approach is seen with larger vendors in the smartphone and communication industry, who promote their products as pager‐replacement solutions and even help customers develop pager‐replacement strategies.[26, 27, 28] Simply replacing pagers with smartphones and sending text messages will have only a limited impact on improving clinical communication and will likely result in unintended negative consequences, as seen in this study.

Whereas the Web‐based messaging system was designed to reduce interruptions from clinical messaging, interruptions actually increased, although the mental burden of each interruption was likely lower because responding to a text message is less interruptive than finding a telephone to answer a page. A key contributor to this effect was a culture of accountability among nurses, pharmacists, and social workers who felt it was their professional obligation to notify physicians about all issues of concern. This belief and related behavior is aligned with the standards promoted by professional regulatory bodies that identify accountability as a vital practice expectation.[29] Nurses and nursing staff take responsibility for the care they provide and answer for their own judgments and actions.[30] The system eliminated many of the previous barriers to paging and provided a less‐personal form of communication. The cumulative and unexpected outcome was an increase of interruptions for physicians and the adoption of workarounds by all healthcare professionals to improve personal productivity. Although the system was built in an iterative fashion with frontline clinicians, it is likely that oversights in the design of the system also contributed to these problems, which speaks to the complexity of clinical communication. Centralizing communication to the team smartphone could have overburdened the physicians covering it at the time, causing them to ignore messages because they were too busy to address them.

There were limitations to this study. One limitation was that this study examined only a cross‐section of messaging activity at a given point in time, and therefore it may not be representative of the behaviors of the physicians, nurses, pharmacists, and social workers over time as the culture of the environment evolves and they adjust to the new technology. The pre‐implementation data were collected 2 years prior to the post‐implementation data, but it was necessary to use data this old because other interventions were implemented prior to the Web‐based messaging system, so baseline paging data were no longer available. Whereas most clinical disciplines were represented in the interviews, the sample included only 17 participants from 1 clinical service, so generalizability of the results may be limited.

Although the reliance on numeric paging technology was previously identified as a primary source of problems with communication, the real issues are much more complex. This study highlighted that many of the underlying obstacles relate to existing social interactions and habits of multiple professions working together. Failures in collaboration among healthcare professionals have a negative impact on health outcomes and routinely stem from the lack of explicit definitions of roles, the absence of clear leadership, insufficient time for team‐building, the us‐and‐them effects created by professional socialization, and frustration created by power and status differentials of each discipline.[31, 32, 33] Therefore, it is critical that healthcare organizations focus on the people and clinical processes when implementing technology to solve issues with clinical communication. These observations are consistent with other studies examining the unintended consequences caused by the sociotechnical aspects of HIT implementation, where workarounds to game the system were also employed.[21]

In summary, improving clinical communication cannot be achieved simply by replacing pagers with newer technology; it requires a fundamental shift in how healthcare professionals interact, with a focus on the sociotechnical aspects of HIT. As patient volumes and the complexity of care continue to increase, more effective methods for facilitating interprofessional communication and collaboration must be developed.

Acknowledgements

Disclosures: This study was funded in part by a Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research. The authors report no conflicts of interest.

References
  1. Coiera E. When conversation is better than computation. J Am Med Inform Assoc. 2000;7(3):277286.
  2. Edwards A, Fitzpatrick LA, Augustine S, et al. Synchronous communication facilitates interruptive workflow for attending physicians and nurses in clinical settings. Int J Med Inform. 2009;78(9):629637.
  3. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377384.
  4. Sutcliffe KM, Lewton E, Rosenthal MM. Communication failures: an insidious contributor to medical mishaps. Acad Med. 2004;79(2):186194.
  5. The Joint Commission. Improving America's Hospitals: The Joint Commission's Annual Report on Quality and Safety. Oakbrook Terrace, IL: The Joint Commission; 2007. Available at: http://www.jointcommission.org/assets/1/6/2007_Annual_Report.pdf. Accessed on April 16, 2012.
  6. Volpp KG, Grande D. Residents' suggestions for reducing errors in teaching hospitals. N Engl J Med. 2003;348(9):851855.
  7. Grundgeiger T, Sanderson P. Interruptions in healthcare: theoretical views. Int J Med Inform. 2009;78(5):293307.
  8. Wong BM, Quan S, Cheung CM, et al. Frequency and clinical importance of pages sent to the wrong physician. Arch Intern Med. 2009;169(11):10721073.
  9. Arora V, Johnson J, Lovinger D, Humphrey HJ, Meltzer DO. Communication failures in patient sign‐out and suggestions for improvement: a critical incident analysis. Qual Saf Health Care. 2005;14(6):401407.
  10. Lingard L, Whyte S, Espin S, Baker GR, Orser B, Doran D. Towards safer interprofessional communication: Constructing a model of “utility” from preoperative team briefings. J Interprof Care. 2006;20(5):471483.
  11. Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice‐based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009(3):CD000072.
  12. Richardson JE, Ash JS. The effects of hands free communication devices on clinical communication: balancing communication access needs with user control. AMIA Annu Symp Proc. 2008;621625.
  13. Locke KA, Duffey‐Rosenstein B, Lio G, Morra D, Hariton N. Beyond paging: building a web‐based communication tool for nurses and physicians. J Gen Intern Med. 2009;24(1):105110.
  14. Wu RC, Morra D, Quan S, et al. The use of smartphones for clinical communication on internal medicine wards. J Hosp Med. 2010;5(9):553559.
  15. Wong BM, Quan S, Shadowitz S, Etchells E. Implementation and evaluation of an alpha‐numeric paging system on a resident inpatient teaching service. J Hosp Med. 2009;4(8):E34E40.
  16. Wu RC, Tran K, Lo V, et al. Effects of clinical communication interventions in hospitals: a systematic review of information and communication technology adoptions for improved communication between clinicians. Int J Med Inform. 2012;81(11):723732.
  17. Wu R, Rossos P, Quan S, et al. An evaluation of the use of smartphones to communicate between clinicians: a mixed‐methods study. J Med Internet Res. 2011;13(3):e59.
  18. Maslove DM, Rizk N, Lowe HJ. Computerized physician order entry in the critical care environment: a review of current literature. J Intensive Care Med. 2011;26(3):165171.
  19. Wetterneck TB, Walker JM, Blosky MA, et al. Factors contributing to an increase in duplicate medication order errors after CPOE implementation. J Am Med Inform Assoc. 2011;18(6):774782.
  20. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293(10):11971203.
  21. Harrison MI, Koppel R, Bar‐Lev S. Unintended consequences of information technologies in health care—an interactive sociotechnical analysis. J Am Med Inform Assoc. 2007;14(5):542549.
  22. Johnson CW. Why did that happen? Exploring the proliferation of barely usable software in healthcare systems. Qual Saf Health Care. 2006;(15 suppl 1):i76i81.
  23. Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system‐related errors. J Am Med Inform Assoc. 2004;11(2):104112.
  24. Priest H, Roberts P, Woods L. An overview of three different approaches to the interpretation of qualitative data. Part 1: Theoretical issues. Nurse Res. 2002;10(1):3042.
  25. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):12771288.
  26. Research in Motion, Amcom Software. Six things hospitals need to know about replacing pagers with smartphones. Available at: http://us.blackberry.com/business/industry/healthcare/6ThingstoKnow_ReplacingHospitalPagers_WhitePaper.pdf. Accessed on April 16, 2012.
  27. Vocera, Wallace Wireless. The Longstreet Clinic: replacing pagers, supercharging communication with WIC pager. Available at: http://www.vocera.com/assets/pdf/case_studies/cs_longstreetclinic_0910_v1.pdf. Accessed on April 16, 2012.
  28. Amcom Software reports strong momentum with its new smartphone messaging and pager replacement solution [press release]. Minneapolis, MN: Amcom Software; September 29, 2010. Available at: http://www.amcomsoftware.com/News/09‐29‐10.aspx. Accessed on April 16, 2012.
  29. College of Nurses of Ontario. 2011 standards and guidelines. Availableat: http://www.cno.org/en/learn‐about‐standards‐guidelines/publications‐list/standards‐and‐guidelines. Accessed on April 16, 2012.
  30. Scrivener R, Hand T, Hooper R. Accountability and responsibility: principle of nursing practice B. Nurs Stand. 2011;25(29):3536.
  31. Baggs JG, Ryan SA, Phelps CE, Richeson JF, Johnson JE. The association between interdisciplinary collaboration and patient outcomes in a medical intensive care unit. Heart Lung. 1992;21(1):1824.
  32. Waugaman WR. Professionalization and socialization in interprofessional collaboration. In: Casto RM, Julia MC, eds. Interprofessional Care and Collaborative Practice. 1st ed. Independence, KY: Cengage Learning; 1994:2331.
  33. Zwarenstein M, Reeves S. Knowledge translation and interprofessional collaboration: where the rubber of evidence‐based care hits the road of teamwork. J Contin Educ Health Prof. 2006;26(1):4654.
References
  1. Coiera E. When conversation is better than computation. J Am Med Inform Assoc. 2000;7(3):277286.
  2. Edwards A, Fitzpatrick LA, Augustine S, et al. Synchronous communication facilitates interruptive workflow for attending physicians and nurses in clinical settings. Int J Med Inform. 2009;78(9):629637.
  3. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377384.
  4. Sutcliffe KM, Lewton E, Rosenthal MM. Communication failures: an insidious contributor to medical mishaps. Acad Med. 2004;79(2):186194.
  5. The Joint Commission. Improving America's Hospitals: The Joint Commission's Annual Report on Quality and Safety. Oakbrook Terrace, IL: The Joint Commission; 2007. Available at: http://www.jointcommission.org/assets/1/6/2007_Annual_Report.pdf. Accessed on April 16, 2012.
  6. Volpp KG, Grande D. Residents' suggestions for reducing errors in teaching hospitals. N Engl J Med. 2003;348(9):851855.
  7. Grundgeiger T, Sanderson P. Interruptions in healthcare: theoretical views. Int J Med Inform. 2009;78(5):293307.
  8. Wong BM, Quan S, Cheung CM, et al. Frequency and clinical importance of pages sent to the wrong physician. Arch Intern Med. 2009;169(11):10721073.
  9. Arora V, Johnson J, Lovinger D, Humphrey HJ, Meltzer DO. Communication failures in patient sign‐out and suggestions for improvement: a critical incident analysis. Qual Saf Health Care. 2005;14(6):401407.
  10. Lingard L, Whyte S, Espin S, Baker GR, Orser B, Doran D. Towards safer interprofessional communication: Constructing a model of “utility” from preoperative team briefings. J Interprof Care. 2006;20(5):471483.
  11. Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice‐based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009(3):CD000072.
  12. Richardson JE, Ash JS. The effects of hands free communication devices on clinical communication: balancing communication access needs with user control. AMIA Annu Symp Proc. 2008;621625.
  13. Locke KA, Duffey‐Rosenstein B, Lio G, Morra D, Hariton N. Beyond paging: building a web‐based communication tool for nurses and physicians. J Gen Intern Med. 2009;24(1):105110.
  14. Wu RC, Morra D, Quan S, et al. The use of smartphones for clinical communication on internal medicine wards. J Hosp Med. 2010;5(9):553559.
  15. Wong BM, Quan S, Shadowitz S, Etchells E. Implementation and evaluation of an alpha‐numeric paging system on a resident inpatient teaching service. J Hosp Med. 2009;4(8):E34E40.
  16. Wu RC, Tran K, Lo V, et al. Effects of clinical communication interventions in hospitals: a systematic review of information and communication technology adoptions for improved communication between clinicians. Int J Med Inform. 2012;81(11):723732.
  17. Wu R, Rossos P, Quan S, et al. An evaluation of the use of smartphones to communicate between clinicians: a mixed‐methods study. J Med Internet Res. 2011;13(3):e59.
  18. Maslove DM, Rizk N, Lowe HJ. Computerized physician order entry in the critical care environment: a review of current literature. J Intensive Care Med. 2011;26(3):165171.
  19. Wetterneck TB, Walker JM, Blosky MA, et al. Factors contributing to an increase in duplicate medication order errors after CPOE implementation. J Am Med Inform Assoc. 2011;18(6):774782.
  20. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293(10):11971203.
  21. Harrison MI, Koppel R, Bar‐Lev S. Unintended consequences of information technologies in health care—an interactive sociotechnical analysis. J Am Med Inform Assoc. 2007;14(5):542549.
  22. Johnson CW. Why did that happen? Exploring the proliferation of barely usable software in healthcare systems. Qual Saf Health Care. 2006;(15 suppl 1):i76i81.
  23. Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system‐related errors. J Am Med Inform Assoc. 2004;11(2):104112.
  24. Priest H, Roberts P, Woods L. An overview of three different approaches to the interpretation of qualitative data. Part 1: Theoretical issues. Nurse Res. 2002;10(1):3042.
  25. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):12771288.
  26. Research in Motion, Amcom Software. Six things hospitals need to know about replacing pagers with smartphones. Available at: http://us.blackberry.com/business/industry/healthcare/6ThingstoKnow_ReplacingHospitalPagers_WhitePaper.pdf. Accessed on April 16, 2012.
  27. Vocera, Wallace Wireless. The Longstreet Clinic: replacing pagers, supercharging communication with WIC pager. Available at: http://www.vocera.com/assets/pdf/case_studies/cs_longstreetclinic_0910_v1.pdf. Accessed on April 16, 2012.
  28. Amcom Software reports strong momentum with its new smartphone messaging and pager replacement solution [press release]. Minneapolis, MN: Amcom Software; September 29, 2010. Available at: http://www.amcomsoftware.com/News/09‐29‐10.aspx. Accessed on April 16, 2012.
  29. College of Nurses of Ontario. 2011 standards and guidelines. Availableat: http://www.cno.org/en/learn‐about‐standards‐guidelines/publications‐list/standards‐and‐guidelines. Accessed on April 16, 2012.
  30. Scrivener R, Hand T, Hooper R. Accountability and responsibility: principle of nursing practice B. Nurs Stand. 2011;25(29):3536.
  31. Baggs JG, Ryan SA, Phelps CE, Richeson JF, Johnson JE. The association between interdisciplinary collaboration and patient outcomes in a medical intensive care unit. Heart Lung. 1992;21(1):1824.
  32. Waugaman WR. Professionalization and socialization in interprofessional collaboration. In: Casto RM, Julia MC, eds. Interprofessional Care and Collaborative Practice. 1st ed. Independence, KY: Cengage Learning; 1994:2331.
  33. Zwarenstein M, Reeves S. Knowledge translation and interprofessional collaboration: where the rubber of evidence‐based care hits the road of teamwork. J Contin Educ Health Prof. 2006;26(1):4654.
Issue
Journal of Hospital Medicine - 8(3)
Issue
Journal of Hospital Medicine - 8(3)
Page Number
137-143
Page Number
137-143
Article Type
Display Headline
It's not about pager replacement: An in‐depth look at the interprofessional nature of communication in healthcare
Display Headline
It's not about pager replacement: An in‐depth look at the interprofessional nature of communication in healthcare
Sections
Article Source

Copyright © 2013 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Sherman Quan, MSc, Centre for Innovation in Complex Care, University Health Network, 190 Elizabeth St., Room 13N1382, Toronto, ON M5G 2C4 Canada; Telephone: 416‐843‐1330; E‐mail: [email protected]
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media
Media Files

Acute Respiratory Failure Epidemiology

Article Type
Changed
Mon, 05/22/2017 - 18:10
Display Headline
Epidemiology and outcomes of acute respiratory failure in the United States, 2001 to 2009: A national survey

Acute respiratory failure (ARF), a common and serious complication in hospitalized patients, may be caused by several conditions including pneumonia, chronic obstructive pulmonary disease (COPD), adult respiratory distress syndrome (ARDS), and congestive heart failure (CHF). Although ARF is conventionally defined by an arterial oxygen tension of <60 mm Hg, an arterial carbon dioxide tension of >45 mm Hg, or both, these thresholds serve as a guide to be used in combination with history and clinical assessment of the patient.[1, 2] Supplemental oxygen and treatment of the underlying cause is the mainstay of therapy for ARF, but in severe cases patients are treated with invasive mechanical ventilation (IMV) or noninvasive ventilation (NIV). ARF is the most frequent reason for admission to the intensive care unit (ICU)[3, 4] and has an in‐hospital mortality rate of 33% to 37% among those who require IMV.[5, 6] The majority of epidemiologic studies of ARF have been limited to patients requiring mechanical ventilation or those admitted to the ICU, and information about the characteristics and outcomes of patients across the full spectrum of severity is much more limited.[5, 7, 8, 9, 10, 11] General improvements in the management of underlying conditions, implementation of more effective ventilation strategies,[12, 13] and increasing use of NIV[14, 15] may have led to better outcomes for patients with ARF, yet empirical evidence of a change in the adjusted mortality rate over time is lacking.

The objective of this study was to provide a broad characterization of the epidemiology of ARF among adults hospitalized in the United States using a large nationally representative database. We sought to evaluate whether incidence, mortality, cost, or ventilation practice associated with ARF in the United States changed over the period of 2001 to 2009.

METHODS

Data Source

We utilized data from the Nationwide Inpatient Sample (NIS) of the Health Care Cost and Utilization Project,[16] which is a 20% stratified probability sample of all US acute‐care hospitals each year. These data are drawn from a sampling frame that contains close to 95% of all discharges in the United States, with the hospital discharge record as the unit of analysis. The NIS has been used to study trends in many different diagnoses.[17, 18, 19] The database contains demographic information, payer information, principal and secondary diagnoses, cost, discharge disposition, and death during hospitalization. It also contains information on hospital characteristics including ownership, size, teaching status, and geographic region.

Definitions

We included patients 18 years old discharged between 2001 and 2009 with a primary or secondary diagnosis of ARF. We identified cases of ARF using diagnostic codes (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD‐9‐CM]) previously used in studies of acute organ dysfunction in sepsis (518.81, 518.82, 518.84, 518.4, 799.1, 786.09).[17, 20, 21] To define ARDS we relied on ICD‐9‐CM codes (518.4, 518.82, 518.5, 786.09) used in prior studies that showed good sensitivity and specificity.[22, 23] The use of ventilatory support was identified using the ICD‐9‐CM procedure codes[24] (93.90, 93.70, 93.71, 93.76). Comorbidities were classified using the Agency for Healthcare Research and Quality's (Rockville, MD) Healthcare Cost and Utilization Project's (HCUP) Comorbidity Software version 3.103.5.[25]

Outcomes

The primary outcomes included the annual number of hospitalizations, population incidence, hospital mortality, and costs of care. Secondary outcomes included length of stay, most common diagnoses associated with ARF, disposition at discharge, and use and type of ventilatory support.

Analysis

We estimated the number of hospitalizations with a diagnosis of ARF/year, and we calculated the weighted frequencies following HCUP‐NIS recommendations using SAS/STAT survey procedures. Using population estimates for the years 2001 to 2009 from the US Census Bureau, we employed direct standardization to calculate age‐, gender‐, and race‐adjusted population incidence and mortality rates of ARF per 100,000 population. Hospital mortality was defined as the ratio of ARF hospitalizations ending in death divided by total number of ARF hospitalizations. Mechanical ventilation rates and rates of selected comorbidities were similarly defined.

We employed indirect standardization to adjust hospital mortality rates for age, sex, race/ethnicity, comorbidities, and hospital characteristics using logistic regression models from 2001 to predict hospital mortality for 2002 to 2009. We used linear regression models to test whether the slope of year was significant for trends in outcomes overtime. Costs were calculated using hospital‐specific cost‐to‐charge ratios when available and a weighted group average at the state level for remaining hospitals. We converted all costs to 2009 US dollars using the Consumer Price Index. Costs and lengths of stay were not normally distributed, so we calculated weighted geometric means (the average of all logarithmic values), then converted back to a base‐10 number. Using a Taylor series expansion, we then calculated standard errors. All analyses were performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC).

The Baystate Medical Center institutional review board determined that the project did not constitute human subjects research.

RESULTS

Hospitalization Trends

The number of hospitalizations with an ARF diagnosis code increased at an average annual rate of 11.3% from 1,007,549 (standard deviation [SD] = 19,268) in 2001 to 1,917,910 (SD = 47,558) in 2009. More than two‐thirds of ARF admissions were associated with medical, rather than surgical, conditions (69.5% in 2001 and 71.2% in 2009). The median age, racial make‐up, and gender did not change significantly. Over the study period we observed an increase in ARF‐related hospitalizations in large, urban, teaching hospitals and in hospitals located in the Midwest (Table 1).

Hospitalizations With Acute Respiratory Failure in the United States, 2001 to 2009, by Patient and Hospital Characteristics
 20012003200520072009
  • NOTE: Abbreviations: ARF, acute respiratory failure; IMV, invasive mechanical ventilation; LOS, length of stay; NIV, noninvasive ventilation; SD, standard deviation; SE standard error. P value for trend <0.01, including all years 20012009, *P value for trend <0.0001, including all years 20012009. Adjusted for sex, age, race, hospital characteristics, and comorbidities. Geometric mean reported, standard errors from Taylor series expansion.

Patient characteristics 
All, N (SD)1,007,549 (19,268)1,184,928 (25,542)1,288,594 (30,493)1,480,270 (32,002)1,917,910 (47,558)
Age, mean (SE), y66.6 (0.2)66.0 (0.2)66.1 (0.2)65.8 (0.2)65.8 (0.2)
Age group, %     
184411.512.011.511.610.9
4564*26.728.929.630.731.7
6584*50.247.847.045.745.3
85+11.511.411.912.012.1
Male*48.148.248.649.349.2
Race     
White75.871.976.571.873.4
Black12.713.611.214.212.5
Hispanic7.29.87.78.57.8
Other4.24.74.75.56.3
Primary ARF20.720.925.926.119.9
Secondary ARF79.379.174.173.980.1
Medical*69.569.169.970.271.2
Surgical*30.530.830.129.828.8
Hospital characteristics, %     
Number of beds     
Small10.010.110.510.811.3
Medium25.225.324.624.022.7
Large64.764.664.965.266.0
Region     
South*18.518.517.617.016.3
Midwest21.422.023.623.223.5
Northeast42.641.741.442.242.1
West*17.517.817.317.618.1
Hospital type     
Rural13.613.011.811.010.8
Urban nonteaching45.544.550.145.345.7
Urban teaching40.942.538.143.743.6
Patient outcomes
Ventilation strategy
IMV*48.548.447.546.542.1
NIV*3.85.36.99.410.1
IMV or NIV50.951.752.152.949.7
Disposition     
Home/home healthcare*42.143.842.843.445.7
Transfer to acute care5.24.74.64.64.4
Nursing facility*24.424.927.428.629.0
Other0.70.80.90.91.0
Adjusted mortality, % (SE)*27.6 (0.3)26.4 (0.4)24.9 (0.4)22.7 (0.4)20.6 (0.3)
Adjusted mean, LOS/case, d (SE)*7.8 (0.1)7.9 (0.1)7.7 (0.1)7.5 (0.1)7.1 (0.1)
Adjusted mean cost/case, 2009 US$, (SE)15,818 (251)16,981 (419)17,236 (411)16,941 (436)15,987 (402)

After adjusting for age and sex, the population incidence of ARF increased from 502 (standard error [SE] = 10) cases per 100,000 in 2001 to 784 (SE = 19) cases per 100,000 in 2009 (a 56% increase, P < 0.0001). Hispanics had the lowest rates of ARF, with both black and white groups having similar rates (Table 2).

Cases of Acute Respiratory Failure per 100,000 Population
 20012003200520072009
  • NOTE: Data are presented as number per 100,000 population (standard error), standardized to 2000 US Census population. *P value for trend < 0.0001, including all years 2001 to 2009.

All*502 (10)569 (12)595 (14)627 (14)784 (19)
Age group     
1844*107 (3)130 (4)137 (4)153 (5)189 (6)
4564*422 (9)500 (12)521 (13)580 (14)739 (19)
6584*1697 (35)1863 (42)1950 (50)2066 (46)2578 (69)
85+3449 (86)3792 (106)3981 (120)3429 (97)4163 (123)
Sex     
Male*491 (10)553 (13)582 (14)629 (14)782 (20)
Female*512 (10)583 (12)607 (15)625 (13)786 (19)
Race/ethnicity     
White*398 (11)427 (12)466 (16)450 (13)699 (21)
Black*423 (27)513 (33)432 (26)574 (38)738 (37)
Hispanic*247 (24)381 (42)307 (27)353 (34)478 (42)
Other*268 (20)342 (29)347 (26)424 (29)713 (77)
In‐hospital mortality140 (3)148 (3)146 (3)140 (3)154 (4)

The most common etiologies of ARF among medical patients were pneumonia, CHF, ARDS, COPD exacerbation, and sepsis. Over the 9‐year study, the proportion of cases secondary to pneumonia and sepsis rose significantly: from 39% to 46% and 13% to 21%, respectively (Figure 1).

Figure 1
Proportion of patients with acute respiratory failure with the 5 most common medical conditions from 2001 to 2009. Abbreviations: ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.

Mortality and Other Outcomes

The number of in‐hospital deaths related to ARF increased from 277,407 deaths in 2001 to 381,155 in 2009 (a 37% increase, P < 0.001). Standardized to the population, deaths increased from 140 in 2001 to 154 cases per 100,000 in 2009 (a 10% increase, P = 0.027). Despite slightly increasing mortality rates at a population level, adjusted in‐hospital mortality improved from 27.6% in 2001 to 20.6% in 2009 (P < 0.001). Mortality declined for both IMV and NIV patients from 35.3% in 2001 to 30.2% in 2009 and from 23.5% to 19%, respectively, but increased for those who required both NIV and IMV (from 26.9% in 2001 to 28% in 2009).

Adjusted hospital length of stay decreased from 7.8 days per patient in 2001 to 7.1 days in 2009 (P < 0.001), with a concomitant increase in discharges to nursing facilities, from 24% in 2001 to 29% in 2009. There was no linear trend in adjusted cost per case, with $15,818 in 2001 and $15,987 in 2009 (in 2009 US dollars) (Table 1).

Ventilation Practices

Overall, 50.9% patients received ventilatory support (NIV or IMV or both) in 2001 and 49.7% in 2009 (P= 0.25). The use of NIV increased from 3.8% to 10.1% (P < 0.001), a 169% increase, whereas the utilization of IMV decreased from 48.5% in 2001 to 42.1% in 2009 (P for trend < 0.0001), a 13% decrease. Uses of both NIV and IMV during hospitalization were seen in 1.4% of cases in 2001 and 2.5% of cases in 2009.

2009 Data Analysis

In 2009 the 1,917,910 hospitalizations with ARF resulted in 381,155 (SD = 8965) deaths and a total inpatient cost of $54 billion. The most common etiologies in patients over 65 years old were pneumonia, CHF, COPD, ARDS, and sepsis. In patients younger than 45 years the most frequent diagnoses were pneumonia, ARDS, sepsis, asthma, drug ingestion, and trauma. Stratified analysis by gender and by age groups showed that mortality rates among men were higher than for women and were highest in patients older than 85 years (Table 3).

Characteristics of Hospitalizations by Etiology (Medical, Surgical, Comorbidities, Procedures) in 2009
DiseaseTotalAge <45 Years4565 Years6584 Years85+ YearsMaleFemale
  • NOTE: One patient can have more than 1 diagnosis. Abbreviations: AMI, acute myocardial infarction; ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; IMV, invasive mechanical ventilation; NIV, noninvasive ventilation. *P < 0.0001 for age group. P < 0.0001 for gender. The P values are not from Rao‐Scott 2 test.

Medical       
Total, N (%)1,364,624 (71.2)144,715 (10.6)416,922 (30.6)615,009 (45.1)187,977 (13.8)647,894 (47.5)716,635 (52.5)
Pneumonia, %*46.141.742.846.954.348.843.7
CHF, %*36.610.427.343.654.835.038.1
ARDS, %*16.122.916.214.515.915.516.7
Sepsis, %*21.218.121.321.323.122.819.8
COPD, %*25.44.225.632.318.325.025.7
AMI, %*9.02.67.110.513.39.38.8
Asthma, %*9.218.111.66.75.46.212.0
Stroke, %*4.82.34.15.56.05.04.7
Trauma or burns, %*3.45.42.93.04.14.32.5
Cardiorespiratory arrest, %*4.13.94.44.13.84.63.7
Drug, %*3.716.65.10.80.33.83.6
IMV, %*37.754.643.733.524.841.134.5
NIV, %*11.97.111.513.012.711.412.3
In‐hospital mortality (CI)22 (21.322.7)12.9 (11.913.9)18.5 (17.619.4)23.9 (23.024.9)31.8 (30.633.1)24.2 (23.325.1)20.9 (20.121.7)
Surgical       
Total, N (%)552971 (28.8)64983 (11.8)190225 (34.4)254336 (46)43426 (7.9)295660 (53.5)257287 (46.5)
Pneumonia, %*34.933.034.035.040.537.132.2
CHF, %*27.28.921.733.342.626.727.7
ARDS, %*45.551.545.244.742.745.046.1
Sepsis, %*25.122.825.425.226.125.424.7
COPD, %*8.21.17.410.87.58.38.1
AMI, %*16.94.917.019.817.919.114.4
Asthma, %*6.17.67.25.43.64.18.5
Stroke, %*8.96.69.29.47.28.98.8
Trauma or burns, %*12.226.59.69.220.313.810.4
Cardiorespiratory arrest, %*5.54.46.05.45.26.14.7
Drug, %*0.51.30.70.20.20.40.6
IMV, %*52.957.154.351.350.054.551.0
NIV, %*5.83.55.56.46.45.66.0
In‐hospital mortality, % (CI)18.6 (17.819.5)10.7 (9.312.0)15.5 (14.216.8)20.8 (19.821.9)29.4 (27.831.1)19.0 (18.219.8)18.3 (17.319.2)

When we examined ventilation practices among medical patients we found that patients older than 85 years, when compared to patients younger than 45 years, were less likely to be treated with IMV (25% vs 55%) and more likely to be treated with NIV (12.7% vs 7%). At the same time, the average cost per case was lowest among patients 85 years and older, and hospital costs per case fell sharply after age 70 years. Costs were considerably higher for those who did not survive during hospitalization, particularly for patients younger than 45 years (Figure 2).

Figure 2
Age‐specific hospital cost per patient (geometric mean) stratified by surviving status.

DISCUSSION

In this large population‐based study, we found that the number of hospitalizations associated with a diagnosis of ARF almost doubled over a 9‐year period. In 2009 there were nearly 2 million hospitalizations with ARF in the United States, resulting in approximately 380,000 deaths and inpatient costs of over $54 billion. The population‐adjusted ARF hospitalization rates increased in all age groups, and patients 85 years and older had the highest age‐specific hospitalization rate. Although overall rates of mechanical ventilation (NIV or IMV) remained stable over the 9‐year period, there was an important shift away from IMV (which decreased from 48% in 2001 to 42% in 2009) toward NIV (which increased from 4% in 2001 to 10% in 2009). Overall, there was a significant increase in the number of total deaths despite a decline in adjusted in‐hospital mortality rates. In‐hospital mortality rates decreased for all cases of ARF regardless of ventilation choice.

The findings of this study mirror results of others that have shown that although the incidence of critical care illnesses like sepsis[17, 20, 21, 26] and acute renal failure[27] has increased over the last decade, in‐hospital mortality rates have decreased.[20, 21, 28] Our results also compliment the results of a recent study that looked at hospitalizations for noncardiogenic ARF, which observed a 3.7‐fold increase in the number of cases and a steady decline in case fatality.[11]

Most prior studies addressing the incidence of ARF have included only patients receiving mechanical ventilation. In 1994, the estimated number of cases of ARF requiring IMV was 329,766,[9] which increased to 790,257 in 2005.[10] In our study we found that in 2009, the number of patients with ARF hospitalizations with IMV increased to 806,538. The increase in the overall number of cases with ARF was mainly driven by a surge in cases of sepsis and pneumonia. Our findings are consistent with national trends over time in noncardiogenic ARF[11] and in conditions that predispose patients to ARF such as sepsis[17, 20, 28] and acute renal failure.[27] As the number of claims for ARF doubled and the number of deaths increased, we found that adjusted hospital mortality improved from 27.6% in 2001 to 20.6% in 2009. This decline in hospital mortality was observed among all patients groups, regardless of ventilation choice. The decline in overall case fatality is consistent with prior findings in noncardiogenic ARF,[11] sepsis,[17, 28] and CHF.[29]

There are a number of potential explanations for the reduction in mortality observed over the study period, including improvements in hospital management of the underlying conditions leading to ARF, an increase in the proportion of patients being treated with NIV,[30] and advances in the care of critically ill patients such as the use of low‐tidal volume ventilation.[31, 32] Another contributor may be an increase in the proportion of discharges to nursing facilities, although this change in discharge disposition cannot fully explain our findings. For example, from 2007 to 2009, mortality decreased by 2 percentage points, and nursing home discharges increased by only 0.4 percentage points. Growth and aging of the US population only partially explain the increase we observed in the incidence of ARF, as age‐ and sex‐adjusted population rates increased by 56% from 2001 to 2009. In addition, the NIS captures data on hospital discharges and not individual patients; thus, a patient may have had multiple admissions. Over the last decade adoption of a more intensive practice style has been associated with improved in‐hospital mortality,[33, 34] and although these patients may be living longer they may have multiple readmissions.[35, 36]

We also observed that older patients were less likely to be treated with IMV, had a higher mortality rate, and less expensive care. These results are consistent with other studies and suggest that the intensity of treatment decreases with increasing age, and decisions to withhold or withdraw life‐supporting treatments are more frequent in the elderly.[26, 37] Prior research has shown that severity of illness is more important than age on patients' prognosis,[38, 39] and aggressive treatment strategies are not less cost‐effective when provided to older patients.[40]

Another important finding of this study is the marked increase in the use of NIV paired with a modest reduction in the use of IMV in the treatment of patients with ARF. This finding adds to evidence from other studies, which have similarly reported a dramatic increase in the use of NIV and a decrease in the use of IMV in patients with COPD as well as in ARF of other etiologies.[30, 41]

Our work has several limitations. First, we identified ARF based on ICD‐9‐CM codes and therefore cannot exclude disease misclassification. We did not find any studies in the literature addressing the accuracy and the completeness of ARF coding. However, we employed the same codes used to define ARF as has been used to define organ dysfunction in studies of severe sepsis,[17, 20] and the ICD‐9‐CM codes that we used to identify cases of ARDS have been used in prior studies.[11, 22, 23] Another limitation is that it is not clear to what extent the trends we observed may be due to changes over time in documentation and coding practices. Although this should be considered given the additional reimbursement associated with the diagnosis of ARF, our observation that rates of assisted ventilation have remained almost flat over the 9‐year period of the study suggest that would not wholly account for the rise in ARF. Second, because we did not have access to physiological data such as results of blood gas testing, we could not determine whether the threshold for applying the diagnosis of ARF or for delivering ventilatory support has changed over time. Third, for the purpose of this study we employed a broad definition of ARF, not limiting cases to those requiring mechanical ventilation, and this led to a more heterogeneous cohort including less severe cases of ARF. However, this is not dissimilar to the heterogeneity in disease severity observed among patients who receive a diagnosis of heart failure or acute renal failure. Fourth, survivors of ARF remain at high risk of death in the months after hospitalization,[42] but we assessed only in‐hospital mortality. It is possible that although in‐hospital mortality has improved, 30‐day mortality remained stable. Finally, as the NIS contains only discharge‐level data, we could not distinguish between patients admitted for ARF from those who developed ARF (potentially iatrogenic) after admission.

In summary, over the period of 2001 to 2009, there was a large increase in the number of patients given a diagnosis of ARF and a concomitant reduction in inpatient mortality. Although rates of mechanical ventilation remained relatively constant, there was a significant shift toward greater use of NIV at the expense of IMV.

Disclosures

Dr. Stefan is supported by KM1 CA156726 from the National Cancer Institute (NCI) and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through grant UL1 RR025752. The work on this study was supported by a Charlton grant from Tufts University School of Medicine. Dr. Lindenauer and Dr. Pekow are supported by 1R18HL108810‐01 from the National Heart, Lung, and Blood Institute (NHLBI). The content of this publication is solely the responsibility of the authors and does not represent the official views of the NIH, NHLBI, or NCI.

All authors have read and approved the manuscript and none of them have any potential conflicts of interest to report.

Dr. Stefan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conception and design: Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Jay Steingrub, Peter K. Lindenauer; analysis and interpretation: Meng‐Shiou Shieh, Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Tara Lagu, Peter K. Lindenauer; drafting the manuscript for important intellectual content: Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Jay Steingrub, Tara Lagu, and Peter K. Lindenauer.

Files
References
  1. Goldman L, Schaffer A. Goldman's Cecil Medicine. 24th ed. Amsterdam, the Netherlands: Elsevier Inc.; 2012.
  2. Murray JF, Nadel JA. Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Saunders; 2010.
  3. Vincent JL, Sakr Y, Ranieri VM. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med. 2003;31(4 suppl):S296S299.
  4. Cartin‐Ceba R, Kojicic M, Li G, et al. Epidemiology of critical care syndromes, organ failures, and life‐support interventions in a suburban US community. Chest. 2011;140(6):14471455.
  5. Carson SS, Cox CE, Holmes GM, Howard A, Carey TS. The changing epidemiology of mechanical ventilation: a population‐based study. J Intensive Care Med. 2006;21(3):173182.
  6. Needham DM, Bronskill SE, Sibbald WJ, Pronovost PJ, Laupacis A. Mechanical ventilation in Ontario, 1992–2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med. 2004;32(7):15041509.
  7. Lewandowski K. Contributions to the epidemiology of acute respiratory failure. Crit Care. 2003;7(4):288290.
  8. Lewandowski K, Metz J, Deutschmann C, et al. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med. 1995;151(4):11211125.
  9. Behrendt CE. Acute respiratory failure in the United States: incidence and 31‐day survival. Chest. 2000;118(4):11001105.
  10. Wunsch H, Linde‐Zwirble WT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation use in the United States. Crit Care Med. 2010;38(10):19471953.
  11. Cooke CR, Erickson SE, Eisner MD, Martin GS. Trends in the incidence of noncardiogenic acute respiratory failure: the role of race. Crit Care Med. 2012;40(5):15321538.
  12. Girou E, Brun‐Buisson C, Taille S, Lemaire F, Brochard L. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290(22):29852991.
  13. Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA. 2000;284(18):23612367.
  14. Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L. Noninvasive versus conventional mechanical ventilation. An epidemiologic survey. Am J Respir Crit Care Med. 2001;163(4):874880.
  15. Nourdine K, Combes P, Carton MJ, Beuret P, Cannamela A, Ducreux JC. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med. 1999;25(6):567573.
  16. Heathcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample. Available at: http://www.hcup‐us.ahrq.gov/nisoverview.jsp. Accessed December 6, 2011.
  17. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2011;40(3):754761.
  18. Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003–2009. JAMA. 2012;307(13):14051413.
  19. Rothberg MB, Cohen J, Lindenauer P, Maselli J, Auerbach A. Little evidence of correlation between growth in health care spending and reduced mortality. Health Aff (Millwood). 2010;29(8):15231531.
  20. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):15461554.
  21. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):12441250.
  22. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest. 2001;119(4):11791184.
  23. Reynolds HN, McCunn M, Borg U, Habashi N, Cottingham C, Bar‐Lavi Y. Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million‐person population base. Crit Care. 1998;2(1):2934.
  24. Quan H, Parsons GA, Ghali WA. Validity of procedure codes in International Classification of Diseases, 9th Revision, Clinical Modification administrative data. Med Care. 2004;42(8):801809.
  25. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):827.
  26. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 suppl):S109S116.
  27. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1(1):4351.
  28. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med. 2005;33(11):25552562.
  29. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries,1998–2008. JAMA. 2011;306(15):16691678.
  30. Chandra D, Stamm JA, Taylor B, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med. 2011;185(2):152159.
  31. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal‐oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333(16):10251032.
  32. Oba Y, Salzman GA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury. N Engl J Med. 2000;343(11):813; author reply 813–814.
  33. Kaufmann PA, Smolle KH, Krejs GJ. Short‐ and long‐term survival of nonsurgical intensive care patients and its relation to diagnosis, severity of disease, age and comorbidities. Curr Aging Sci. 2009;2(3):240248.
  34. Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction—a ten‐year retrospective observational study. Chest. 2012;141(6):14411448.
  35. Barsky AJ. The paradox of health. N Engl J Med. 1988;318(7):414418.
  36. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee‐for‐service program. N Engl J Med. 2009;360(14):14181428.
  37. Hamel MB, Phillips RS, Davis RB, et al. Outcomes and cost‐effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med. 2000;109(8):614620.
  38. Hamel MB, Davis RB, Teno JM, et al. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1999;131(10):721728.
  39. Hamel MB, Teno JM, Goldman L, et al. Patient age and decisions to withhold life‐sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med. 1999;130(2):116125.
  40. Hamel MB, Phillips RS, Davis RB, et al. Are aggressive treatment strategies less cost‐effective for older patients? The case of ventilator support and aggressive care for patients with acute respiratory failure. J Am Geriatr Soc. 2001;49(4):382390.
  41. Walkey AJ, Wiener RS. Utilization of non‐invasive ventilation in patients with acute respiratory failure from 2000–2009: a population‐based study. Am J Respir Crit Care Med. 2012;185:A6488.
  42. Herridge MS, Cheung AM, Tansey CM, et al. One‐year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348(8):683693.
Article PDF
Issue
Journal of Hospital Medicine - 8(2)
Page Number
76-82
Sections
Files
Files
Article PDF
Article PDF

Acute respiratory failure (ARF), a common and serious complication in hospitalized patients, may be caused by several conditions including pneumonia, chronic obstructive pulmonary disease (COPD), adult respiratory distress syndrome (ARDS), and congestive heart failure (CHF). Although ARF is conventionally defined by an arterial oxygen tension of <60 mm Hg, an arterial carbon dioxide tension of >45 mm Hg, or both, these thresholds serve as a guide to be used in combination with history and clinical assessment of the patient.[1, 2] Supplemental oxygen and treatment of the underlying cause is the mainstay of therapy for ARF, but in severe cases patients are treated with invasive mechanical ventilation (IMV) or noninvasive ventilation (NIV). ARF is the most frequent reason for admission to the intensive care unit (ICU)[3, 4] and has an in‐hospital mortality rate of 33% to 37% among those who require IMV.[5, 6] The majority of epidemiologic studies of ARF have been limited to patients requiring mechanical ventilation or those admitted to the ICU, and information about the characteristics and outcomes of patients across the full spectrum of severity is much more limited.[5, 7, 8, 9, 10, 11] General improvements in the management of underlying conditions, implementation of more effective ventilation strategies,[12, 13] and increasing use of NIV[14, 15] may have led to better outcomes for patients with ARF, yet empirical evidence of a change in the adjusted mortality rate over time is lacking.

The objective of this study was to provide a broad characterization of the epidemiology of ARF among adults hospitalized in the United States using a large nationally representative database. We sought to evaluate whether incidence, mortality, cost, or ventilation practice associated with ARF in the United States changed over the period of 2001 to 2009.

METHODS

Data Source

We utilized data from the Nationwide Inpatient Sample (NIS) of the Health Care Cost and Utilization Project,[16] which is a 20% stratified probability sample of all US acute‐care hospitals each year. These data are drawn from a sampling frame that contains close to 95% of all discharges in the United States, with the hospital discharge record as the unit of analysis. The NIS has been used to study trends in many different diagnoses.[17, 18, 19] The database contains demographic information, payer information, principal and secondary diagnoses, cost, discharge disposition, and death during hospitalization. It also contains information on hospital characteristics including ownership, size, teaching status, and geographic region.

Definitions

We included patients 18 years old discharged between 2001 and 2009 with a primary or secondary diagnosis of ARF. We identified cases of ARF using diagnostic codes (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD‐9‐CM]) previously used in studies of acute organ dysfunction in sepsis (518.81, 518.82, 518.84, 518.4, 799.1, 786.09).[17, 20, 21] To define ARDS we relied on ICD‐9‐CM codes (518.4, 518.82, 518.5, 786.09) used in prior studies that showed good sensitivity and specificity.[22, 23] The use of ventilatory support was identified using the ICD‐9‐CM procedure codes[24] (93.90, 93.70, 93.71, 93.76). Comorbidities were classified using the Agency for Healthcare Research and Quality's (Rockville, MD) Healthcare Cost and Utilization Project's (HCUP) Comorbidity Software version 3.103.5.[25]

Outcomes

The primary outcomes included the annual number of hospitalizations, population incidence, hospital mortality, and costs of care. Secondary outcomes included length of stay, most common diagnoses associated with ARF, disposition at discharge, and use and type of ventilatory support.

Analysis

We estimated the number of hospitalizations with a diagnosis of ARF/year, and we calculated the weighted frequencies following HCUP‐NIS recommendations using SAS/STAT survey procedures. Using population estimates for the years 2001 to 2009 from the US Census Bureau, we employed direct standardization to calculate age‐, gender‐, and race‐adjusted population incidence and mortality rates of ARF per 100,000 population. Hospital mortality was defined as the ratio of ARF hospitalizations ending in death divided by total number of ARF hospitalizations. Mechanical ventilation rates and rates of selected comorbidities were similarly defined.

We employed indirect standardization to adjust hospital mortality rates for age, sex, race/ethnicity, comorbidities, and hospital characteristics using logistic regression models from 2001 to predict hospital mortality for 2002 to 2009. We used linear regression models to test whether the slope of year was significant for trends in outcomes overtime. Costs were calculated using hospital‐specific cost‐to‐charge ratios when available and a weighted group average at the state level for remaining hospitals. We converted all costs to 2009 US dollars using the Consumer Price Index. Costs and lengths of stay were not normally distributed, so we calculated weighted geometric means (the average of all logarithmic values), then converted back to a base‐10 number. Using a Taylor series expansion, we then calculated standard errors. All analyses were performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC).

The Baystate Medical Center institutional review board determined that the project did not constitute human subjects research.

RESULTS

Hospitalization Trends

The number of hospitalizations with an ARF diagnosis code increased at an average annual rate of 11.3% from 1,007,549 (standard deviation [SD] = 19,268) in 2001 to 1,917,910 (SD = 47,558) in 2009. More than two‐thirds of ARF admissions were associated with medical, rather than surgical, conditions (69.5% in 2001 and 71.2% in 2009). The median age, racial make‐up, and gender did not change significantly. Over the study period we observed an increase in ARF‐related hospitalizations in large, urban, teaching hospitals and in hospitals located in the Midwest (Table 1).

Hospitalizations With Acute Respiratory Failure in the United States, 2001 to 2009, by Patient and Hospital Characteristics
 20012003200520072009
  • NOTE: Abbreviations: ARF, acute respiratory failure; IMV, invasive mechanical ventilation; LOS, length of stay; NIV, noninvasive ventilation; SD, standard deviation; SE standard error. P value for trend <0.01, including all years 20012009, *P value for trend <0.0001, including all years 20012009. Adjusted for sex, age, race, hospital characteristics, and comorbidities. Geometric mean reported, standard errors from Taylor series expansion.

Patient characteristics 
All, N (SD)1,007,549 (19,268)1,184,928 (25,542)1,288,594 (30,493)1,480,270 (32,002)1,917,910 (47,558)
Age, mean (SE), y66.6 (0.2)66.0 (0.2)66.1 (0.2)65.8 (0.2)65.8 (0.2)
Age group, %     
184411.512.011.511.610.9
4564*26.728.929.630.731.7
6584*50.247.847.045.745.3
85+11.511.411.912.012.1
Male*48.148.248.649.349.2
Race     
White75.871.976.571.873.4
Black12.713.611.214.212.5
Hispanic7.29.87.78.57.8
Other4.24.74.75.56.3
Primary ARF20.720.925.926.119.9
Secondary ARF79.379.174.173.980.1
Medical*69.569.169.970.271.2
Surgical*30.530.830.129.828.8
Hospital characteristics, %     
Number of beds     
Small10.010.110.510.811.3
Medium25.225.324.624.022.7
Large64.764.664.965.266.0
Region     
South*18.518.517.617.016.3
Midwest21.422.023.623.223.5
Northeast42.641.741.442.242.1
West*17.517.817.317.618.1
Hospital type     
Rural13.613.011.811.010.8
Urban nonteaching45.544.550.145.345.7
Urban teaching40.942.538.143.743.6
Patient outcomes
Ventilation strategy
IMV*48.548.447.546.542.1
NIV*3.85.36.99.410.1
IMV or NIV50.951.752.152.949.7
Disposition     
Home/home healthcare*42.143.842.843.445.7
Transfer to acute care5.24.74.64.64.4
Nursing facility*24.424.927.428.629.0
Other0.70.80.90.91.0
Adjusted mortality, % (SE)*27.6 (0.3)26.4 (0.4)24.9 (0.4)22.7 (0.4)20.6 (0.3)
Adjusted mean, LOS/case, d (SE)*7.8 (0.1)7.9 (0.1)7.7 (0.1)7.5 (0.1)7.1 (0.1)
Adjusted mean cost/case, 2009 US$, (SE)15,818 (251)16,981 (419)17,236 (411)16,941 (436)15,987 (402)

After adjusting for age and sex, the population incidence of ARF increased from 502 (standard error [SE] = 10) cases per 100,000 in 2001 to 784 (SE = 19) cases per 100,000 in 2009 (a 56% increase, P < 0.0001). Hispanics had the lowest rates of ARF, with both black and white groups having similar rates (Table 2).

Cases of Acute Respiratory Failure per 100,000 Population
 20012003200520072009
  • NOTE: Data are presented as number per 100,000 population (standard error), standardized to 2000 US Census population. *P value for trend < 0.0001, including all years 2001 to 2009.

All*502 (10)569 (12)595 (14)627 (14)784 (19)
Age group     
1844*107 (3)130 (4)137 (4)153 (5)189 (6)
4564*422 (9)500 (12)521 (13)580 (14)739 (19)
6584*1697 (35)1863 (42)1950 (50)2066 (46)2578 (69)
85+3449 (86)3792 (106)3981 (120)3429 (97)4163 (123)
Sex     
Male*491 (10)553 (13)582 (14)629 (14)782 (20)
Female*512 (10)583 (12)607 (15)625 (13)786 (19)
Race/ethnicity     
White*398 (11)427 (12)466 (16)450 (13)699 (21)
Black*423 (27)513 (33)432 (26)574 (38)738 (37)
Hispanic*247 (24)381 (42)307 (27)353 (34)478 (42)
Other*268 (20)342 (29)347 (26)424 (29)713 (77)
In‐hospital mortality140 (3)148 (3)146 (3)140 (3)154 (4)

The most common etiologies of ARF among medical patients were pneumonia, CHF, ARDS, COPD exacerbation, and sepsis. Over the 9‐year study, the proportion of cases secondary to pneumonia and sepsis rose significantly: from 39% to 46% and 13% to 21%, respectively (Figure 1).

Figure 1
Proportion of patients with acute respiratory failure with the 5 most common medical conditions from 2001 to 2009. Abbreviations: ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.

Mortality and Other Outcomes

The number of in‐hospital deaths related to ARF increased from 277,407 deaths in 2001 to 381,155 in 2009 (a 37% increase, P < 0.001). Standardized to the population, deaths increased from 140 in 2001 to 154 cases per 100,000 in 2009 (a 10% increase, P = 0.027). Despite slightly increasing mortality rates at a population level, adjusted in‐hospital mortality improved from 27.6% in 2001 to 20.6% in 2009 (P < 0.001). Mortality declined for both IMV and NIV patients from 35.3% in 2001 to 30.2% in 2009 and from 23.5% to 19%, respectively, but increased for those who required both NIV and IMV (from 26.9% in 2001 to 28% in 2009).

Adjusted hospital length of stay decreased from 7.8 days per patient in 2001 to 7.1 days in 2009 (P < 0.001), with a concomitant increase in discharges to nursing facilities, from 24% in 2001 to 29% in 2009. There was no linear trend in adjusted cost per case, with $15,818 in 2001 and $15,987 in 2009 (in 2009 US dollars) (Table 1).

Ventilation Practices

Overall, 50.9% patients received ventilatory support (NIV or IMV or both) in 2001 and 49.7% in 2009 (P= 0.25). The use of NIV increased from 3.8% to 10.1% (P < 0.001), a 169% increase, whereas the utilization of IMV decreased from 48.5% in 2001 to 42.1% in 2009 (P for trend < 0.0001), a 13% decrease. Uses of both NIV and IMV during hospitalization were seen in 1.4% of cases in 2001 and 2.5% of cases in 2009.

2009 Data Analysis

In 2009 the 1,917,910 hospitalizations with ARF resulted in 381,155 (SD = 8965) deaths and a total inpatient cost of $54 billion. The most common etiologies in patients over 65 years old were pneumonia, CHF, COPD, ARDS, and sepsis. In patients younger than 45 years the most frequent diagnoses were pneumonia, ARDS, sepsis, asthma, drug ingestion, and trauma. Stratified analysis by gender and by age groups showed that mortality rates among men were higher than for women and were highest in patients older than 85 years (Table 3).

Characteristics of Hospitalizations by Etiology (Medical, Surgical, Comorbidities, Procedures) in 2009
DiseaseTotalAge <45 Years4565 Years6584 Years85+ YearsMaleFemale
  • NOTE: One patient can have more than 1 diagnosis. Abbreviations: AMI, acute myocardial infarction; ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; IMV, invasive mechanical ventilation; NIV, noninvasive ventilation. *P < 0.0001 for age group. P < 0.0001 for gender. The P values are not from Rao‐Scott 2 test.

Medical       
Total, N (%)1,364,624 (71.2)144,715 (10.6)416,922 (30.6)615,009 (45.1)187,977 (13.8)647,894 (47.5)716,635 (52.5)
Pneumonia, %*46.141.742.846.954.348.843.7
CHF, %*36.610.427.343.654.835.038.1
ARDS, %*16.122.916.214.515.915.516.7
Sepsis, %*21.218.121.321.323.122.819.8
COPD, %*25.44.225.632.318.325.025.7
AMI, %*9.02.67.110.513.39.38.8
Asthma, %*9.218.111.66.75.46.212.0
Stroke, %*4.82.34.15.56.05.04.7
Trauma or burns, %*3.45.42.93.04.14.32.5
Cardiorespiratory arrest, %*4.13.94.44.13.84.63.7
Drug, %*3.716.65.10.80.33.83.6
IMV, %*37.754.643.733.524.841.134.5
NIV, %*11.97.111.513.012.711.412.3
In‐hospital mortality (CI)22 (21.322.7)12.9 (11.913.9)18.5 (17.619.4)23.9 (23.024.9)31.8 (30.633.1)24.2 (23.325.1)20.9 (20.121.7)
Surgical       
Total, N (%)552971 (28.8)64983 (11.8)190225 (34.4)254336 (46)43426 (7.9)295660 (53.5)257287 (46.5)
Pneumonia, %*34.933.034.035.040.537.132.2
CHF, %*27.28.921.733.342.626.727.7
ARDS, %*45.551.545.244.742.745.046.1
Sepsis, %*25.122.825.425.226.125.424.7
COPD, %*8.21.17.410.87.58.38.1
AMI, %*16.94.917.019.817.919.114.4
Asthma, %*6.17.67.25.43.64.18.5
Stroke, %*8.96.69.29.47.28.98.8
Trauma or burns, %*12.226.59.69.220.313.810.4
Cardiorespiratory arrest, %*5.54.46.05.45.26.14.7
Drug, %*0.51.30.70.20.20.40.6
IMV, %*52.957.154.351.350.054.551.0
NIV, %*5.83.55.56.46.45.66.0
In‐hospital mortality, % (CI)18.6 (17.819.5)10.7 (9.312.0)15.5 (14.216.8)20.8 (19.821.9)29.4 (27.831.1)19.0 (18.219.8)18.3 (17.319.2)

When we examined ventilation practices among medical patients we found that patients older than 85 years, when compared to patients younger than 45 years, were less likely to be treated with IMV (25% vs 55%) and more likely to be treated with NIV (12.7% vs 7%). At the same time, the average cost per case was lowest among patients 85 years and older, and hospital costs per case fell sharply after age 70 years. Costs were considerably higher for those who did not survive during hospitalization, particularly for patients younger than 45 years (Figure 2).

Figure 2
Age‐specific hospital cost per patient (geometric mean) stratified by surviving status.

DISCUSSION

In this large population‐based study, we found that the number of hospitalizations associated with a diagnosis of ARF almost doubled over a 9‐year period. In 2009 there were nearly 2 million hospitalizations with ARF in the United States, resulting in approximately 380,000 deaths and inpatient costs of over $54 billion. The population‐adjusted ARF hospitalization rates increased in all age groups, and patients 85 years and older had the highest age‐specific hospitalization rate. Although overall rates of mechanical ventilation (NIV or IMV) remained stable over the 9‐year period, there was an important shift away from IMV (which decreased from 48% in 2001 to 42% in 2009) toward NIV (which increased from 4% in 2001 to 10% in 2009). Overall, there was a significant increase in the number of total deaths despite a decline in adjusted in‐hospital mortality rates. In‐hospital mortality rates decreased for all cases of ARF regardless of ventilation choice.

The findings of this study mirror results of others that have shown that although the incidence of critical care illnesses like sepsis[17, 20, 21, 26] and acute renal failure[27] has increased over the last decade, in‐hospital mortality rates have decreased.[20, 21, 28] Our results also compliment the results of a recent study that looked at hospitalizations for noncardiogenic ARF, which observed a 3.7‐fold increase in the number of cases and a steady decline in case fatality.[11]

Most prior studies addressing the incidence of ARF have included only patients receiving mechanical ventilation. In 1994, the estimated number of cases of ARF requiring IMV was 329,766,[9] which increased to 790,257 in 2005.[10] In our study we found that in 2009, the number of patients with ARF hospitalizations with IMV increased to 806,538. The increase in the overall number of cases with ARF was mainly driven by a surge in cases of sepsis and pneumonia. Our findings are consistent with national trends over time in noncardiogenic ARF[11] and in conditions that predispose patients to ARF such as sepsis[17, 20, 28] and acute renal failure.[27] As the number of claims for ARF doubled and the number of deaths increased, we found that adjusted hospital mortality improved from 27.6% in 2001 to 20.6% in 2009. This decline in hospital mortality was observed among all patients groups, regardless of ventilation choice. The decline in overall case fatality is consistent with prior findings in noncardiogenic ARF,[11] sepsis,[17, 28] and CHF.[29]

There are a number of potential explanations for the reduction in mortality observed over the study period, including improvements in hospital management of the underlying conditions leading to ARF, an increase in the proportion of patients being treated with NIV,[30] and advances in the care of critically ill patients such as the use of low‐tidal volume ventilation.[31, 32] Another contributor may be an increase in the proportion of discharges to nursing facilities, although this change in discharge disposition cannot fully explain our findings. For example, from 2007 to 2009, mortality decreased by 2 percentage points, and nursing home discharges increased by only 0.4 percentage points. Growth and aging of the US population only partially explain the increase we observed in the incidence of ARF, as age‐ and sex‐adjusted population rates increased by 56% from 2001 to 2009. In addition, the NIS captures data on hospital discharges and not individual patients; thus, a patient may have had multiple admissions. Over the last decade adoption of a more intensive practice style has been associated with improved in‐hospital mortality,[33, 34] and although these patients may be living longer they may have multiple readmissions.[35, 36]

We also observed that older patients were less likely to be treated with IMV, had a higher mortality rate, and less expensive care. These results are consistent with other studies and suggest that the intensity of treatment decreases with increasing age, and decisions to withhold or withdraw life‐supporting treatments are more frequent in the elderly.[26, 37] Prior research has shown that severity of illness is more important than age on patients' prognosis,[38, 39] and aggressive treatment strategies are not less cost‐effective when provided to older patients.[40]

Another important finding of this study is the marked increase in the use of NIV paired with a modest reduction in the use of IMV in the treatment of patients with ARF. This finding adds to evidence from other studies, which have similarly reported a dramatic increase in the use of NIV and a decrease in the use of IMV in patients with COPD as well as in ARF of other etiologies.[30, 41]

Our work has several limitations. First, we identified ARF based on ICD‐9‐CM codes and therefore cannot exclude disease misclassification. We did not find any studies in the literature addressing the accuracy and the completeness of ARF coding. However, we employed the same codes used to define ARF as has been used to define organ dysfunction in studies of severe sepsis,[17, 20] and the ICD‐9‐CM codes that we used to identify cases of ARDS have been used in prior studies.[11, 22, 23] Another limitation is that it is not clear to what extent the trends we observed may be due to changes over time in documentation and coding practices. Although this should be considered given the additional reimbursement associated with the diagnosis of ARF, our observation that rates of assisted ventilation have remained almost flat over the 9‐year period of the study suggest that would not wholly account for the rise in ARF. Second, because we did not have access to physiological data such as results of blood gas testing, we could not determine whether the threshold for applying the diagnosis of ARF or for delivering ventilatory support has changed over time. Third, for the purpose of this study we employed a broad definition of ARF, not limiting cases to those requiring mechanical ventilation, and this led to a more heterogeneous cohort including less severe cases of ARF. However, this is not dissimilar to the heterogeneity in disease severity observed among patients who receive a diagnosis of heart failure or acute renal failure. Fourth, survivors of ARF remain at high risk of death in the months after hospitalization,[42] but we assessed only in‐hospital mortality. It is possible that although in‐hospital mortality has improved, 30‐day mortality remained stable. Finally, as the NIS contains only discharge‐level data, we could not distinguish between patients admitted for ARF from those who developed ARF (potentially iatrogenic) after admission.

In summary, over the period of 2001 to 2009, there was a large increase in the number of patients given a diagnosis of ARF and a concomitant reduction in inpatient mortality. Although rates of mechanical ventilation remained relatively constant, there was a significant shift toward greater use of NIV at the expense of IMV.

Disclosures

Dr. Stefan is supported by KM1 CA156726 from the National Cancer Institute (NCI) and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through grant UL1 RR025752. The work on this study was supported by a Charlton grant from Tufts University School of Medicine. Dr. Lindenauer and Dr. Pekow are supported by 1R18HL108810‐01 from the National Heart, Lung, and Blood Institute (NHLBI). The content of this publication is solely the responsibility of the authors and does not represent the official views of the NIH, NHLBI, or NCI.

All authors have read and approved the manuscript and none of them have any potential conflicts of interest to report.

Dr. Stefan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conception and design: Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Jay Steingrub, Peter K. Lindenauer; analysis and interpretation: Meng‐Shiou Shieh, Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Tara Lagu, Peter K. Lindenauer; drafting the manuscript for important intellectual content: Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Jay Steingrub, Tara Lagu, and Peter K. Lindenauer.

Acute respiratory failure (ARF), a common and serious complication in hospitalized patients, may be caused by several conditions including pneumonia, chronic obstructive pulmonary disease (COPD), adult respiratory distress syndrome (ARDS), and congestive heart failure (CHF). Although ARF is conventionally defined by an arterial oxygen tension of <60 mm Hg, an arterial carbon dioxide tension of >45 mm Hg, or both, these thresholds serve as a guide to be used in combination with history and clinical assessment of the patient.[1, 2] Supplemental oxygen and treatment of the underlying cause is the mainstay of therapy for ARF, but in severe cases patients are treated with invasive mechanical ventilation (IMV) or noninvasive ventilation (NIV). ARF is the most frequent reason for admission to the intensive care unit (ICU)[3, 4] and has an in‐hospital mortality rate of 33% to 37% among those who require IMV.[5, 6] The majority of epidemiologic studies of ARF have been limited to patients requiring mechanical ventilation or those admitted to the ICU, and information about the characteristics and outcomes of patients across the full spectrum of severity is much more limited.[5, 7, 8, 9, 10, 11] General improvements in the management of underlying conditions, implementation of more effective ventilation strategies,[12, 13] and increasing use of NIV[14, 15] may have led to better outcomes for patients with ARF, yet empirical evidence of a change in the adjusted mortality rate over time is lacking.

The objective of this study was to provide a broad characterization of the epidemiology of ARF among adults hospitalized in the United States using a large nationally representative database. We sought to evaluate whether incidence, mortality, cost, or ventilation practice associated with ARF in the United States changed over the period of 2001 to 2009.

METHODS

Data Source

We utilized data from the Nationwide Inpatient Sample (NIS) of the Health Care Cost and Utilization Project,[16] which is a 20% stratified probability sample of all US acute‐care hospitals each year. These data are drawn from a sampling frame that contains close to 95% of all discharges in the United States, with the hospital discharge record as the unit of analysis. The NIS has been used to study trends in many different diagnoses.[17, 18, 19] The database contains demographic information, payer information, principal and secondary diagnoses, cost, discharge disposition, and death during hospitalization. It also contains information on hospital characteristics including ownership, size, teaching status, and geographic region.

Definitions

We included patients 18 years old discharged between 2001 and 2009 with a primary or secondary diagnosis of ARF. We identified cases of ARF using diagnostic codes (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD‐9‐CM]) previously used in studies of acute organ dysfunction in sepsis (518.81, 518.82, 518.84, 518.4, 799.1, 786.09).[17, 20, 21] To define ARDS we relied on ICD‐9‐CM codes (518.4, 518.82, 518.5, 786.09) used in prior studies that showed good sensitivity and specificity.[22, 23] The use of ventilatory support was identified using the ICD‐9‐CM procedure codes[24] (93.90, 93.70, 93.71, 93.76). Comorbidities were classified using the Agency for Healthcare Research and Quality's (Rockville, MD) Healthcare Cost and Utilization Project's (HCUP) Comorbidity Software version 3.103.5.[25]

Outcomes

The primary outcomes included the annual number of hospitalizations, population incidence, hospital mortality, and costs of care. Secondary outcomes included length of stay, most common diagnoses associated with ARF, disposition at discharge, and use and type of ventilatory support.

Analysis

We estimated the number of hospitalizations with a diagnosis of ARF/year, and we calculated the weighted frequencies following HCUP‐NIS recommendations using SAS/STAT survey procedures. Using population estimates for the years 2001 to 2009 from the US Census Bureau, we employed direct standardization to calculate age‐, gender‐, and race‐adjusted population incidence and mortality rates of ARF per 100,000 population. Hospital mortality was defined as the ratio of ARF hospitalizations ending in death divided by total number of ARF hospitalizations. Mechanical ventilation rates and rates of selected comorbidities were similarly defined.

We employed indirect standardization to adjust hospital mortality rates for age, sex, race/ethnicity, comorbidities, and hospital characteristics using logistic regression models from 2001 to predict hospital mortality for 2002 to 2009. We used linear regression models to test whether the slope of year was significant for trends in outcomes overtime. Costs were calculated using hospital‐specific cost‐to‐charge ratios when available and a weighted group average at the state level for remaining hospitals. We converted all costs to 2009 US dollars using the Consumer Price Index. Costs and lengths of stay were not normally distributed, so we calculated weighted geometric means (the average of all logarithmic values), then converted back to a base‐10 number. Using a Taylor series expansion, we then calculated standard errors. All analyses were performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC).

The Baystate Medical Center institutional review board determined that the project did not constitute human subjects research.

RESULTS

Hospitalization Trends

The number of hospitalizations with an ARF diagnosis code increased at an average annual rate of 11.3% from 1,007,549 (standard deviation [SD] = 19,268) in 2001 to 1,917,910 (SD = 47,558) in 2009. More than two‐thirds of ARF admissions were associated with medical, rather than surgical, conditions (69.5% in 2001 and 71.2% in 2009). The median age, racial make‐up, and gender did not change significantly. Over the study period we observed an increase in ARF‐related hospitalizations in large, urban, teaching hospitals and in hospitals located in the Midwest (Table 1).

Hospitalizations With Acute Respiratory Failure in the United States, 2001 to 2009, by Patient and Hospital Characteristics
 20012003200520072009
  • NOTE: Abbreviations: ARF, acute respiratory failure; IMV, invasive mechanical ventilation; LOS, length of stay; NIV, noninvasive ventilation; SD, standard deviation; SE standard error. P value for trend <0.01, including all years 20012009, *P value for trend <0.0001, including all years 20012009. Adjusted for sex, age, race, hospital characteristics, and comorbidities. Geometric mean reported, standard errors from Taylor series expansion.

Patient characteristics 
All, N (SD)1,007,549 (19,268)1,184,928 (25,542)1,288,594 (30,493)1,480,270 (32,002)1,917,910 (47,558)
Age, mean (SE), y66.6 (0.2)66.0 (0.2)66.1 (0.2)65.8 (0.2)65.8 (0.2)
Age group, %     
184411.512.011.511.610.9
4564*26.728.929.630.731.7
6584*50.247.847.045.745.3
85+11.511.411.912.012.1
Male*48.148.248.649.349.2
Race     
White75.871.976.571.873.4
Black12.713.611.214.212.5
Hispanic7.29.87.78.57.8
Other4.24.74.75.56.3
Primary ARF20.720.925.926.119.9
Secondary ARF79.379.174.173.980.1
Medical*69.569.169.970.271.2
Surgical*30.530.830.129.828.8
Hospital characteristics, %     
Number of beds     
Small10.010.110.510.811.3
Medium25.225.324.624.022.7
Large64.764.664.965.266.0
Region     
South*18.518.517.617.016.3
Midwest21.422.023.623.223.5
Northeast42.641.741.442.242.1
West*17.517.817.317.618.1
Hospital type     
Rural13.613.011.811.010.8
Urban nonteaching45.544.550.145.345.7
Urban teaching40.942.538.143.743.6
Patient outcomes
Ventilation strategy
IMV*48.548.447.546.542.1
NIV*3.85.36.99.410.1
IMV or NIV50.951.752.152.949.7
Disposition     
Home/home healthcare*42.143.842.843.445.7
Transfer to acute care5.24.74.64.64.4
Nursing facility*24.424.927.428.629.0
Other0.70.80.90.91.0
Adjusted mortality, % (SE)*27.6 (0.3)26.4 (0.4)24.9 (0.4)22.7 (0.4)20.6 (0.3)
Adjusted mean, LOS/case, d (SE)*7.8 (0.1)7.9 (0.1)7.7 (0.1)7.5 (0.1)7.1 (0.1)
Adjusted mean cost/case, 2009 US$, (SE)15,818 (251)16,981 (419)17,236 (411)16,941 (436)15,987 (402)

After adjusting for age and sex, the population incidence of ARF increased from 502 (standard error [SE] = 10) cases per 100,000 in 2001 to 784 (SE = 19) cases per 100,000 in 2009 (a 56% increase, P < 0.0001). Hispanics had the lowest rates of ARF, with both black and white groups having similar rates (Table 2).

Cases of Acute Respiratory Failure per 100,000 Population
 20012003200520072009
  • NOTE: Data are presented as number per 100,000 population (standard error), standardized to 2000 US Census population. *P value for trend < 0.0001, including all years 2001 to 2009.

All*502 (10)569 (12)595 (14)627 (14)784 (19)
Age group     
1844*107 (3)130 (4)137 (4)153 (5)189 (6)
4564*422 (9)500 (12)521 (13)580 (14)739 (19)
6584*1697 (35)1863 (42)1950 (50)2066 (46)2578 (69)
85+3449 (86)3792 (106)3981 (120)3429 (97)4163 (123)
Sex     
Male*491 (10)553 (13)582 (14)629 (14)782 (20)
Female*512 (10)583 (12)607 (15)625 (13)786 (19)
Race/ethnicity     
White*398 (11)427 (12)466 (16)450 (13)699 (21)
Black*423 (27)513 (33)432 (26)574 (38)738 (37)
Hispanic*247 (24)381 (42)307 (27)353 (34)478 (42)
Other*268 (20)342 (29)347 (26)424 (29)713 (77)
In‐hospital mortality140 (3)148 (3)146 (3)140 (3)154 (4)

The most common etiologies of ARF among medical patients were pneumonia, CHF, ARDS, COPD exacerbation, and sepsis. Over the 9‐year study, the proportion of cases secondary to pneumonia and sepsis rose significantly: from 39% to 46% and 13% to 21%, respectively (Figure 1).

Figure 1
Proportion of patients with acute respiratory failure with the 5 most common medical conditions from 2001 to 2009. Abbreviations: ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.

Mortality and Other Outcomes

The number of in‐hospital deaths related to ARF increased from 277,407 deaths in 2001 to 381,155 in 2009 (a 37% increase, P < 0.001). Standardized to the population, deaths increased from 140 in 2001 to 154 cases per 100,000 in 2009 (a 10% increase, P = 0.027). Despite slightly increasing mortality rates at a population level, adjusted in‐hospital mortality improved from 27.6% in 2001 to 20.6% in 2009 (P < 0.001). Mortality declined for both IMV and NIV patients from 35.3% in 2001 to 30.2% in 2009 and from 23.5% to 19%, respectively, but increased for those who required both NIV and IMV (from 26.9% in 2001 to 28% in 2009).

Adjusted hospital length of stay decreased from 7.8 days per patient in 2001 to 7.1 days in 2009 (P < 0.001), with a concomitant increase in discharges to nursing facilities, from 24% in 2001 to 29% in 2009. There was no linear trend in adjusted cost per case, with $15,818 in 2001 and $15,987 in 2009 (in 2009 US dollars) (Table 1).

Ventilation Practices

Overall, 50.9% patients received ventilatory support (NIV or IMV or both) in 2001 and 49.7% in 2009 (P= 0.25). The use of NIV increased from 3.8% to 10.1% (P < 0.001), a 169% increase, whereas the utilization of IMV decreased from 48.5% in 2001 to 42.1% in 2009 (P for trend < 0.0001), a 13% decrease. Uses of both NIV and IMV during hospitalization were seen in 1.4% of cases in 2001 and 2.5% of cases in 2009.

2009 Data Analysis

In 2009 the 1,917,910 hospitalizations with ARF resulted in 381,155 (SD = 8965) deaths and a total inpatient cost of $54 billion. The most common etiologies in patients over 65 years old were pneumonia, CHF, COPD, ARDS, and sepsis. In patients younger than 45 years the most frequent diagnoses were pneumonia, ARDS, sepsis, asthma, drug ingestion, and trauma. Stratified analysis by gender and by age groups showed that mortality rates among men were higher than for women and were highest in patients older than 85 years (Table 3).

Characteristics of Hospitalizations by Etiology (Medical, Surgical, Comorbidities, Procedures) in 2009
DiseaseTotalAge <45 Years4565 Years6584 Years85+ YearsMaleFemale
  • NOTE: One patient can have more than 1 diagnosis. Abbreviations: AMI, acute myocardial infarction; ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; IMV, invasive mechanical ventilation; NIV, noninvasive ventilation. *P < 0.0001 for age group. P < 0.0001 for gender. The P values are not from Rao‐Scott 2 test.

Medical       
Total, N (%)1,364,624 (71.2)144,715 (10.6)416,922 (30.6)615,009 (45.1)187,977 (13.8)647,894 (47.5)716,635 (52.5)
Pneumonia, %*46.141.742.846.954.348.843.7
CHF, %*36.610.427.343.654.835.038.1
ARDS, %*16.122.916.214.515.915.516.7
Sepsis, %*21.218.121.321.323.122.819.8
COPD, %*25.44.225.632.318.325.025.7
AMI, %*9.02.67.110.513.39.38.8
Asthma, %*9.218.111.66.75.46.212.0
Stroke, %*4.82.34.15.56.05.04.7
Trauma or burns, %*3.45.42.93.04.14.32.5
Cardiorespiratory arrest, %*4.13.94.44.13.84.63.7
Drug, %*3.716.65.10.80.33.83.6
IMV, %*37.754.643.733.524.841.134.5
NIV, %*11.97.111.513.012.711.412.3
In‐hospital mortality (CI)22 (21.322.7)12.9 (11.913.9)18.5 (17.619.4)23.9 (23.024.9)31.8 (30.633.1)24.2 (23.325.1)20.9 (20.121.7)
Surgical       
Total, N (%)552971 (28.8)64983 (11.8)190225 (34.4)254336 (46)43426 (7.9)295660 (53.5)257287 (46.5)
Pneumonia, %*34.933.034.035.040.537.132.2
CHF, %*27.28.921.733.342.626.727.7
ARDS, %*45.551.545.244.742.745.046.1
Sepsis, %*25.122.825.425.226.125.424.7
COPD, %*8.21.17.410.87.58.38.1
AMI, %*16.94.917.019.817.919.114.4
Asthma, %*6.17.67.25.43.64.18.5
Stroke, %*8.96.69.29.47.28.98.8
Trauma or burns, %*12.226.59.69.220.313.810.4
Cardiorespiratory arrest, %*5.54.46.05.45.26.14.7
Drug, %*0.51.30.70.20.20.40.6
IMV, %*52.957.154.351.350.054.551.0
NIV, %*5.83.55.56.46.45.66.0
In‐hospital mortality, % (CI)18.6 (17.819.5)10.7 (9.312.0)15.5 (14.216.8)20.8 (19.821.9)29.4 (27.831.1)19.0 (18.219.8)18.3 (17.319.2)

When we examined ventilation practices among medical patients we found that patients older than 85 years, when compared to patients younger than 45 years, were less likely to be treated with IMV (25% vs 55%) and more likely to be treated with NIV (12.7% vs 7%). At the same time, the average cost per case was lowest among patients 85 years and older, and hospital costs per case fell sharply after age 70 years. Costs were considerably higher for those who did not survive during hospitalization, particularly for patients younger than 45 years (Figure 2).

Figure 2
Age‐specific hospital cost per patient (geometric mean) stratified by surviving status.

DISCUSSION

In this large population‐based study, we found that the number of hospitalizations associated with a diagnosis of ARF almost doubled over a 9‐year period. In 2009 there were nearly 2 million hospitalizations with ARF in the United States, resulting in approximately 380,000 deaths and inpatient costs of over $54 billion. The population‐adjusted ARF hospitalization rates increased in all age groups, and patients 85 years and older had the highest age‐specific hospitalization rate. Although overall rates of mechanical ventilation (NIV or IMV) remained stable over the 9‐year period, there was an important shift away from IMV (which decreased from 48% in 2001 to 42% in 2009) toward NIV (which increased from 4% in 2001 to 10% in 2009). Overall, there was a significant increase in the number of total deaths despite a decline in adjusted in‐hospital mortality rates. In‐hospital mortality rates decreased for all cases of ARF regardless of ventilation choice.

The findings of this study mirror results of others that have shown that although the incidence of critical care illnesses like sepsis[17, 20, 21, 26] and acute renal failure[27] has increased over the last decade, in‐hospital mortality rates have decreased.[20, 21, 28] Our results also compliment the results of a recent study that looked at hospitalizations for noncardiogenic ARF, which observed a 3.7‐fold increase in the number of cases and a steady decline in case fatality.[11]

Most prior studies addressing the incidence of ARF have included only patients receiving mechanical ventilation. In 1994, the estimated number of cases of ARF requiring IMV was 329,766,[9] which increased to 790,257 in 2005.[10] In our study we found that in 2009, the number of patients with ARF hospitalizations with IMV increased to 806,538. The increase in the overall number of cases with ARF was mainly driven by a surge in cases of sepsis and pneumonia. Our findings are consistent with national trends over time in noncardiogenic ARF[11] and in conditions that predispose patients to ARF such as sepsis[17, 20, 28] and acute renal failure.[27] As the number of claims for ARF doubled and the number of deaths increased, we found that adjusted hospital mortality improved from 27.6% in 2001 to 20.6% in 2009. This decline in hospital mortality was observed among all patients groups, regardless of ventilation choice. The decline in overall case fatality is consistent with prior findings in noncardiogenic ARF,[11] sepsis,[17, 28] and CHF.[29]

There are a number of potential explanations for the reduction in mortality observed over the study period, including improvements in hospital management of the underlying conditions leading to ARF, an increase in the proportion of patients being treated with NIV,[30] and advances in the care of critically ill patients such as the use of low‐tidal volume ventilation.[31, 32] Another contributor may be an increase in the proportion of discharges to nursing facilities, although this change in discharge disposition cannot fully explain our findings. For example, from 2007 to 2009, mortality decreased by 2 percentage points, and nursing home discharges increased by only 0.4 percentage points. Growth and aging of the US population only partially explain the increase we observed in the incidence of ARF, as age‐ and sex‐adjusted population rates increased by 56% from 2001 to 2009. In addition, the NIS captures data on hospital discharges and not individual patients; thus, a patient may have had multiple admissions. Over the last decade adoption of a more intensive practice style has been associated with improved in‐hospital mortality,[33, 34] and although these patients may be living longer they may have multiple readmissions.[35, 36]

We also observed that older patients were less likely to be treated with IMV, had a higher mortality rate, and less expensive care. These results are consistent with other studies and suggest that the intensity of treatment decreases with increasing age, and decisions to withhold or withdraw life‐supporting treatments are more frequent in the elderly.[26, 37] Prior research has shown that severity of illness is more important than age on patients' prognosis,[38, 39] and aggressive treatment strategies are not less cost‐effective when provided to older patients.[40]

Another important finding of this study is the marked increase in the use of NIV paired with a modest reduction in the use of IMV in the treatment of patients with ARF. This finding adds to evidence from other studies, which have similarly reported a dramatic increase in the use of NIV and a decrease in the use of IMV in patients with COPD as well as in ARF of other etiologies.[30, 41]

Our work has several limitations. First, we identified ARF based on ICD‐9‐CM codes and therefore cannot exclude disease misclassification. We did not find any studies in the literature addressing the accuracy and the completeness of ARF coding. However, we employed the same codes used to define ARF as has been used to define organ dysfunction in studies of severe sepsis,[17, 20] and the ICD‐9‐CM codes that we used to identify cases of ARDS have been used in prior studies.[11, 22, 23] Another limitation is that it is not clear to what extent the trends we observed may be due to changes over time in documentation and coding practices. Although this should be considered given the additional reimbursement associated with the diagnosis of ARF, our observation that rates of assisted ventilation have remained almost flat over the 9‐year period of the study suggest that would not wholly account for the rise in ARF. Second, because we did not have access to physiological data such as results of blood gas testing, we could not determine whether the threshold for applying the diagnosis of ARF or for delivering ventilatory support has changed over time. Third, for the purpose of this study we employed a broad definition of ARF, not limiting cases to those requiring mechanical ventilation, and this led to a more heterogeneous cohort including less severe cases of ARF. However, this is not dissimilar to the heterogeneity in disease severity observed among patients who receive a diagnosis of heart failure or acute renal failure. Fourth, survivors of ARF remain at high risk of death in the months after hospitalization,[42] but we assessed only in‐hospital mortality. It is possible that although in‐hospital mortality has improved, 30‐day mortality remained stable. Finally, as the NIS contains only discharge‐level data, we could not distinguish between patients admitted for ARF from those who developed ARF (potentially iatrogenic) after admission.

In summary, over the period of 2001 to 2009, there was a large increase in the number of patients given a diagnosis of ARF and a concomitant reduction in inpatient mortality. Although rates of mechanical ventilation remained relatively constant, there was a significant shift toward greater use of NIV at the expense of IMV.

Disclosures

Dr. Stefan is supported by KM1 CA156726 from the National Cancer Institute (NCI) and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through grant UL1 RR025752. The work on this study was supported by a Charlton grant from Tufts University School of Medicine. Dr. Lindenauer and Dr. Pekow are supported by 1R18HL108810‐01 from the National Heart, Lung, and Blood Institute (NHLBI). The content of this publication is solely the responsibility of the authors and does not represent the official views of the NIH, NHLBI, or NCI.

All authors have read and approved the manuscript and none of them have any potential conflicts of interest to report.

Dr. Stefan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conception and design: Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Jay Steingrub, Peter K. Lindenauer; analysis and interpretation: Meng‐Shiou Shieh, Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Tara Lagu, Peter K. Lindenauer; drafting the manuscript for important intellectual content: Mihaela S. Stefan, Penelope S. Pekow, Michael B. Rothberg, Jay Steingrub, Tara Lagu, and Peter K. Lindenauer.

References
  1. Goldman L, Schaffer A. Goldman's Cecil Medicine. 24th ed. Amsterdam, the Netherlands: Elsevier Inc.; 2012.
  2. Murray JF, Nadel JA. Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Saunders; 2010.
  3. Vincent JL, Sakr Y, Ranieri VM. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med. 2003;31(4 suppl):S296S299.
  4. Cartin‐Ceba R, Kojicic M, Li G, et al. Epidemiology of critical care syndromes, organ failures, and life‐support interventions in a suburban US community. Chest. 2011;140(6):14471455.
  5. Carson SS, Cox CE, Holmes GM, Howard A, Carey TS. The changing epidemiology of mechanical ventilation: a population‐based study. J Intensive Care Med. 2006;21(3):173182.
  6. Needham DM, Bronskill SE, Sibbald WJ, Pronovost PJ, Laupacis A. Mechanical ventilation in Ontario, 1992–2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med. 2004;32(7):15041509.
  7. Lewandowski K. Contributions to the epidemiology of acute respiratory failure. Crit Care. 2003;7(4):288290.
  8. Lewandowski K, Metz J, Deutschmann C, et al. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med. 1995;151(4):11211125.
  9. Behrendt CE. Acute respiratory failure in the United States: incidence and 31‐day survival. Chest. 2000;118(4):11001105.
  10. Wunsch H, Linde‐Zwirble WT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation use in the United States. Crit Care Med. 2010;38(10):19471953.
  11. Cooke CR, Erickson SE, Eisner MD, Martin GS. Trends in the incidence of noncardiogenic acute respiratory failure: the role of race. Crit Care Med. 2012;40(5):15321538.
  12. Girou E, Brun‐Buisson C, Taille S, Lemaire F, Brochard L. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290(22):29852991.
  13. Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA. 2000;284(18):23612367.
  14. Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L. Noninvasive versus conventional mechanical ventilation. An epidemiologic survey. Am J Respir Crit Care Med. 2001;163(4):874880.
  15. Nourdine K, Combes P, Carton MJ, Beuret P, Cannamela A, Ducreux JC. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med. 1999;25(6):567573.
  16. Heathcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample. Available at: http://www.hcup‐us.ahrq.gov/nisoverview.jsp. Accessed December 6, 2011.
  17. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2011;40(3):754761.
  18. Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003–2009. JAMA. 2012;307(13):14051413.
  19. Rothberg MB, Cohen J, Lindenauer P, Maselli J, Auerbach A. Little evidence of correlation between growth in health care spending and reduced mortality. Health Aff (Millwood). 2010;29(8):15231531.
  20. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):15461554.
  21. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):12441250.
  22. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest. 2001;119(4):11791184.
  23. Reynolds HN, McCunn M, Borg U, Habashi N, Cottingham C, Bar‐Lavi Y. Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million‐person population base. Crit Care. 1998;2(1):2934.
  24. Quan H, Parsons GA, Ghali WA. Validity of procedure codes in International Classification of Diseases, 9th Revision, Clinical Modification administrative data. Med Care. 2004;42(8):801809.
  25. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):827.
  26. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 suppl):S109S116.
  27. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1(1):4351.
  28. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med. 2005;33(11):25552562.
  29. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries,1998–2008. JAMA. 2011;306(15):16691678.
  30. Chandra D, Stamm JA, Taylor B, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med. 2011;185(2):152159.
  31. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal‐oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333(16):10251032.
  32. Oba Y, Salzman GA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury. N Engl J Med. 2000;343(11):813; author reply 813–814.
  33. Kaufmann PA, Smolle KH, Krejs GJ. Short‐ and long‐term survival of nonsurgical intensive care patients and its relation to diagnosis, severity of disease, age and comorbidities. Curr Aging Sci. 2009;2(3):240248.
  34. Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction—a ten‐year retrospective observational study. Chest. 2012;141(6):14411448.
  35. Barsky AJ. The paradox of health. N Engl J Med. 1988;318(7):414418.
  36. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee‐for‐service program. N Engl J Med. 2009;360(14):14181428.
  37. Hamel MB, Phillips RS, Davis RB, et al. Outcomes and cost‐effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med. 2000;109(8):614620.
  38. Hamel MB, Davis RB, Teno JM, et al. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1999;131(10):721728.
  39. Hamel MB, Teno JM, Goldman L, et al. Patient age and decisions to withhold life‐sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med. 1999;130(2):116125.
  40. Hamel MB, Phillips RS, Davis RB, et al. Are aggressive treatment strategies less cost‐effective for older patients? The case of ventilator support and aggressive care for patients with acute respiratory failure. J Am Geriatr Soc. 2001;49(4):382390.
  41. Walkey AJ, Wiener RS. Utilization of non‐invasive ventilation in patients with acute respiratory failure from 2000–2009: a population‐based study. Am J Respir Crit Care Med. 2012;185:A6488.
  42. Herridge MS, Cheung AM, Tansey CM, et al. One‐year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348(8):683693.
References
  1. Goldman L, Schaffer A. Goldman's Cecil Medicine. 24th ed. Amsterdam, the Netherlands: Elsevier Inc.; 2012.
  2. Murray JF, Nadel JA. Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Saunders; 2010.
  3. Vincent JL, Sakr Y, Ranieri VM. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med. 2003;31(4 suppl):S296S299.
  4. Cartin‐Ceba R, Kojicic M, Li G, et al. Epidemiology of critical care syndromes, organ failures, and life‐support interventions in a suburban US community. Chest. 2011;140(6):14471455.
  5. Carson SS, Cox CE, Holmes GM, Howard A, Carey TS. The changing epidemiology of mechanical ventilation: a population‐based study. J Intensive Care Med. 2006;21(3):173182.
  6. Needham DM, Bronskill SE, Sibbald WJ, Pronovost PJ, Laupacis A. Mechanical ventilation in Ontario, 1992–2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med. 2004;32(7):15041509.
  7. Lewandowski K. Contributions to the epidemiology of acute respiratory failure. Crit Care. 2003;7(4):288290.
  8. Lewandowski K, Metz J, Deutschmann C, et al. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med. 1995;151(4):11211125.
  9. Behrendt CE. Acute respiratory failure in the United States: incidence and 31‐day survival. Chest. 2000;118(4):11001105.
  10. Wunsch H, Linde‐Zwirble WT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation use in the United States. Crit Care Med. 2010;38(10):19471953.
  11. Cooke CR, Erickson SE, Eisner MD, Martin GS. Trends in the incidence of noncardiogenic acute respiratory failure: the role of race. Crit Care Med. 2012;40(5):15321538.
  12. Girou E, Brun‐Buisson C, Taille S, Lemaire F, Brochard L. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290(22):29852991.
  13. Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA. 2000;284(18):23612367.
  14. Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L. Noninvasive versus conventional mechanical ventilation. An epidemiologic survey. Am J Respir Crit Care Med. 2001;163(4):874880.
  15. Nourdine K, Combes P, Carton MJ, Beuret P, Cannamela A, Ducreux JC. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med. 1999;25(6):567573.
  16. Heathcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample. Available at: http://www.hcup‐us.ahrq.gov/nisoverview.jsp. Accessed December 6, 2011.
  17. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2011;40(3):754761.
  18. Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003–2009. JAMA. 2012;307(13):14051413.
  19. Rothberg MB, Cohen J, Lindenauer P, Maselli J, Auerbach A. Little evidence of correlation between growth in health care spending and reduced mortality. Health Aff (Millwood). 2010;29(8):15231531.
  20. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):15461554.
  21. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):12441250.
  22. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest. 2001;119(4):11791184.
  23. Reynolds HN, McCunn M, Borg U, Habashi N, Cottingham C, Bar‐Lavi Y. Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million‐person population base. Crit Care. 1998;2(1):2934.
  24. Quan H, Parsons GA, Ghali WA. Validity of procedure codes in International Classification of Diseases, 9th Revision, Clinical Modification administrative data. Med Care. 2004;42(8):801809.
  25. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):827.
  26. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 suppl):S109S116.
  27. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1(1):4351.
  28. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med. 2005;33(11):25552562.
  29. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries,1998–2008. JAMA. 2011;306(15):16691678.
  30. Chandra D, Stamm JA, Taylor B, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med. 2011;185(2):152159.
  31. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal‐oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333(16):10251032.
  32. Oba Y, Salzman GA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury. N Engl J Med. 2000;343(11):813; author reply 813–814.
  33. Kaufmann PA, Smolle KH, Krejs GJ. Short‐ and long‐term survival of nonsurgical intensive care patients and its relation to diagnosis, severity of disease, age and comorbidities. Curr Aging Sci. 2009;2(3):240248.
  34. Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction—a ten‐year retrospective observational study. Chest. 2012;141(6):14411448.
  35. Barsky AJ. The paradox of health. N Engl J Med. 1988;318(7):414418.
  36. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee‐for‐service program. N Engl J Med. 2009;360(14):14181428.
  37. Hamel MB, Phillips RS, Davis RB, et al. Outcomes and cost‐effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med. 2000;109(8):614620.
  38. Hamel MB, Davis RB, Teno JM, et al. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1999;131(10):721728.
  39. Hamel MB, Teno JM, Goldman L, et al. Patient age and decisions to withhold life‐sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med. 1999;130(2):116125.
  40. Hamel MB, Phillips RS, Davis RB, et al. Are aggressive treatment strategies less cost‐effective for older patients? The case of ventilator support and aggressive care for patients with acute respiratory failure. J Am Geriatr Soc. 2001;49(4):382390.
  41. Walkey AJ, Wiener RS. Utilization of non‐invasive ventilation in patients with acute respiratory failure from 2000–2009: a population‐based study. Am J Respir Crit Care Med. 2012;185:A6488.
  42. Herridge MS, Cheung AM, Tansey CM, et al. One‐year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348(8):683693.
Issue
Journal of Hospital Medicine - 8(2)
Issue
Journal of Hospital Medicine - 8(2)
Page Number
76-82
Page Number
76-82
Article Type
Display Headline
Epidemiology and outcomes of acute respiratory failure in the United States, 2001 to 2009: A national survey
Display Headline
Epidemiology and outcomes of acute respiratory failure in the United States, 2001 to 2009: A national survey
Sections
Article Source

Copyright © 2012 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Mihaela S. Stefan, MD, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199; Telephone: 413‐794‐8121; Fax: 413 794 4054. E‐mail: [email protected]
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media
Media Files

New Strategies to Combat an Old Foe

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Looking for new strategies to combat an old foe

In the early part of the 20th century, pneumonia was a leading causes of death, particularly among older adults, for whom Osler termed it the Captain of the Men of Death.[1] Mortality rates from severe (bacteremic) pneumonia were typically 80% to 90%, and the introduction of antibacterial therapy in the 1940s reduced that mortality to 10% to 20%. However, as pointed out by Austrian and Gold in a landmark paper in the 1950s, mortality for patients dying within the first 4 to 5 days was not reduced in the postantibiotic era.[2] The survival rates for patients with severe community‐acquired pneumonia minimally improved over the ensuing 50 years, despite the introduction of numerous new antimicrobial drugs and other medical interventions.

One promising area for therapeutic intervention relates to the potential adverse effects of the host inflammatory response in the setting of pneumonia. A growing body of literature supports the conclusion that the window of optimal host response may be relatively narrow. Too little response and patients quickly succumb to overwhelming sepsis. Too much response and a patient's hyperactivated inflammatory system can set off a cascade of secondary events, triggering events such as acute lung injury or ischemic heart disease.[3] Studies have also established that the level of inflammation, as measured by biomarkers such as C‐reactive protein, tumor necrosis factor, and interleukins, can identify patients at increased risk of adverse outcomes.[4] Thus, it is logical to ask whether immune modulating therapies can improve outcomes for these patients.

In this issue of the Journal of Hospital Medicine, Shafiq and colleagues completed a systematic review and meta‐analysis of corticosteroid therapy for patients with pneumonia.[5] Updating prior reviews, they included 8 randomized controlled trials, all of which consisted of low‐dose, systemic, steroid therapy as the intervention and standard care as the control arm. The overall quality of the included studies was judged moderate, and the overall size of the pooled data was only 1119 patients. In their analysis, adjunctive steroid therapy did not reduce in‐hospital mortality, with 4 studies demonstrating effect sizes suggesting benefit, 3 studies demonstrating no benefit or harm, and 1 study favoring the nonsteroid arm. In these situations with grossly heterogeneous study results, it seems prudent to avoid overly interpreting pooled results, even if statistical tests for heterogeneity are nonsignificant. The investigators also reported a range of secondary outcomes, noting that hospital length of stay was significantly reduced in the pooled steroid treated arms.

The overall negative finding is clearly disappointing at a time when clinicians are looking for new treatments to improve outcomes for these patients. Pneumonia is a heterogeneous disorder, representing a wide range of microbial pathogens and underlying host risk factors. Current treatment guidelines for patients with community‐acquired pneumonia are largely empirical and do not focus on pathogen identification, host risk factor analysis, or biomarker distributions to select antimicrobial therapy.[6] In this regard, despite being 1 of the oldest conditions for which we have published guidelines for treatment, the treatment approach for pneumonia remains quite antiquated, ignoring recent advances in the incorporation of personalized treatment strategies for other illnesses. We may have reached the limits of one‐size‐fits‐all treatment strategies for hospitalized adults with community‐acquired pneumonia. To improve outcomes further, we need to understand the heterogeneity of the disorder and tailor therapies at an individual level. Rapid point‐of‐care tests for pathogens and host response offer the most promising approach toward this strategy.

It is notable that the majority of studies focus on in‐hospital mortality, even though the impact of steroid therapy may be observed over a longer period of follow‐up. Moreover, although mortality is clearly a relevant outcome, it is not the only patient‐centered outcome of importance. However, other outcomes that are typically assessed, such as length of hospitalization and cost, are not patient‐centered outcomes. These are process measures that reflect physician judgment as much as any patient response to treatment. We need to move the field forward by embracing patient outcomes beyond mortality to optimally evaluate new treatment strategies, particularly because the majority of patients will survive hospitalization for the illness. These outcomes would include time to resolution of major symptoms, such as cough and fatigue, and functional outcomes, including return to work and usual activities. Future comparative efficacy and effectiveness studies in pneumonia need to consider a much wider range of true patient outcomes.[7]

It is increasingly fashionable to adopt cross‐disease approaches toward optimizing patient care, particularly in the hospital. Important initiatives that aim to reduce hospital injuries and improve transitions of care are relatively agnostic to specific disease states. Much of the research agenda of hospital medicine avoids a disease‐specific focus, assuming such disease‐specific approaches are the domain of specialists. Yet, it is worth remembering that much of the progress for medical care can be traced to traditional considerations of disease pathophysiology and empirical studies of risk factors and treatments for specific disease. Hospitalists remain at the front line in dealing with most of the common illnesses that afflict patients. Battling those conditions 1 at a time should be an important component of the broader hospitalist research agenda. One hundred years after Osler charged the medical community to identify new strategies for treating an old enemy, we are still struggling to win the battle.

Disclosure

This work was supported in part by K24‐AI073957 (JPM) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The author has no conflicts of interest to report.

Files
References
  1. Osler W. The Principles and Practices of Medicine. 7th ed. New York, London: D. Appleton and Co.; 1909.
  2. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759776.
  3. Corrales‐Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009;88(3):154159.
  4. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):16551663.
  5. Shafiq M, Mansoor M, Khan A, Sohail M, Murad M. Adjuvant steroid therapy in community‐acquired pneumonia: a systematic review and meta‐analysis. J Hosp Med. 2013.
  6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27S72.
  7. Powers JH. Reassessing the design, conduct, and analysis of clinical trials of therapy for community‐acquired pneumonia. Clin Infect Dis. 2008;46(8):11521156.
Article PDF
Issue
Journal of Hospital Medicine - 8(2)
Page Number
59-60
Sections
Files
Files
Article PDF
Article PDF

In the early part of the 20th century, pneumonia was a leading causes of death, particularly among older adults, for whom Osler termed it the Captain of the Men of Death.[1] Mortality rates from severe (bacteremic) pneumonia were typically 80% to 90%, and the introduction of antibacterial therapy in the 1940s reduced that mortality to 10% to 20%. However, as pointed out by Austrian and Gold in a landmark paper in the 1950s, mortality for patients dying within the first 4 to 5 days was not reduced in the postantibiotic era.[2] The survival rates for patients with severe community‐acquired pneumonia minimally improved over the ensuing 50 years, despite the introduction of numerous new antimicrobial drugs and other medical interventions.

One promising area for therapeutic intervention relates to the potential adverse effects of the host inflammatory response in the setting of pneumonia. A growing body of literature supports the conclusion that the window of optimal host response may be relatively narrow. Too little response and patients quickly succumb to overwhelming sepsis. Too much response and a patient's hyperactivated inflammatory system can set off a cascade of secondary events, triggering events such as acute lung injury or ischemic heart disease.[3] Studies have also established that the level of inflammation, as measured by biomarkers such as C‐reactive protein, tumor necrosis factor, and interleukins, can identify patients at increased risk of adverse outcomes.[4] Thus, it is logical to ask whether immune modulating therapies can improve outcomes for these patients.

In this issue of the Journal of Hospital Medicine, Shafiq and colleagues completed a systematic review and meta‐analysis of corticosteroid therapy for patients with pneumonia.[5] Updating prior reviews, they included 8 randomized controlled trials, all of which consisted of low‐dose, systemic, steroid therapy as the intervention and standard care as the control arm. The overall quality of the included studies was judged moderate, and the overall size of the pooled data was only 1119 patients. In their analysis, adjunctive steroid therapy did not reduce in‐hospital mortality, with 4 studies demonstrating effect sizes suggesting benefit, 3 studies demonstrating no benefit or harm, and 1 study favoring the nonsteroid arm. In these situations with grossly heterogeneous study results, it seems prudent to avoid overly interpreting pooled results, even if statistical tests for heterogeneity are nonsignificant. The investigators also reported a range of secondary outcomes, noting that hospital length of stay was significantly reduced in the pooled steroid treated arms.

The overall negative finding is clearly disappointing at a time when clinicians are looking for new treatments to improve outcomes for these patients. Pneumonia is a heterogeneous disorder, representing a wide range of microbial pathogens and underlying host risk factors. Current treatment guidelines for patients with community‐acquired pneumonia are largely empirical and do not focus on pathogen identification, host risk factor analysis, or biomarker distributions to select antimicrobial therapy.[6] In this regard, despite being 1 of the oldest conditions for which we have published guidelines for treatment, the treatment approach for pneumonia remains quite antiquated, ignoring recent advances in the incorporation of personalized treatment strategies for other illnesses. We may have reached the limits of one‐size‐fits‐all treatment strategies for hospitalized adults with community‐acquired pneumonia. To improve outcomes further, we need to understand the heterogeneity of the disorder and tailor therapies at an individual level. Rapid point‐of‐care tests for pathogens and host response offer the most promising approach toward this strategy.

It is notable that the majority of studies focus on in‐hospital mortality, even though the impact of steroid therapy may be observed over a longer period of follow‐up. Moreover, although mortality is clearly a relevant outcome, it is not the only patient‐centered outcome of importance. However, other outcomes that are typically assessed, such as length of hospitalization and cost, are not patient‐centered outcomes. These are process measures that reflect physician judgment as much as any patient response to treatment. We need to move the field forward by embracing patient outcomes beyond mortality to optimally evaluate new treatment strategies, particularly because the majority of patients will survive hospitalization for the illness. These outcomes would include time to resolution of major symptoms, such as cough and fatigue, and functional outcomes, including return to work and usual activities. Future comparative efficacy and effectiveness studies in pneumonia need to consider a much wider range of true patient outcomes.[7]

It is increasingly fashionable to adopt cross‐disease approaches toward optimizing patient care, particularly in the hospital. Important initiatives that aim to reduce hospital injuries and improve transitions of care are relatively agnostic to specific disease states. Much of the research agenda of hospital medicine avoids a disease‐specific focus, assuming such disease‐specific approaches are the domain of specialists. Yet, it is worth remembering that much of the progress for medical care can be traced to traditional considerations of disease pathophysiology and empirical studies of risk factors and treatments for specific disease. Hospitalists remain at the front line in dealing with most of the common illnesses that afflict patients. Battling those conditions 1 at a time should be an important component of the broader hospitalist research agenda. One hundred years after Osler charged the medical community to identify new strategies for treating an old enemy, we are still struggling to win the battle.

Disclosure

This work was supported in part by K24‐AI073957 (JPM) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The author has no conflicts of interest to report.

In the early part of the 20th century, pneumonia was a leading causes of death, particularly among older adults, for whom Osler termed it the Captain of the Men of Death.[1] Mortality rates from severe (bacteremic) pneumonia were typically 80% to 90%, and the introduction of antibacterial therapy in the 1940s reduced that mortality to 10% to 20%. However, as pointed out by Austrian and Gold in a landmark paper in the 1950s, mortality for patients dying within the first 4 to 5 days was not reduced in the postantibiotic era.[2] The survival rates for patients with severe community‐acquired pneumonia minimally improved over the ensuing 50 years, despite the introduction of numerous new antimicrobial drugs and other medical interventions.

One promising area for therapeutic intervention relates to the potential adverse effects of the host inflammatory response in the setting of pneumonia. A growing body of literature supports the conclusion that the window of optimal host response may be relatively narrow. Too little response and patients quickly succumb to overwhelming sepsis. Too much response and a patient's hyperactivated inflammatory system can set off a cascade of secondary events, triggering events such as acute lung injury or ischemic heart disease.[3] Studies have also established that the level of inflammation, as measured by biomarkers such as C‐reactive protein, tumor necrosis factor, and interleukins, can identify patients at increased risk of adverse outcomes.[4] Thus, it is logical to ask whether immune modulating therapies can improve outcomes for these patients.

In this issue of the Journal of Hospital Medicine, Shafiq and colleagues completed a systematic review and meta‐analysis of corticosteroid therapy for patients with pneumonia.[5] Updating prior reviews, they included 8 randomized controlled trials, all of which consisted of low‐dose, systemic, steroid therapy as the intervention and standard care as the control arm. The overall quality of the included studies was judged moderate, and the overall size of the pooled data was only 1119 patients. In their analysis, adjunctive steroid therapy did not reduce in‐hospital mortality, with 4 studies demonstrating effect sizes suggesting benefit, 3 studies demonstrating no benefit or harm, and 1 study favoring the nonsteroid arm. In these situations with grossly heterogeneous study results, it seems prudent to avoid overly interpreting pooled results, even if statistical tests for heterogeneity are nonsignificant. The investigators also reported a range of secondary outcomes, noting that hospital length of stay was significantly reduced in the pooled steroid treated arms.

The overall negative finding is clearly disappointing at a time when clinicians are looking for new treatments to improve outcomes for these patients. Pneumonia is a heterogeneous disorder, representing a wide range of microbial pathogens and underlying host risk factors. Current treatment guidelines for patients with community‐acquired pneumonia are largely empirical and do not focus on pathogen identification, host risk factor analysis, or biomarker distributions to select antimicrobial therapy.[6] In this regard, despite being 1 of the oldest conditions for which we have published guidelines for treatment, the treatment approach for pneumonia remains quite antiquated, ignoring recent advances in the incorporation of personalized treatment strategies for other illnesses. We may have reached the limits of one‐size‐fits‐all treatment strategies for hospitalized adults with community‐acquired pneumonia. To improve outcomes further, we need to understand the heterogeneity of the disorder and tailor therapies at an individual level. Rapid point‐of‐care tests for pathogens and host response offer the most promising approach toward this strategy.

It is notable that the majority of studies focus on in‐hospital mortality, even though the impact of steroid therapy may be observed over a longer period of follow‐up. Moreover, although mortality is clearly a relevant outcome, it is not the only patient‐centered outcome of importance. However, other outcomes that are typically assessed, such as length of hospitalization and cost, are not patient‐centered outcomes. These are process measures that reflect physician judgment as much as any patient response to treatment. We need to move the field forward by embracing patient outcomes beyond mortality to optimally evaluate new treatment strategies, particularly because the majority of patients will survive hospitalization for the illness. These outcomes would include time to resolution of major symptoms, such as cough and fatigue, and functional outcomes, including return to work and usual activities. Future comparative efficacy and effectiveness studies in pneumonia need to consider a much wider range of true patient outcomes.[7]

It is increasingly fashionable to adopt cross‐disease approaches toward optimizing patient care, particularly in the hospital. Important initiatives that aim to reduce hospital injuries and improve transitions of care are relatively agnostic to specific disease states. Much of the research agenda of hospital medicine avoids a disease‐specific focus, assuming such disease‐specific approaches are the domain of specialists. Yet, it is worth remembering that much of the progress for medical care can be traced to traditional considerations of disease pathophysiology and empirical studies of risk factors and treatments for specific disease. Hospitalists remain at the front line in dealing with most of the common illnesses that afflict patients. Battling those conditions 1 at a time should be an important component of the broader hospitalist research agenda. One hundred years after Osler charged the medical community to identify new strategies for treating an old enemy, we are still struggling to win the battle.

Disclosure

This work was supported in part by K24‐AI073957 (JPM) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The author has no conflicts of interest to report.

References
  1. Osler W. The Principles and Practices of Medicine. 7th ed. New York, London: D. Appleton and Co.; 1909.
  2. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759776.
  3. Corrales‐Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009;88(3):154159.
  4. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):16551663.
  5. Shafiq M, Mansoor M, Khan A, Sohail M, Murad M. Adjuvant steroid therapy in community‐acquired pneumonia: a systematic review and meta‐analysis. J Hosp Med. 2013.
  6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27S72.
  7. Powers JH. Reassessing the design, conduct, and analysis of clinical trials of therapy for community‐acquired pneumonia. Clin Infect Dis. 2008;46(8):11521156.
References
  1. Osler W. The Principles and Practices of Medicine. 7th ed. New York, London: D. Appleton and Co.; 1909.
  2. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759776.
  3. Corrales‐Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009;88(3):154159.
  4. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):16551663.
  5. Shafiq M, Mansoor M, Khan A, Sohail M, Murad M. Adjuvant steroid therapy in community‐acquired pneumonia: a systematic review and meta‐analysis. J Hosp Med. 2013.
  6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27S72.
  7. Powers JH. Reassessing the design, conduct, and analysis of clinical trials of therapy for community‐acquired pneumonia. Clin Infect Dis. 2008;46(8):11521156.
Issue
Journal of Hospital Medicine - 8(2)
Issue
Journal of Hospital Medicine - 8(2)
Page Number
59-60
Page Number
59-60
Article Type
Display Headline
Looking for new strategies to combat an old foe
Display Headline
Looking for new strategies to combat an old foe
Sections
Article Source
Copyright © 2012 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Joshua P. Metlay, MD, PhD, Perelman School of Medicine, University of Pennsylvania, 1232 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104; Telephone: 215‐898‐1484; Fax: 215‐573‐0198; E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media
Media Files